STUDYID,DOMAIN,USUBJID,QSSEQ,QSTESTCD,QSTEST,QSCAT,QSSCAT,QSORRES,QSSTRESC,QSSTRESN,QSSTAT,QSREASND,QSBLFL,VISITNUM,VISIT,QSDTC,QSDY
STUDY001,QS,STUDY001-SUBJ0001,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0001,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0001,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0001,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0001,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0001,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0001,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0001,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0001,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0001,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0001,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,36,36,36.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0001,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0001,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0001,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0001,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0001,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,NOT DONE,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0001,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0001,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0001,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0001,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0001,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0001,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,55,55,55.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0001,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0001,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0001,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0001,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0001,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0001,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0001,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0001,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0001,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0001,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0001,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,64,64,64.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0001,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0001,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0001,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0001,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0001,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0001,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0001,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0001,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0001,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0001,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0001,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,87,87,87.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0001,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0001,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0001,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0001,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0001,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0001,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0001,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0001,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0001,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0001,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0001,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0002,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-03-06,1
STUDY001,QS,STUDY001-SUBJ0002,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-03-06,1
STUDY001,QS,STUDY001-SUBJ0002,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-03-06,1
STUDY001,QS,STUDY001-SUBJ0002,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-03-06,1
STUDY001,QS,STUDY001-SUBJ0002,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-03-06,1
STUDY001,QS,STUDY001-SUBJ0002,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-03-06,1
STUDY001,QS,STUDY001-SUBJ0002,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-03-06,1
STUDY001,QS,STUDY001-SUBJ0002,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-03-06,1
STUDY001,QS,STUDY001-SUBJ0002,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-03-06,1
STUDY001,QS,STUDY001-SUBJ0002,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-03-06,1
STUDY001,QS,STUDY001-SUBJ0002,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,33,33,33.0,,,Y,1,BASELINE,2025-03-06,1
STUDY001,QS,STUDY001-SUBJ0002,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-04-02,28
STUDY001,QS,STUDY001-SUBJ0002,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-04-02,28
STUDY001,QS,STUDY001-SUBJ0002,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-04-02,28
STUDY001,QS,STUDY001-SUBJ0002,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-04-02,28
STUDY001,QS,STUDY001-SUBJ0002,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-04-02,28
STUDY001,QS,STUDY001-SUBJ0002,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-04-02,28
STUDY001,QS,STUDY001-SUBJ0002,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-04-02,28
STUDY001,QS,STUDY001-SUBJ0002,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-04-02,28
STUDY001,QS,STUDY001-SUBJ0002,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-04-02,28
STUDY001,QS,STUDY001-SUBJ0002,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-04-02,28
STUDY001,QS,STUDY001-SUBJ0002,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,64,64,64.0,,,,2,WEEK 4,2025-04-02,28
STUDY001,QS,STUDY001-SUBJ0002,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-04-30,56
STUDY001,QS,STUDY001-SUBJ0002,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-30,56
STUDY001,QS,STUDY001-SUBJ0002,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-30,56
STUDY001,QS,STUDY001-SUBJ0002,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-30,56
STUDY001,QS,STUDY001-SUBJ0002,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-30,56
STUDY001,QS,STUDY001-SUBJ0002,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-28,84
STUDY001,QS,STUDY001-SUBJ0002,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-05-28,84
STUDY001,QS,STUDY001-SUBJ0002,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-28,84
STUDY001,QS,STUDY001-SUBJ0002,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-28,84
STUDY001,QS,STUDY001-SUBJ0002,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-28,84
STUDY001,QS,STUDY001-SUBJ0002,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-28,84
STUDY001,QS,STUDY001-SUBJ0002,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-05-28,84
STUDY001,QS,STUDY001-SUBJ0002,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-28,84
STUDY001,QS,STUDY001-SUBJ0002,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-05-28,84
STUDY001,QS,STUDY001-SUBJ0002,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-28,84
STUDY001,QS,STUDY001-SUBJ0002,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,86,86,86.0,,,,4,WEEK 12,2025-05-28,84
STUDY001,QS,STUDY001-SUBJ0002,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-23,140
STUDY001,QS,STUDY001-SUBJ0002,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-07-23,140
STUDY001,QS,STUDY001-SUBJ0002,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-23,140
STUDY001,QS,STUDY001-SUBJ0002,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-23,140
STUDY001,QS,STUDY001-SUBJ0002,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-23,140
STUDY001,QS,STUDY001-SUBJ0002,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-23,140
STUDY001,QS,STUDY001-SUBJ0002,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-07-23,140
STUDY001,QS,STUDY001-SUBJ0002,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-23,140
STUDY001,QS,STUDY001-SUBJ0002,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-07-23,140
STUDY001,QS,STUDY001-SUBJ0002,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-23,140
STUDY001,QS,STUDY001-SUBJ0002,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-07-23,140
STUDY001,QS,STUDY001-SUBJ0003,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-08,1
STUDY001,QS,STUDY001-SUBJ0003,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-04-08,1
STUDY001,QS,STUDY001-SUBJ0003,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-08,1
STUDY001,QS,STUDY001-SUBJ0003,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-08,1
STUDY001,QS,STUDY001-SUBJ0003,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-08,1
STUDY001,QS,STUDY001-SUBJ0003,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-08,1
STUDY001,QS,STUDY001-SUBJ0003,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-04-08,1
STUDY001,QS,STUDY001-SUBJ0003,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-08,1
STUDY001,QS,STUDY001-SUBJ0003,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-04-08,1
STUDY001,QS,STUDY001-SUBJ0003,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-08,1
STUDY001,QS,STUDY001-SUBJ0003,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,41,41,41.0,,,Y,1,BASELINE,2025-04-08,1
STUDY001,QS,STUDY001-SUBJ0003,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-05,28
STUDY001,QS,STUDY001-SUBJ0003,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-05-05,28
STUDY001,QS,STUDY001-SUBJ0003,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-05,28
STUDY001,QS,STUDY001-SUBJ0003,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,2,WEEK 4,2025-05-05,28
STUDY001,QS,STUDY001-SUBJ0003,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-05,28
STUDY001,QS,STUDY001-SUBJ0003,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-05,28
STUDY001,QS,STUDY001-SUBJ0003,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-05-05,28
STUDY001,QS,STUDY001-SUBJ0003,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-05,28
STUDY001,QS,STUDY001-SUBJ0003,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-05-05,28
STUDY001,QS,STUDY001-SUBJ0003,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-05,28
STUDY001,QS,STUDY001-SUBJ0003,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,57,57,57.0,,,,2,WEEK 4,2025-05-05,28
STUDY001,QS,STUDY001-SUBJ0003,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-02,56
STUDY001,QS,STUDY001-SUBJ0003,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-06-02,56
STUDY001,QS,STUDY001-SUBJ0003,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-02,56
STUDY001,QS,STUDY001-SUBJ0003,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-02,56
STUDY001,QS,STUDY001-SUBJ0003,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-02,56
STUDY001,QS,STUDY001-SUBJ0003,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-02,56
STUDY001,QS,STUDY001-SUBJ0003,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-06-02,56
STUDY001,QS,STUDY001-SUBJ0003,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-02,56
STUDY001,QS,STUDY001-SUBJ0003,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-06-02,56
STUDY001,QS,STUDY001-SUBJ0003,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-02,56
STUDY001,QS,STUDY001-SUBJ0003,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,72,72,72.0,,,,3,WEEK 8,2025-06-02,56
STUDY001,QS,STUDY001-SUBJ0003,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-06-30,84
STUDY001,QS,STUDY001-SUBJ0003,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-30,84
STUDY001,QS,STUDY001-SUBJ0003,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-30,84
STUDY001,QS,STUDY001-SUBJ0003,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-30,84
STUDY001,QS,STUDY001-SUBJ0003,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-30,84
STUDY001,QS,STUDY001-SUBJ0003,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-25,140
STUDY001,QS,STUDY001-SUBJ0003,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-08-25,140
STUDY001,QS,STUDY001-SUBJ0003,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-25,140
STUDY001,QS,STUDY001-SUBJ0003,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,5,END OF TREATMENT,2025-08-25,140
STUDY001,QS,STUDY001-SUBJ0003,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-25,140
STUDY001,QS,STUDY001-SUBJ0003,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-25,140
STUDY001,QS,STUDY001-SUBJ0003,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-08-25,140
STUDY001,QS,STUDY001-SUBJ0003,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-25,140
STUDY001,QS,STUDY001-SUBJ0003,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-08-25,140
STUDY001,QS,STUDY001-SUBJ0003,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-25,140
STUDY001,QS,STUDY001-SUBJ0003,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-08-25,140
STUDY001,QS,STUDY001-SUBJ0004,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0004,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0004,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0004,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0004,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0004,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0004,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0004,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0004,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0004,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0004,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,55,55,55.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0004,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0004,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0004,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0004,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0004,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0004,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0004,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0004,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0004,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0004,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0004,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,61,61,61.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0004,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0004,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0004,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0004,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0004,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0004,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0004,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0004,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0004,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0004,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0004,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,74,74,74.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0004,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0004,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0004,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0004,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0004,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0004,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0004,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0004,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0004,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0004,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0004,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0004,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0004,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0004,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0004,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0004,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0004,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0004,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0004,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0004,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0004,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0004,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0005,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-12-06,1
STUDY001,QS,STUDY001-SUBJ0005,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-12-06,1
STUDY001,QS,STUDY001-SUBJ0005,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-12-06,1
STUDY001,QS,STUDY001-SUBJ0005,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-12-06,1
STUDY001,QS,STUDY001-SUBJ0005,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-12-06,1
STUDY001,QS,STUDY001-SUBJ0006,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-06-18,1
STUDY001,QS,STUDY001-SUBJ0006,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-06-18,1
STUDY001,QS,STUDY001-SUBJ0006,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-06-18,1
STUDY001,QS,STUDY001-SUBJ0006,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-18,1
STUDY001,QS,STUDY001-SUBJ0006,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-06-18,1
STUDY001,QS,STUDY001-SUBJ0006,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-18,1
STUDY001,QS,STUDY001-SUBJ0006,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-06-18,1
STUDY001,QS,STUDY001-SUBJ0006,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-18,1
STUDY001,QS,STUDY001-SUBJ0006,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-06-18,1
STUDY001,QS,STUDY001-SUBJ0006,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-18,1
STUDY001,QS,STUDY001-SUBJ0006,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,67,67,67.0,NOT DONE,,Y,1,BASELINE,2025-06-18,1
STUDY001,QS,STUDY001-SUBJ0006,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-07-15,28
STUDY001,QS,STUDY001-SUBJ0006,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-15,28
STUDY001,QS,STUDY001-SUBJ0006,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-07-15,28
STUDY001,QS,STUDY001-SUBJ0006,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-15,28
STUDY001,QS,STUDY001-SUBJ0006,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-15,28
STUDY001,QS,STUDY001-SUBJ0006,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-12,56
STUDY001,QS,STUDY001-SUBJ0006,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-08-12,56
STUDY001,QS,STUDY001-SUBJ0006,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-12,56
STUDY001,QS,STUDY001-SUBJ0006,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-08-12,56
STUDY001,QS,STUDY001-SUBJ0006,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-12,56
STUDY001,QS,STUDY001-SUBJ0006,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-08-12,56
STUDY001,QS,STUDY001-SUBJ0006,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-08-12,56
STUDY001,QS,STUDY001-SUBJ0006,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-08-12,56
STUDY001,QS,STUDY001-SUBJ0006,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-08-12,56
STUDY001,QS,STUDY001-SUBJ0006,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-08-12,56
STUDY001,QS,STUDY001-SUBJ0006,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,68,68,68.0,,,,3,WEEK 8,2025-08-12,56
STUDY001,QS,STUDY001-SUBJ0006,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-09,84
STUDY001,QS,STUDY001-SUBJ0006,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-09-09,84
STUDY001,QS,STUDY001-SUBJ0006,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-09,84
STUDY001,QS,STUDY001-SUBJ0006,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-09,84
STUDY001,QS,STUDY001-SUBJ0006,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-09,84
STUDY001,QS,STUDY001-SUBJ0006,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-09,84
STUDY001,QS,STUDY001-SUBJ0006,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-09-09,84
STUDY001,QS,STUDY001-SUBJ0006,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-09,84
STUDY001,QS,STUDY001-SUBJ0006,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-09-09,84
STUDY001,QS,STUDY001-SUBJ0006,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-09,84
STUDY001,QS,STUDY001-SUBJ0006,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,85,85,85.0,,,,4,WEEK 12,2025-09-09,84
STUDY001,QS,STUDY001-SUBJ0006,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-04,140
STUDY001,QS,STUDY001-SUBJ0006,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-11-04,140
STUDY001,QS,STUDY001-SUBJ0006,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-04,140
STUDY001,QS,STUDY001-SUBJ0006,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-04,140
STUDY001,QS,STUDY001-SUBJ0006,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-04,140
STUDY001,QS,STUDY001-SUBJ0006,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-04,140
STUDY001,QS,STUDY001-SUBJ0006,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-11-04,140
STUDY001,QS,STUDY001-SUBJ0006,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-04,140
STUDY001,QS,STUDY001-SUBJ0006,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,NOT DONE,,,5,END OF TREATMENT,2025-11-04,140
STUDY001,QS,STUDY001-SUBJ0006,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-04,140
STUDY001,QS,STUDY001-SUBJ0006,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-11-04,140
STUDY001,QS,STUDY001-SUBJ0007,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0007,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0007,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0007,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0007,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,NOT DONE,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0007,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,33,33,33.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0007,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-11-20,28
STUDY001,QS,STUDY001-SUBJ0007,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-20,28
STUDY001,QS,STUDY001-SUBJ0007,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-20,28
STUDY001,QS,STUDY001-SUBJ0007,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-20,28
STUDY001,QS,STUDY001-SUBJ0007,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-20,28
STUDY001,QS,STUDY001-SUBJ0008,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-08-03,1
STUDY001,QS,STUDY001-SUBJ0008,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-08-03,1
STUDY001,QS,STUDY001-SUBJ0008,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-08-03,1
STUDY001,QS,STUDY001-SUBJ0008,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-08-03,1
STUDY001,QS,STUDY001-SUBJ0008,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-08-03,1
STUDY001,QS,STUDY001-SUBJ0008,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,2,WEEK 4,2025-08-30,28
STUDY001,QS,STUDY001-SUBJ0008,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-08-30,28
STUDY001,QS,STUDY001-SUBJ0008,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-08-30,28
STUDY001,QS,STUDY001-SUBJ0008,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-30,28
STUDY001,QS,STUDY001-SUBJ0008,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-08-30,28
STUDY001,QS,STUDY001-SUBJ0008,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-30,28
STUDY001,QS,STUDY001-SUBJ0008,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-08-30,28
STUDY001,QS,STUDY001-SUBJ0008,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-30,28
STUDY001,QS,STUDY001-SUBJ0008,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-08-30,28
STUDY001,QS,STUDY001-SUBJ0008,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-30,28
STUDY001,QS,STUDY001-SUBJ0008,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,60,60,60.0,,,,2,WEEK 4,2025-08-30,28
STUDY001,QS,STUDY001-SUBJ0008,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-27,56
STUDY001,QS,STUDY001-SUBJ0008,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-09-27,56
STUDY001,QS,STUDY001-SUBJ0008,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-27,56
STUDY001,QS,STUDY001-SUBJ0008,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-27,56
STUDY001,QS,STUDY001-SUBJ0008,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-27,56
STUDY001,QS,STUDY001-SUBJ0008,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-27,56
STUDY001,QS,STUDY001-SUBJ0008,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-09-27,56
STUDY001,QS,STUDY001-SUBJ0008,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-27,56
STUDY001,QS,STUDY001-SUBJ0008,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-09-27,56
STUDY001,QS,STUDY001-SUBJ0008,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-27,56
STUDY001,QS,STUDY001-SUBJ0008,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,72,72,72.0,,,,3,WEEK 8,2025-09-27,56
STUDY001,QS,STUDY001-SUBJ0008,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-25,84
STUDY001,QS,STUDY001-SUBJ0008,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-10-25,84
STUDY001,QS,STUDY001-SUBJ0008,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-25,84
STUDY001,QS,STUDY001-SUBJ0008,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-25,84
STUDY001,QS,STUDY001-SUBJ0008,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-25,84
STUDY001,QS,STUDY001-SUBJ0008,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-25,84
STUDY001,QS,STUDY001-SUBJ0008,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-10-25,84
STUDY001,QS,STUDY001-SUBJ0008,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-25,84
STUDY001,QS,STUDY001-SUBJ0008,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-10-25,84
STUDY001,QS,STUDY001-SUBJ0008,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-25,84
STUDY001,QS,STUDY001-SUBJ0008,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-10-25,84
STUDY001,QS,STUDY001-SUBJ0008,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-20,140
STUDY001,QS,STUDY001-SUBJ0008,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,NOT DONE,,,5,END OF TREATMENT,2025-12-20,140
STUDY001,QS,STUDY001-SUBJ0008,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-20,140
STUDY001,QS,STUDY001-SUBJ0008,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-20,140
STUDY001,QS,STUDY001-SUBJ0008,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-20,140
STUDY001,QS,STUDY001-SUBJ0008,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-20,140
STUDY001,QS,STUDY001-SUBJ0008,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-12-20,140
STUDY001,QS,STUDY001-SUBJ0008,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-20,140
STUDY001,QS,STUDY001-SUBJ0008,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-12-20,140
STUDY001,QS,STUDY001-SUBJ0008,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-20,140
STUDY001,QS,STUDY001-SUBJ0008,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-12-20,140
STUDY001,QS,STUDY001-SUBJ0009,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0009,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0009,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0009,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0009,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0009,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0009,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0009,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0009,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0009,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0009,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,35,35,35.0,,,Y,1,BASELINE,2025-07-18,1
STUDY001,QS,STUDY001-SUBJ0009,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0009,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0009,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,NOT DONE,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0009,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0009,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0009,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0009,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0009,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0009,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0009,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0009,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,55,55,55.0,,,,2,WEEK 4,2025-08-14,28
STUDY001,QS,STUDY001-SUBJ0009,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0009,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0009,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0009,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0009,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0009,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0009,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0009,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0009,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0009,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0009,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,72,72,72.0,,,,3,WEEK 8,2025-09-11,56
STUDY001,QS,STUDY001-SUBJ0009,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0009,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0009,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0009,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0009,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0009,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0009,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0009,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0009,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0009,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0009,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-10-09,84
STUDY001,QS,STUDY001-SUBJ0009,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0009,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0009,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0009,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0009,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0009,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0009,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0009,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0009,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0009,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0009,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-12-04,140
STUDY001,QS,STUDY001-SUBJ0010,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-17,1
STUDY001,QS,STUDY001-SUBJ0010,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-10-17,1
STUDY001,QS,STUDY001-SUBJ0010,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-17,1
STUDY001,QS,STUDY001-SUBJ0010,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-10-17,1
STUDY001,QS,STUDY001-SUBJ0010,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-17,1
STUDY001,QS,STUDY001-SUBJ0010,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-10-17,1
STUDY001,QS,STUDY001-SUBJ0010,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-10-17,1
STUDY001,QS,STUDY001-SUBJ0010,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-10-17,1
STUDY001,QS,STUDY001-SUBJ0010,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-10-17,1
STUDY001,QS,STUDY001-SUBJ0010,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-10-17,1
STUDY001,QS,STUDY001-SUBJ0010,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,40,40,40.0,NOT DONE,,Y,1,BASELINE,2025-10-17,1
STUDY001,QS,STUDY001-SUBJ0010,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-13,28
STUDY001,QS,STUDY001-SUBJ0010,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-11-13,28
STUDY001,QS,STUDY001-SUBJ0010,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-13,28
STUDY001,QS,STUDY001-SUBJ0010,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-13,28
STUDY001,QS,STUDY001-SUBJ0010,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-13,28
STUDY001,QS,STUDY001-SUBJ0010,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-13,28
STUDY001,QS,STUDY001-SUBJ0010,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-11-13,28
STUDY001,QS,STUDY001-SUBJ0010,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-13,28
STUDY001,QS,STUDY001-SUBJ0010,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-11-13,28
STUDY001,QS,STUDY001-SUBJ0010,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-13,28
STUDY001,QS,STUDY001-SUBJ0010,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,59,59,59.0,,,,2,WEEK 4,2025-11-13,28
STUDY001,QS,STUDY001-SUBJ0010,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-11,56
STUDY001,QS,STUDY001-SUBJ0010,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-12-11,56
STUDY001,QS,STUDY001-SUBJ0010,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-11,56
STUDY001,QS,STUDY001-SUBJ0010,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-11,56
STUDY001,QS,STUDY001-SUBJ0010,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-11,56
STUDY001,QS,STUDY001-SUBJ0010,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-11,56
STUDY001,QS,STUDY001-SUBJ0010,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-12-11,56
STUDY001,QS,STUDY001-SUBJ0010,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-11,56
STUDY001,QS,STUDY001-SUBJ0010,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-12-11,56
STUDY001,QS,STUDY001-SUBJ0010,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-11,56
STUDY001,QS,STUDY001-SUBJ0010,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,66,66,66.0,,,,3,WEEK 8,2025-12-11,56
STUDY001,QS,STUDY001-SUBJ0011,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-03-17,1
STUDY001,QS,STUDY001-SUBJ0011,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,NOT DONE,,Y,1,BASELINE,2025-03-17,1
STUDY001,QS,STUDY001-SUBJ0011,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-03-17,1
STUDY001,QS,STUDY001-SUBJ0011,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-03-17,1
STUDY001,QS,STUDY001-SUBJ0011,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-03-17,1
STUDY001,QS,STUDY001-SUBJ0011,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-03-17,1
STUDY001,QS,STUDY001-SUBJ0011,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-03-17,1
STUDY001,QS,STUDY001-SUBJ0011,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-03-17,1
STUDY001,QS,STUDY001-SUBJ0011,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-03-17,1
STUDY001,QS,STUDY001-SUBJ0011,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-03-17,1
STUDY001,QS,STUDY001-SUBJ0011,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,40,40,40.0,,,Y,1,BASELINE,2025-03-17,1
STUDY001,QS,STUDY001-SUBJ0011,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,NOT DONE,,,2,WEEK 4,2025-04-13,28
STUDY001,QS,STUDY001-SUBJ0011,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-04-13,28
STUDY001,QS,STUDY001-SUBJ0011,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-04-13,28
STUDY001,QS,STUDY001-SUBJ0011,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-04-13,28
STUDY001,QS,STUDY001-SUBJ0011,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-04-13,28
STUDY001,QS,STUDY001-SUBJ0011,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-11,56
STUDY001,QS,STUDY001-SUBJ0011,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-05-11,56
STUDY001,QS,STUDY001-SUBJ0011,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-11,56
STUDY001,QS,STUDY001-SUBJ0011,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-11,56
STUDY001,QS,STUDY001-SUBJ0011,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-11,56
STUDY001,QS,STUDY001-SUBJ0011,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-11,56
STUDY001,QS,STUDY001-SUBJ0011,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-05-11,56
STUDY001,QS,STUDY001-SUBJ0011,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-11,56
STUDY001,QS,STUDY001-SUBJ0011,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-05-11,56
STUDY001,QS,STUDY001-SUBJ0011,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-11,56
STUDY001,QS,STUDY001-SUBJ0011,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,77,77,77.0,,,,3,WEEK 8,2025-05-11,56
STUDY001,QS,STUDY001-SUBJ0011,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-06-08,84
STUDY001,QS,STUDY001-SUBJ0011,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-06-08,84
STUDY001,QS,STUDY001-SUBJ0011,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-06-08,84
STUDY001,QS,STUDY001-SUBJ0011,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-08,84
STUDY001,QS,STUDY001-SUBJ0011,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-06-08,84
STUDY001,QS,STUDY001-SUBJ0011,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-08,84
STUDY001,QS,STUDY001-SUBJ0011,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-06-08,84
STUDY001,QS,STUDY001-SUBJ0011,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-08,84
STUDY001,QS,STUDY001-SUBJ0011,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-06-08,84
STUDY001,QS,STUDY001-SUBJ0011,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-08,84
STUDY001,QS,STUDY001-SUBJ0011,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-06-08,84
STUDY001,QS,STUDY001-SUBJ0011,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-03,140
STUDY001,QS,STUDY001-SUBJ0011,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-08-03,140
STUDY001,QS,STUDY001-SUBJ0011,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-03,140
STUDY001,QS,STUDY001-SUBJ0011,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-03,140
STUDY001,QS,STUDY001-SUBJ0011,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,5,END OF TREATMENT,2025-08-03,140
STUDY001,QS,STUDY001-SUBJ0011,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-03,140
STUDY001,QS,STUDY001-SUBJ0011,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-08-03,140
STUDY001,QS,STUDY001-SUBJ0011,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-03,140
STUDY001,QS,STUDY001-SUBJ0011,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-08-03,140
STUDY001,QS,STUDY001-SUBJ0011,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-03,140
STUDY001,QS,STUDY001-SUBJ0011,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-08-03,140
STUDY001,QS,STUDY001-SUBJ0012,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-20,1
STUDY001,QS,STUDY001-SUBJ0012,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-04-20,1
STUDY001,QS,STUDY001-SUBJ0012,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-20,1
STUDY001,QS,STUDY001-SUBJ0012,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-04-20,1
STUDY001,QS,STUDY001-SUBJ0012,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-20,1
STUDY001,QS,STUDY001-SUBJ0012,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-04-20,1
STUDY001,QS,STUDY001-SUBJ0012,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-04-20,1
STUDY001,QS,STUDY001-SUBJ0012,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-04-20,1
STUDY001,QS,STUDY001-SUBJ0012,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-04-20,1
STUDY001,QS,STUDY001-SUBJ0012,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-04-20,1
STUDY001,QS,STUDY001-SUBJ0012,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,45,45,45.0,,,Y,1,BASELINE,2025-04-20,1
STUDY001,QS,STUDY001-SUBJ0012,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-05-17,28
STUDY001,QS,STUDY001-SUBJ0012,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-17,28
STUDY001,QS,STUDY001-SUBJ0012,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-17,28
STUDY001,QS,STUDY001-SUBJ0012,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-17,28
STUDY001,QS,STUDY001-SUBJ0012,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-17,28
STUDY001,QS,STUDY001-SUBJ0012,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-14,56
STUDY001,QS,STUDY001-SUBJ0012,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-06-14,56
STUDY001,QS,STUDY001-SUBJ0012,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-14,56
STUDY001,QS,STUDY001-SUBJ0012,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-14,56
STUDY001,QS,STUDY001-SUBJ0012,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-14,56
STUDY001,QS,STUDY001-SUBJ0012,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-14,56
STUDY001,QS,STUDY001-SUBJ0012,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-06-14,56
STUDY001,QS,STUDY001-SUBJ0012,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-14,56
STUDY001,QS,STUDY001-SUBJ0012,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-06-14,56
STUDY001,QS,STUDY001-SUBJ0012,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-14,56
STUDY001,QS,STUDY001-SUBJ0012,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,62,62,62.0,,,,3,WEEK 8,2025-06-14,56
STUDY001,QS,STUDY001-SUBJ0012,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-07-12,84
STUDY001,QS,STUDY001-SUBJ0012,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-07-12,84
STUDY001,QS,STUDY001-SUBJ0012,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-07-12,84
STUDY001,QS,STUDY001-SUBJ0012,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-12,84
STUDY001,QS,STUDY001-SUBJ0012,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-07-12,84
STUDY001,QS,STUDY001-SUBJ0012,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-12,84
STUDY001,QS,STUDY001-SUBJ0012,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,NOT DONE,,,4,WEEK 12,2025-07-12,84
STUDY001,QS,STUDY001-SUBJ0012,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-12,84
STUDY001,QS,STUDY001-SUBJ0012,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,4,WEEK 12,2025-07-12,84
STUDY001,QS,STUDY001-SUBJ0012,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-12,84
STUDY001,QS,STUDY001-SUBJ0012,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,79,79,79.0,,,,4,WEEK 12,2025-07-12,84
STUDY001,QS,STUDY001-SUBJ0012,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-06,140
STUDY001,QS,STUDY001-SUBJ0012,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-09-06,140
STUDY001,QS,STUDY001-SUBJ0012,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-06,140
STUDY001,QS,STUDY001-SUBJ0012,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-06,140
STUDY001,QS,STUDY001-SUBJ0012,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-06,140
STUDY001,QS,STUDY001-SUBJ0012,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-06,140
STUDY001,QS,STUDY001-SUBJ0012,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-09-06,140
STUDY001,QS,STUDY001-SUBJ0012,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-06,140
STUDY001,QS,STUDY001-SUBJ0012,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-09-06,140
STUDY001,QS,STUDY001-SUBJ0012,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-06,140
STUDY001,QS,STUDY001-SUBJ0012,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-09-06,140
STUDY001,QS,STUDY001-SUBJ0013,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,Y,1,BASELINE,2025-07-04,1
STUDY001,QS,STUDY001-SUBJ0013,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-07-04,1
STUDY001,QS,STUDY001-SUBJ0013,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-07-04,1
STUDY001,QS,STUDY001-SUBJ0013,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,Y,1,BASELINE,2025-07-04,1
STUDY001,QS,STUDY001-SUBJ0013,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-07-04,1
STUDY001,QS,STUDY001-SUBJ0013,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-07-04,1
STUDY001,QS,STUDY001-SUBJ0013,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-07-04,1
STUDY001,QS,STUDY001-SUBJ0013,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-07-04,1
STUDY001,QS,STUDY001-SUBJ0013,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,NOT DONE,,Y,1,BASELINE,2025-07-04,1
STUDY001,QS,STUDY001-SUBJ0013,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-07-04,1
STUDY001,QS,STUDY001-SUBJ0013,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,60,60,60.0,,,Y,1,BASELINE,2025-07-04,1
STUDY001,QS,STUDY001-SUBJ0013,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-31,28
STUDY001,QS,STUDY001-SUBJ0013,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-07-31,28
STUDY001,QS,STUDY001-SUBJ0013,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-31,28
STUDY001,QS,STUDY001-SUBJ0013,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-07-31,28
STUDY001,QS,STUDY001-SUBJ0013,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-31,28
STUDY001,QS,STUDY001-SUBJ0013,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-31,28
STUDY001,QS,STUDY001-SUBJ0013,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-07-31,28
STUDY001,QS,STUDY001-SUBJ0013,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-31,28
STUDY001,QS,STUDY001-SUBJ0013,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-07-31,28
STUDY001,QS,STUDY001-SUBJ0013,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-31,28
STUDY001,QS,STUDY001-SUBJ0013,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,55,55,55.0,,,,2,WEEK 4,2025-07-31,28
STUDY001,QS,STUDY001-SUBJ0013,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-28,56
STUDY001,QS,STUDY001-SUBJ0013,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-28,56
STUDY001,QS,STUDY001-SUBJ0013,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-28,56
STUDY001,QS,STUDY001-SUBJ0013,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-08-28,56
STUDY001,QS,STUDY001-SUBJ0013,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-08-28,56
STUDY001,QS,STUDY001-SUBJ0013,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,68,68,68.0,,,,3,WEEK 8,2025-08-28,56
STUDY001,QS,STUDY001-SUBJ0013,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-09-25,84
STUDY001,QS,STUDY001-SUBJ0013,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-09-25,84
STUDY001,QS,STUDY001-SUBJ0013,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-09-25,84
STUDY001,QS,STUDY001-SUBJ0013,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-25,84
STUDY001,QS,STUDY001-SUBJ0013,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-09-25,84
STUDY001,QS,STUDY001-SUBJ0013,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-25,84
STUDY001,QS,STUDY001-SUBJ0013,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,4,WEEK 12,2025-09-25,84
STUDY001,QS,STUDY001-SUBJ0013,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-25,84
STUDY001,QS,STUDY001-SUBJ0013,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,4,WEEK 12,2025-09-25,84
STUDY001,QS,STUDY001-SUBJ0013,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-25,84
STUDY001,QS,STUDY001-SUBJ0013,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,76,76,76.0,,,,4,WEEK 12,2025-09-25,84
STUDY001,QS,STUDY001-SUBJ0013,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-20,140
STUDY001,QS,STUDY001-SUBJ0013,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-11-20,140
STUDY001,QS,STUDY001-SUBJ0013,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-20,140
STUDY001,QS,STUDY001-SUBJ0013,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-20,140
STUDY001,QS,STUDY001-SUBJ0013,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-20,140
STUDY001,QS,STUDY001-SUBJ0013,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-20,140
STUDY001,QS,STUDY001-SUBJ0013,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,NOT DONE,,,5,END OF TREATMENT,2025-11-20,140
STUDY001,QS,STUDY001-SUBJ0013,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-20,140
STUDY001,QS,STUDY001-SUBJ0013,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-11-20,140
STUDY001,QS,STUDY001-SUBJ0013,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-20,140
STUDY001,QS,STUDY001-SUBJ0013,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-11-20,140
STUDY001,QS,STUDY001-SUBJ0014,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,NOT DONE,,Y,1,BASELINE,2025-09-20,1
STUDY001,QS,STUDY001-SUBJ0014,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-09-20,1
STUDY001,QS,STUDY001-SUBJ0014,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-09-20,1
STUDY001,QS,STUDY001-SUBJ0014,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-20,1
STUDY001,QS,STUDY001-SUBJ0014,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-09-20,1
STUDY001,QS,STUDY001-SUBJ0014,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-20,1
STUDY001,QS,STUDY001-SUBJ0014,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-09-20,1
STUDY001,QS,STUDY001-SUBJ0014,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-20,1
STUDY001,QS,STUDY001-SUBJ0014,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,NOT DONE,,Y,1,BASELINE,2025-09-20,1
STUDY001,QS,STUDY001-SUBJ0014,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-20,1
STUDY001,QS,STUDY001-SUBJ0014,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,45,45,45.0,,,Y,1,BASELINE,2025-09-20,1
STUDY001,QS,STUDY001-SUBJ0014,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,NOT DONE,,,2,WEEK 4,2025-10-17,28
STUDY001,QS,STUDY001-SUBJ0014,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-10-17,28
STUDY001,QS,STUDY001-SUBJ0014,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-10-17,28
STUDY001,QS,STUDY001-SUBJ0014,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-17,28
STUDY001,QS,STUDY001-SUBJ0014,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-10-17,28
STUDY001,QS,STUDY001-SUBJ0014,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-17,28
STUDY001,QS,STUDY001-SUBJ0014,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-10-17,28
STUDY001,QS,STUDY001-SUBJ0014,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-17,28
STUDY001,QS,STUDY001-SUBJ0014,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-10-17,28
STUDY001,QS,STUDY001-SUBJ0014,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-17,28
STUDY001,QS,STUDY001-SUBJ0014,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,,,,2,WEEK 4,2025-10-17,28
STUDY001,QS,STUDY001-SUBJ0014,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-14,56
STUDY001,QS,STUDY001-SUBJ0014,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-11-14,56
STUDY001,QS,STUDY001-SUBJ0014,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-14,56
STUDY001,QS,STUDY001-SUBJ0014,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-14,56
STUDY001,QS,STUDY001-SUBJ0014,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-14,56
STUDY001,QS,STUDY001-SUBJ0014,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-14,56
STUDY001,QS,STUDY001-SUBJ0014,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-11-14,56
STUDY001,QS,STUDY001-SUBJ0014,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-14,56
STUDY001,QS,STUDY001-SUBJ0014,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,NOT DONE,,,3,WEEK 8,2025-11-14,56
STUDY001,QS,STUDY001-SUBJ0014,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-14,56
STUDY001,QS,STUDY001-SUBJ0014,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,67,67,67.0,,,,3,WEEK 8,2025-11-14,56
STUDY001,QS,STUDY001-SUBJ0014,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-12-12,84
STUDY001,QS,STUDY001-SUBJ0014,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-12-12,84
STUDY001,QS,STUDY001-SUBJ0014,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-12-12,84
STUDY001,QS,STUDY001-SUBJ0014,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-12-12,84
STUDY001,QS,STUDY001-SUBJ0014,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-12-12,84
STUDY001,QS,STUDY001-SUBJ0014,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,88,88,88.0,,,,4,WEEK 12,2025-12-12,84
STUDY001,QS,STUDY001-SUBJ0015,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-11-28,1
STUDY001,QS,STUDY001-SUBJ0015,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,NOT DONE,,Y,1,BASELINE,2025-11-28,1
STUDY001,QS,STUDY001-SUBJ0015,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-11-28,1
STUDY001,QS,STUDY001-SUBJ0015,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-28,1
STUDY001,QS,STUDY001-SUBJ0015,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-11-28,1
STUDY001,QS,STUDY001-SUBJ0015,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-28,1
STUDY001,QS,STUDY001-SUBJ0015,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-11-28,1
STUDY001,QS,STUDY001-SUBJ0015,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-28,1
STUDY001,QS,STUDY001-SUBJ0015,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-11-28,1
STUDY001,QS,STUDY001-SUBJ0015,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-28,1
STUDY001,QS,STUDY001-SUBJ0015,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,65,65,65.0,,,Y,1,BASELINE,2025-11-28,1
STUDY001,QS,STUDY001-SUBJ0015,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-12-25,28
STUDY001,QS,STUDY001-SUBJ0015,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-12-25,28
STUDY001,QS,STUDY001-SUBJ0015,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-12-25,28
STUDY001,QS,STUDY001-SUBJ0015,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-25,28
STUDY001,QS,STUDY001-SUBJ0015,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-12-25,28
STUDY001,QS,STUDY001-SUBJ0015,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-25,28
STUDY001,QS,STUDY001-SUBJ0015,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-12-25,28
STUDY001,QS,STUDY001-SUBJ0015,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-25,28
STUDY001,QS,STUDY001-SUBJ0015,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-12-25,28
STUDY001,QS,STUDY001-SUBJ0015,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-25,28
STUDY001,QS,STUDY001-SUBJ0015,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,55,55,55.0,,,,2,WEEK 4,2025-12-25,28
STUDY001,QS,STUDY001-SUBJ0016,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-08-28,1
STUDY001,QS,STUDY001-SUBJ0016,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-08-28,1
STUDY001,QS,STUDY001-SUBJ0016,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-08-28,1
STUDY001,QS,STUDY001-SUBJ0016,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-08-28,1
STUDY001,QS,STUDY001-SUBJ0016,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-08-28,1
STUDY001,QS,STUDY001-SUBJ0016,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-08-28,1
STUDY001,QS,STUDY001-SUBJ0016,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-08-28,1
STUDY001,QS,STUDY001-SUBJ0016,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-08-28,1
STUDY001,QS,STUDY001-SUBJ0016,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-08-28,1
STUDY001,QS,STUDY001-SUBJ0016,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,Y,1,BASELINE,2025-08-28,1
STUDY001,QS,STUDY001-SUBJ0016,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,30,30,30.0,,,Y,1,BASELINE,2025-08-28,1
STUDY001,QS,STUDY001-SUBJ0016,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-09-24,28
STUDY001,QS,STUDY001-SUBJ0016,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-24,28
STUDY001,QS,STUDY001-SUBJ0016,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-24,28
STUDY001,QS,STUDY001-SUBJ0016,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-24,28
STUDY001,QS,STUDY001-SUBJ0016,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-24,28
STUDY001,QS,STUDY001-SUBJ0016,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-22,56
STUDY001,QS,STUDY001-SUBJ0016,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-10-22,56
STUDY001,QS,STUDY001-SUBJ0016,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-22,56
STUDY001,QS,STUDY001-SUBJ0016,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-10-22,56
STUDY001,QS,STUDY001-SUBJ0016,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-22,56
STUDY001,QS,STUDY001-SUBJ0016,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-10-22,56
STUDY001,QS,STUDY001-SUBJ0016,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,NOT DONE,,,3,WEEK 8,2025-10-22,56
STUDY001,QS,STUDY001-SUBJ0016,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-10-22,56
STUDY001,QS,STUDY001-SUBJ0016,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-10-22,56
STUDY001,QS,STUDY001-SUBJ0016,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-10-22,56
STUDY001,QS,STUDY001-SUBJ0016,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,79,79,79.0,,,,3,WEEK 8,2025-10-22,56
STUDY001,QS,STUDY001-SUBJ0016,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-11-19,84
STUDY001,QS,STUDY001-SUBJ0016,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-11-19,84
STUDY001,QS,STUDY001-SUBJ0016,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-11-19,84
STUDY001,QS,STUDY001-SUBJ0016,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-19,84
STUDY001,QS,STUDY001-SUBJ0016,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-11-19,84
STUDY001,QS,STUDY001-SUBJ0016,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-19,84
STUDY001,QS,STUDY001-SUBJ0016,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-11-19,84
STUDY001,QS,STUDY001-SUBJ0016,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-19,84
STUDY001,QS,STUDY001-SUBJ0016,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-11-19,84
STUDY001,QS,STUDY001-SUBJ0016,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-19,84
STUDY001,QS,STUDY001-SUBJ0016,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-11-19,84
STUDY001,QS,STUDY001-SUBJ0017,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-03-05,1
STUDY001,QS,STUDY001-SUBJ0017,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-03-05,1
STUDY001,QS,STUDY001-SUBJ0017,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-03-05,1
STUDY001,QS,STUDY001-SUBJ0017,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-03-05,1
STUDY001,QS,STUDY001-SUBJ0017,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-03-05,1
STUDY001,QS,STUDY001-SUBJ0017,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-03-05,1
STUDY001,QS,STUDY001-SUBJ0017,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-03-05,1
STUDY001,QS,STUDY001-SUBJ0017,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-03-05,1
STUDY001,QS,STUDY001-SUBJ0017,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-03-05,1
STUDY001,QS,STUDY001-SUBJ0017,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-03-05,1
STUDY001,QS,STUDY001-SUBJ0017,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,66,66,66.0,NOT DONE,,Y,1,BASELINE,2025-03-05,1
STUDY001,QS,STUDY001-SUBJ0017,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-04-01,28
STUDY001,QS,STUDY001-SUBJ0017,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-01,28
STUDY001,QS,STUDY001-SUBJ0017,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-01,28
STUDY001,QS,STUDY001-SUBJ0017,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-01,28
STUDY001,QS,STUDY001-SUBJ0017,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-01,28
STUDY001,QS,STUDY001-SUBJ0017,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-29,56
STUDY001,QS,STUDY001-SUBJ0017,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-04-29,56
STUDY001,QS,STUDY001-SUBJ0017,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-29,56
STUDY001,QS,STUDY001-SUBJ0017,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-29,56
STUDY001,QS,STUDY001-SUBJ0017,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-29,56
STUDY001,QS,STUDY001-SUBJ0017,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-29,56
STUDY001,QS,STUDY001-SUBJ0017,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-04-29,56
STUDY001,QS,STUDY001-SUBJ0017,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,3,WEEK 8,2025-04-29,56
STUDY001,QS,STUDY001-SUBJ0017,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-04-29,56
STUDY001,QS,STUDY001-SUBJ0017,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-29,56
STUDY001,QS,STUDY001-SUBJ0017,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,64,64,64.0,,,,3,WEEK 8,2025-04-29,56
STUDY001,QS,STUDY001-SUBJ0017,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-27,84
STUDY001,QS,STUDY001-SUBJ0017,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-05-27,84
STUDY001,QS,STUDY001-SUBJ0017,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-27,84
STUDY001,QS,STUDY001-SUBJ0017,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-27,84
STUDY001,QS,STUDY001-SUBJ0017,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-27,84
STUDY001,QS,STUDY001-SUBJ0017,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-27,84
STUDY001,QS,STUDY001-SUBJ0017,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-05-27,84
STUDY001,QS,STUDY001-SUBJ0017,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-27,84
STUDY001,QS,STUDY001-SUBJ0017,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-05-27,84
STUDY001,QS,STUDY001-SUBJ0017,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-27,84
STUDY001,QS,STUDY001-SUBJ0017,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,80,80,80.0,,,,4,WEEK 12,2025-05-27,84
STUDY001,QS,STUDY001-SUBJ0017,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-22,140
STUDY001,QS,STUDY001-SUBJ0017,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-07-22,140
STUDY001,QS,STUDY001-SUBJ0017,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-22,140
STUDY001,QS,STUDY001-SUBJ0017,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-22,140
STUDY001,QS,STUDY001-SUBJ0017,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-22,140
STUDY001,QS,STUDY001-SUBJ0017,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-22,140
STUDY001,QS,STUDY001-SUBJ0017,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-07-22,140
STUDY001,QS,STUDY001-SUBJ0017,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-22,140
STUDY001,QS,STUDY001-SUBJ0017,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-07-22,140
STUDY001,QS,STUDY001-SUBJ0017,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,5,END OF TREATMENT,2025-07-22,140
STUDY001,QS,STUDY001-SUBJ0017,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-07-22,140
STUDY001,QS,STUDY001-SUBJ0018,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-02-26,1
STUDY001,QS,STUDY001-SUBJ0018,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-02-26,1
STUDY001,QS,STUDY001-SUBJ0018,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-02-26,1
STUDY001,QS,STUDY001-SUBJ0018,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-26,1
STUDY001,QS,STUDY001-SUBJ0018,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-02-26,1
STUDY001,QS,STUDY001-SUBJ0018,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-26,1
STUDY001,QS,STUDY001-SUBJ0018,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,NOT DONE,,Y,1,BASELINE,2025-02-26,1
STUDY001,QS,STUDY001-SUBJ0018,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-26,1
STUDY001,QS,STUDY001-SUBJ0018,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-02-26,1
STUDY001,QS,STUDY001-SUBJ0018,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-26,1
STUDY001,QS,STUDY001-SUBJ0018,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,38,38,38.0,,,Y,1,BASELINE,2025-02-26,1
STUDY001,QS,STUDY001-SUBJ0018,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-25,28
STUDY001,QS,STUDY001-SUBJ0018,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-03-25,28
STUDY001,QS,STUDY001-SUBJ0018,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-25,28
STUDY001,QS,STUDY001-SUBJ0018,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-25,28
STUDY001,QS,STUDY001-SUBJ0018,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-25,28
STUDY001,QS,STUDY001-SUBJ0018,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-25,28
STUDY001,QS,STUDY001-SUBJ0018,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-03-25,28
STUDY001,QS,STUDY001-SUBJ0018,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-25,28
STUDY001,QS,STUDY001-SUBJ0018,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-03-25,28
STUDY001,QS,STUDY001-SUBJ0018,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-03-25,28
STUDY001,QS,STUDY001-SUBJ0018,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,61,61,61.0,,,,2,WEEK 4,2025-03-25,28
STUDY001,QS,STUDY001-SUBJ0018,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-22,56
STUDY001,QS,STUDY001-SUBJ0018,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-04-22,56
STUDY001,QS,STUDY001-SUBJ0018,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-22,56
STUDY001,QS,STUDY001-SUBJ0018,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-22,56
STUDY001,QS,STUDY001-SUBJ0018,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-22,56
STUDY001,QS,STUDY001-SUBJ0018,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-22,56
STUDY001,QS,STUDY001-SUBJ0018,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-04-22,56
STUDY001,QS,STUDY001-SUBJ0018,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-22,56
STUDY001,QS,STUDY001-SUBJ0018,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-04-22,56
STUDY001,QS,STUDY001-SUBJ0018,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-22,56
STUDY001,QS,STUDY001-SUBJ0018,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,68,68,68.0,,,,3,WEEK 8,2025-04-22,56
STUDY001,QS,STUDY001-SUBJ0018,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-20,84
STUDY001,QS,STUDY001-SUBJ0018,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-05-20,84
STUDY001,QS,STUDY001-SUBJ0018,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-20,84
STUDY001,QS,STUDY001-SUBJ0018,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-20,84
STUDY001,QS,STUDY001-SUBJ0018,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-20,84
STUDY001,QS,STUDY001-SUBJ0018,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-20,84
STUDY001,QS,STUDY001-SUBJ0018,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-05-20,84
STUDY001,QS,STUDY001-SUBJ0018,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-20,84
STUDY001,QS,STUDY001-SUBJ0018,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-05-20,84
STUDY001,QS,STUDY001-SUBJ0018,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-20,84
STUDY001,QS,STUDY001-SUBJ0018,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,89,89,89.0,,,,4,WEEK 12,2025-05-20,84
STUDY001,QS,STUDY001-SUBJ0018,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-15,140
STUDY001,QS,STUDY001-SUBJ0018,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-07-15,140
STUDY001,QS,STUDY001-SUBJ0018,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-15,140
STUDY001,QS,STUDY001-SUBJ0018,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-15,140
STUDY001,QS,STUDY001-SUBJ0018,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-15,140
STUDY001,QS,STUDY001-SUBJ0018,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-15,140
STUDY001,QS,STUDY001-SUBJ0018,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-07-15,140
STUDY001,QS,STUDY001-SUBJ0018,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-15,140
STUDY001,QS,STUDY001-SUBJ0018,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-07-15,140
STUDY001,QS,STUDY001-SUBJ0018,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-15,140
STUDY001,QS,STUDY001-SUBJ0018,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-07-15,140
STUDY001,QS,STUDY001-SUBJ0019,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-10-08,1
STUDY001,QS,STUDY001-SUBJ0019,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-08,1
STUDY001,QS,STUDY001-SUBJ0019,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-08,1
STUDY001,QS,STUDY001-SUBJ0019,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-08,1
STUDY001,QS,STUDY001-SUBJ0019,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-08,1
STUDY001,QS,STUDY001-SUBJ0019,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-11-04,28
STUDY001,QS,STUDY001-SUBJ0019,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-11-04,28
STUDY001,QS,STUDY001-SUBJ0019,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-11-04,28
STUDY001,QS,STUDY001-SUBJ0019,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-11-04,28
STUDY001,QS,STUDY001-SUBJ0019,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-11-04,28
STUDY001,QS,STUDY001-SUBJ0019,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-02,56
STUDY001,QS,STUDY001-SUBJ0019,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-12-02,56
STUDY001,QS,STUDY001-SUBJ0019,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-02,56
STUDY001,QS,STUDY001-SUBJ0019,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-02,56
STUDY001,QS,STUDY001-SUBJ0019,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-02,56
STUDY001,QS,STUDY001-SUBJ0019,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-02,56
STUDY001,QS,STUDY001-SUBJ0019,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-12-02,56
STUDY001,QS,STUDY001-SUBJ0019,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-02,56
STUDY001,QS,STUDY001-SUBJ0019,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-12-02,56
STUDY001,QS,STUDY001-SUBJ0019,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-02,56
STUDY001,QS,STUDY001-SUBJ0019,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,66,66,66.0,,,,3,WEEK 8,2025-12-02,56
STUDY001,QS,STUDY001-SUBJ0020,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-05-12,1
STUDY001,QS,STUDY001-SUBJ0020,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-05-12,1
STUDY001,QS,STUDY001-SUBJ0020,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-05-12,1
STUDY001,QS,STUDY001-SUBJ0020,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-05-12,1
STUDY001,QS,STUDY001-SUBJ0020,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-05-12,1
STUDY001,QS,STUDY001-SUBJ0020,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-05-12,1
STUDY001,QS,STUDY001-SUBJ0020,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-05-12,1
STUDY001,QS,STUDY001-SUBJ0020,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-05-12,1
STUDY001,QS,STUDY001-SUBJ0020,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-05-12,1
STUDY001,QS,STUDY001-SUBJ0020,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-05-12,1
STUDY001,QS,STUDY001-SUBJ0020,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,,,Y,1,BASELINE,2025-05-12,1
STUDY001,QS,STUDY001-SUBJ0020,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-06-08,28
STUDY001,QS,STUDY001-SUBJ0020,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,NOT DONE,,,2,WEEK 4,2025-06-08,28
STUDY001,QS,STUDY001-SUBJ0020,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-06-08,28
STUDY001,QS,STUDY001-SUBJ0020,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-08,28
STUDY001,QS,STUDY001-SUBJ0020,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-06-08,28
STUDY001,QS,STUDY001-SUBJ0020,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-08,28
STUDY001,QS,STUDY001-SUBJ0020,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-06-08,28
STUDY001,QS,STUDY001-SUBJ0020,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-08,28
STUDY001,QS,STUDY001-SUBJ0020,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-06-08,28
STUDY001,QS,STUDY001-SUBJ0020,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-06-08,28
STUDY001,QS,STUDY001-SUBJ0020,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,,,,2,WEEK 4,2025-06-08,28
STUDY001,QS,STUDY001-SUBJ0020,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-06,56
STUDY001,QS,STUDY001-SUBJ0020,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-07-06,56
STUDY001,QS,STUDY001-SUBJ0020,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-06,56
STUDY001,QS,STUDY001-SUBJ0020,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-07-06,56
STUDY001,QS,STUDY001-SUBJ0020,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-06,56
STUDY001,QS,STUDY001-SUBJ0020,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-07-06,56
STUDY001,QS,STUDY001-SUBJ0020,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-07-06,56
STUDY001,QS,STUDY001-SUBJ0020,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-07-06,56
STUDY001,QS,STUDY001-SUBJ0020,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-07-06,56
STUDY001,QS,STUDY001-SUBJ0020,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-07-06,56
STUDY001,QS,STUDY001-SUBJ0020,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,3,WEEK 8,2025-07-06,56
STUDY001,QS,STUDY001-SUBJ0020,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-08-03,84
STUDY001,QS,STUDY001-SUBJ0020,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-08-03,84
STUDY001,QS,STUDY001-SUBJ0020,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-08-03,84
STUDY001,QS,STUDY001-SUBJ0020,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-03,84
STUDY001,QS,STUDY001-SUBJ0020,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-08-03,84
STUDY001,QS,STUDY001-SUBJ0020,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-03,84
STUDY001,QS,STUDY001-SUBJ0020,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,NOT DONE,,,4,WEEK 12,2025-08-03,84
STUDY001,QS,STUDY001-SUBJ0020,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-03,84
STUDY001,QS,STUDY001-SUBJ0020,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,4,WEEK 12,2025-08-03,84
STUDY001,QS,STUDY001-SUBJ0020,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-03,84
STUDY001,QS,STUDY001-SUBJ0020,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,77,77,77.0,,,,4,WEEK 12,2025-08-03,84
STUDY001,QS,STUDY001-SUBJ0020,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-28,140
STUDY001,QS,STUDY001-SUBJ0020,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-09-28,140
STUDY001,QS,STUDY001-SUBJ0020,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-28,140
STUDY001,QS,STUDY001-SUBJ0020,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-28,140
STUDY001,QS,STUDY001-SUBJ0020,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-28,140
STUDY001,QS,STUDY001-SUBJ0020,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-28,140
STUDY001,QS,STUDY001-SUBJ0020,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-09-28,140
STUDY001,QS,STUDY001-SUBJ0020,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-28,140
STUDY001,QS,STUDY001-SUBJ0020,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-09-28,140
STUDY001,QS,STUDY001-SUBJ0020,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-28,140
STUDY001,QS,STUDY001-SUBJ0020,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-09-28,140
STUDY001,QS,STUDY001-SUBJ0021,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-01-24,1
STUDY001,QS,STUDY001-SUBJ0021,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-01-24,1
STUDY001,QS,STUDY001-SUBJ0021,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-01-24,1
STUDY001,QS,STUDY001-SUBJ0021,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-01-24,1
STUDY001,QS,STUDY001-SUBJ0021,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-01-24,1
STUDY001,QS,STUDY001-SUBJ0021,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-01-24,1
STUDY001,QS,STUDY001-SUBJ0021,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-01-24,1
STUDY001,QS,STUDY001-SUBJ0021,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-01-24,1
STUDY001,QS,STUDY001-SUBJ0021,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-01-24,1
STUDY001,QS,STUDY001-SUBJ0021,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-01-24,1
STUDY001,QS,STUDY001-SUBJ0021,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,NOT DONE,,Y,1,BASELINE,2025-01-24,1
STUDY001,QS,STUDY001-SUBJ0021,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-02-20,28
STUDY001,QS,STUDY001-SUBJ0021,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-02-20,28
STUDY001,QS,STUDY001-SUBJ0021,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-02-20,28
STUDY001,QS,STUDY001-SUBJ0021,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-20,28
STUDY001,QS,STUDY001-SUBJ0021,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-02-20,28
STUDY001,QS,STUDY001-SUBJ0021,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-20,28
STUDY001,QS,STUDY001-SUBJ0021,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-02-20,28
STUDY001,QS,STUDY001-SUBJ0021,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-20,28
STUDY001,QS,STUDY001-SUBJ0021,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-02-20,28
STUDY001,QS,STUDY001-SUBJ0021,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-20,28
STUDY001,QS,STUDY001-SUBJ0021,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,,,,2,WEEK 4,2025-02-20,28
STUDY001,QS,STUDY001-SUBJ0021,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-20,56
STUDY001,QS,STUDY001-SUBJ0021,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-03-20,56
STUDY001,QS,STUDY001-SUBJ0021,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-20,56
STUDY001,QS,STUDY001-SUBJ0021,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-20,56
STUDY001,QS,STUDY001-SUBJ0021,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-20,56
STUDY001,QS,STUDY001-SUBJ0021,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-20,56
STUDY001,QS,STUDY001-SUBJ0021,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-03-20,56
STUDY001,QS,STUDY001-SUBJ0021,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-20,56
STUDY001,QS,STUDY001-SUBJ0021,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-03-20,56
STUDY001,QS,STUDY001-SUBJ0021,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,3,WEEK 8,2025-03-20,56
STUDY001,QS,STUDY001-SUBJ0021,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,3,WEEK 8,2025-03-20,56
STUDY001,QS,STUDY001-SUBJ0021,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-17,84
STUDY001,QS,STUDY001-SUBJ0021,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-04-17,84
STUDY001,QS,STUDY001-SUBJ0021,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-17,84
STUDY001,QS,STUDY001-SUBJ0021,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-17,84
STUDY001,QS,STUDY001-SUBJ0021,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-17,84
STUDY001,QS,STUDY001-SUBJ0021,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-17,84
STUDY001,QS,STUDY001-SUBJ0021,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-04-17,84
STUDY001,QS,STUDY001-SUBJ0021,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-17,84
STUDY001,QS,STUDY001-SUBJ0021,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-04-17,84
STUDY001,QS,STUDY001-SUBJ0021,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-17,84
STUDY001,QS,STUDY001-SUBJ0021,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,87,87,87.0,,,,4,WEEK 12,2025-04-17,84
STUDY001,QS,STUDY001-SUBJ0021,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-12,140
STUDY001,QS,STUDY001-SUBJ0021,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-06-12,140
STUDY001,QS,STUDY001-SUBJ0021,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-12,140
STUDY001,QS,STUDY001-SUBJ0021,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-12,140
STUDY001,QS,STUDY001-SUBJ0021,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-12,140
STUDY001,QS,STUDY001-SUBJ0021,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,5,END OF TREATMENT,2025-06-12,140
STUDY001,QS,STUDY001-SUBJ0021,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-06-12,140
STUDY001,QS,STUDY001-SUBJ0021,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,5,END OF TREATMENT,2025-06-12,140
STUDY001,QS,STUDY001-SUBJ0021,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-06-12,140
STUDY001,QS,STUDY001-SUBJ0021,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-12,140
STUDY001,QS,STUDY001-SUBJ0021,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-06-12,140
STUDY001,QS,STUDY001-SUBJ0022,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0022,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0022,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0022,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0022,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0022,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0022,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0022,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0022,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0022,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0022,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,36,36,36.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0022,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0022,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,NOT DONE,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0022,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0022,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0022,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0022,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0022,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0022,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0022,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0022,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0022,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,58,58,58.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0022,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0022,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0022,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0022,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0022,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0022,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0022,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,NOT DONE,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0022,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0022,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0022,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0022,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,67,67,67.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0022,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0022,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,NOT DONE,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0022,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0022,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0022,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0022,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0022,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0022,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0022,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0022,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0022,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,89,89,89.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0022,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0022,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0022,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0022,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0022,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0022,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0022,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0022,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0022,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0022,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0022,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0023,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-06-03,1
STUDY001,QS,STUDY001-SUBJ0023,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-06-03,1
STUDY001,QS,STUDY001-SUBJ0023,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-06-03,1
STUDY001,QS,STUDY001-SUBJ0023,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-03,1
STUDY001,QS,STUDY001-SUBJ0023,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-06-03,1
STUDY001,QS,STUDY001-SUBJ0023,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-03,1
STUDY001,QS,STUDY001-SUBJ0023,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-06-03,1
STUDY001,QS,STUDY001-SUBJ0023,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-03,1
STUDY001,QS,STUDY001-SUBJ0023,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-06-03,1
STUDY001,QS,STUDY001-SUBJ0023,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-03,1
STUDY001,QS,STUDY001-SUBJ0023,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,39,39,39.0,,,Y,1,BASELINE,2025-06-03,1
STUDY001,QS,STUDY001-SUBJ0023,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-06-30,28
STUDY001,QS,STUDY001-SUBJ0023,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-06-30,28
STUDY001,QS,STUDY001-SUBJ0023,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-06-30,28
STUDY001,QS,STUDY001-SUBJ0023,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-06-30,28
STUDY001,QS,STUDY001-SUBJ0023,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-06-30,28
STUDY001,QS,STUDY001-SUBJ0023,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-06-30,28
STUDY001,QS,STUDY001-SUBJ0023,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-06-30,28
STUDY001,QS,STUDY001-SUBJ0023,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-06-30,28
STUDY001,QS,STUDY001-SUBJ0023,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-06-30,28
STUDY001,QS,STUDY001-SUBJ0023,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,2,WEEK 4,2025-06-30,28
STUDY001,QS,STUDY001-SUBJ0023,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,2,WEEK 4,2025-06-30,28
STUDY001,QS,STUDY001-SUBJ0023,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-28,56
STUDY001,QS,STUDY001-SUBJ0023,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-07-28,56
STUDY001,QS,STUDY001-SUBJ0023,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-28,56
STUDY001,QS,STUDY001-SUBJ0023,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-28,56
STUDY001,QS,STUDY001-SUBJ0023,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-28,56
STUDY001,QS,STUDY001-SUBJ0023,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-28,56
STUDY001,QS,STUDY001-SUBJ0023,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-07-28,56
STUDY001,QS,STUDY001-SUBJ0023,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-28,56
STUDY001,QS,STUDY001-SUBJ0023,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-07-28,56
STUDY001,QS,STUDY001-SUBJ0023,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-28,56
STUDY001,QS,STUDY001-SUBJ0023,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,72,72,72.0,,,,3,WEEK 8,2025-07-28,56
STUDY001,QS,STUDY001-SUBJ0023,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-08-25,84
STUDY001,QS,STUDY001-SUBJ0023,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-25,84
STUDY001,QS,STUDY001-SUBJ0023,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-25,84
STUDY001,QS,STUDY001-SUBJ0023,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-25,84
STUDY001,QS,STUDY001-SUBJ0023,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-25,84
STUDY001,QS,STUDY001-SUBJ0023,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-20,140
STUDY001,QS,STUDY001-SUBJ0023,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-10-20,140
STUDY001,QS,STUDY001-SUBJ0023,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-20,140
STUDY001,QS,STUDY001-SUBJ0023,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-20,140
STUDY001,QS,STUDY001-SUBJ0023,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-20,140
STUDY001,QS,STUDY001-SUBJ0023,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-20,140
STUDY001,QS,STUDY001-SUBJ0023,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-10-20,140
STUDY001,QS,STUDY001-SUBJ0023,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-20,140
STUDY001,QS,STUDY001-SUBJ0023,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-10-20,140
STUDY001,QS,STUDY001-SUBJ0023,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-20,140
STUDY001,QS,STUDY001-SUBJ0023,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-10-20,140
STUDY001,QS,STUDY001-SUBJ0024,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-05-19,1
STUDY001,QS,STUDY001-SUBJ0024,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-05-19,1
STUDY001,QS,STUDY001-SUBJ0024,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-05-19,1
STUDY001,QS,STUDY001-SUBJ0024,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-05-19,1
STUDY001,QS,STUDY001-SUBJ0024,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-05-19,1
STUDY001,QS,STUDY001-SUBJ0024,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-05-19,1
STUDY001,QS,STUDY001-SUBJ0024,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-05-19,1
STUDY001,QS,STUDY001-SUBJ0024,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-05-19,1
STUDY001,QS,STUDY001-SUBJ0024,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-05-19,1
STUDY001,QS,STUDY001-SUBJ0024,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-05-19,1
STUDY001,QS,STUDY001-SUBJ0024,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,68,68,68.0,,,Y,1,BASELINE,2025-05-19,1
STUDY001,QS,STUDY001-SUBJ0024,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,NOT DONE,,,2,WEEK 4,2025-06-15,28
STUDY001,QS,STUDY001-SUBJ0024,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-15,28
STUDY001,QS,STUDY001-SUBJ0024,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-15,28
STUDY001,QS,STUDY001-SUBJ0024,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-15,28
STUDY001,QS,STUDY001-SUBJ0024,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-15,28
STUDY001,QS,STUDY001-SUBJ0024,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-13,56
STUDY001,QS,STUDY001-SUBJ0024,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-07-13,56
STUDY001,QS,STUDY001-SUBJ0024,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-13,56
STUDY001,QS,STUDY001-SUBJ0024,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-07-13,56
STUDY001,QS,STUDY001-SUBJ0024,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-13,56
STUDY001,QS,STUDY001-SUBJ0024,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-07-13,56
STUDY001,QS,STUDY001-SUBJ0024,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-07-13,56
STUDY001,QS,STUDY001-SUBJ0024,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-07-13,56
STUDY001,QS,STUDY001-SUBJ0024,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-07-13,56
STUDY001,QS,STUDY001-SUBJ0024,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-07-13,56
STUDY001,QS,STUDY001-SUBJ0024,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,64,64,64.0,,,,3,WEEK 8,2025-07-13,56
STUDY001,QS,STUDY001-SUBJ0024,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-08-10,84
STUDY001,QS,STUDY001-SUBJ0024,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-10,84
STUDY001,QS,STUDY001-SUBJ0024,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-10,84
STUDY001,QS,STUDY001-SUBJ0024,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-10,84
STUDY001,QS,STUDY001-SUBJ0024,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-10,84
STUDY001,QS,STUDY001-SUBJ0024,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,5,END OF TREATMENT,2025-10-05,140
STUDY001,QS,STUDY001-SUBJ0024,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-10-05,140
STUDY001,QS,STUDY001-SUBJ0024,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-05,140
STUDY001,QS,STUDY001-SUBJ0024,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-05,140
STUDY001,QS,STUDY001-SUBJ0024,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-05,140
STUDY001,QS,STUDY001-SUBJ0024,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-05,140
STUDY001,QS,STUDY001-SUBJ0024,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-10-05,140
STUDY001,QS,STUDY001-SUBJ0024,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-05,140
STUDY001,QS,STUDY001-SUBJ0024,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,NOT DONE,,,5,END OF TREATMENT,2025-10-05,140
STUDY001,QS,STUDY001-SUBJ0024,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-05,140
STUDY001,QS,STUDY001-SUBJ0024,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-10-05,140
STUDY001,QS,STUDY001-SUBJ0025,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0025,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0025,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0025,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0025,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0025,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0025,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,NOT DONE,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0025,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0025,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0025,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0025,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,48,48,48.0,,,Y,1,BASELINE,2025-10-24,1
STUDY001,QS,STUDY001-SUBJ0025,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-20,28
STUDY001,QS,STUDY001-SUBJ0025,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-20,28
STUDY001,QS,STUDY001-SUBJ0025,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-20,28
STUDY001,QS,STUDY001-SUBJ0025,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-11-20,28
STUDY001,QS,STUDY001-SUBJ0025,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-11-20,28
STUDY001,QS,STUDY001-SUBJ0025,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,55,55,55.0,,,,2,WEEK 4,2025-11-20,28
STUDY001,QS,STUDY001-SUBJ0025,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-18,56
STUDY001,QS,STUDY001-SUBJ0025,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-12-18,56
STUDY001,QS,STUDY001-SUBJ0025,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-18,56
STUDY001,QS,STUDY001-SUBJ0025,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-18,56
STUDY001,QS,STUDY001-SUBJ0025,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-18,56
STUDY001,QS,STUDY001-SUBJ0025,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-18,56
STUDY001,QS,STUDY001-SUBJ0025,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-12-18,56
STUDY001,QS,STUDY001-SUBJ0025,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-18,56
STUDY001,QS,STUDY001-SUBJ0025,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-12-18,56
STUDY001,QS,STUDY001-SUBJ0025,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-18,56
STUDY001,QS,STUDY001-SUBJ0025,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,3,WEEK 8,2025-12-18,56
STUDY001,QS,STUDY001-SUBJ0026,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-01,1
STUDY001,QS,STUDY001-SUBJ0026,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-02-01,1
STUDY001,QS,STUDY001-SUBJ0026,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-01,1
STUDY001,QS,STUDY001-SUBJ0026,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-02-01,1
STUDY001,QS,STUDY001-SUBJ0026,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-01,1
STUDY001,QS,STUDY001-SUBJ0026,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-02-01,1
STUDY001,QS,STUDY001-SUBJ0026,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-02-01,1
STUDY001,QS,STUDY001-SUBJ0026,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-02-01,1
STUDY001,QS,STUDY001-SUBJ0026,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-02-01,1
STUDY001,QS,STUDY001-SUBJ0026,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-02-01,1
STUDY001,QS,STUDY001-SUBJ0026,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,47,47,47.0,,,Y,1,BASELINE,2025-02-01,1
STUDY001,QS,STUDY001-SUBJ0026,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-02-28,28
STUDY001,QS,STUDY001-SUBJ0026,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-02-28,28
STUDY001,QS,STUDY001-SUBJ0026,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-02-28,28
STUDY001,QS,STUDY001-SUBJ0026,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-02-28,28
STUDY001,QS,STUDY001-SUBJ0026,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-02-28,28
STUDY001,QS,STUDY001-SUBJ0026,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-02-28,28
STUDY001,QS,STUDY001-SUBJ0026,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-02-28,28
STUDY001,QS,STUDY001-SUBJ0026,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-02-28,28
STUDY001,QS,STUDY001-SUBJ0026,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-02-28,28
STUDY001,QS,STUDY001-SUBJ0026,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-02-28,28
STUDY001,QS,STUDY001-SUBJ0026,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,60,60,60.0,,,,2,WEEK 4,2025-02-28,28
STUDY001,QS,STUDY001-SUBJ0026,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-28,56
STUDY001,QS,STUDY001-SUBJ0026,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-03-28,56
STUDY001,QS,STUDY001-SUBJ0026,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-28,56
STUDY001,QS,STUDY001-SUBJ0026,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-28,56
STUDY001,QS,STUDY001-SUBJ0026,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-28,56
STUDY001,QS,STUDY001-SUBJ0026,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-28,56
STUDY001,QS,STUDY001-SUBJ0026,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-03-28,56
STUDY001,QS,STUDY001-SUBJ0026,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-28,56
STUDY001,QS,STUDY001-SUBJ0026,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-03-28,56
STUDY001,QS,STUDY001-SUBJ0026,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-28,56
STUDY001,QS,STUDY001-SUBJ0026,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,67,67,67.0,,,,3,WEEK 8,2025-03-28,56
STUDY001,QS,STUDY001-SUBJ0026,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-25,84
STUDY001,QS,STUDY001-SUBJ0026,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-04-25,84
STUDY001,QS,STUDY001-SUBJ0026,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-25,84
STUDY001,QS,STUDY001-SUBJ0026,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-25,84
STUDY001,QS,STUDY001-SUBJ0026,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-25,84
STUDY001,QS,STUDY001-SUBJ0026,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-25,84
STUDY001,QS,STUDY001-SUBJ0026,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-04-25,84
STUDY001,QS,STUDY001-SUBJ0026,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-25,84
STUDY001,QS,STUDY001-SUBJ0026,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-04-25,84
STUDY001,QS,STUDY001-SUBJ0026,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-25,84
STUDY001,QS,STUDY001-SUBJ0026,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,89,89,89.0,,,,4,WEEK 12,2025-04-25,84
STUDY001,QS,STUDY001-SUBJ0026,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-20,140
STUDY001,QS,STUDY001-SUBJ0026,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,NOT DONE,,,5,END OF TREATMENT,2025-06-20,140
STUDY001,QS,STUDY001-SUBJ0026,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-20,140
STUDY001,QS,STUDY001-SUBJ0026,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-20,140
STUDY001,QS,STUDY001-SUBJ0026,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-20,140
STUDY001,QS,STUDY001-SUBJ0026,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-20,140
STUDY001,QS,STUDY001-SUBJ0026,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-06-20,140
STUDY001,QS,STUDY001-SUBJ0026,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-20,140
STUDY001,QS,STUDY001-SUBJ0026,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-06-20,140
STUDY001,QS,STUDY001-SUBJ0026,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-20,140
STUDY001,QS,STUDY001-SUBJ0026,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-06-20,140
STUDY001,QS,STUDY001-SUBJ0027,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-04,1
STUDY001,QS,STUDY001-SUBJ0027,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-02-04,1
STUDY001,QS,STUDY001-SUBJ0027,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-04,1
STUDY001,QS,STUDY001-SUBJ0027,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-04,1
STUDY001,QS,STUDY001-SUBJ0027,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-04,1
STUDY001,QS,STUDY001-SUBJ0027,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-04,1
STUDY001,QS,STUDY001-SUBJ0027,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-02-04,1
STUDY001,QS,STUDY001-SUBJ0027,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-04,1
STUDY001,QS,STUDY001-SUBJ0027,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-02-04,1
STUDY001,QS,STUDY001-SUBJ0027,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-04,1
STUDY001,QS,STUDY001-SUBJ0027,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,45,45,45.0,,,Y,1,BASELINE,2025-02-04,1
STUDY001,QS,STUDY001-SUBJ0027,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,2,WEEK 4,2025-03-03,28
STUDY001,QS,STUDY001-SUBJ0027,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-03-03,28
STUDY001,QS,STUDY001-SUBJ0027,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-03,28
STUDY001,QS,STUDY001-SUBJ0027,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-03-03,28
STUDY001,QS,STUDY001-SUBJ0027,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-03,28
STUDY001,QS,STUDY001-SUBJ0027,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-03-03,28
STUDY001,QS,STUDY001-SUBJ0027,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-03-03,28
STUDY001,QS,STUDY001-SUBJ0027,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-03-03,28
STUDY001,QS,STUDY001-SUBJ0027,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-03-03,28
STUDY001,QS,STUDY001-SUBJ0027,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-03-03,28
STUDY001,QS,STUDY001-SUBJ0027,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,2,WEEK 4,2025-03-03,28
STUDY001,QS,STUDY001-SUBJ0027,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,3,WEEK 8,2025-03-31,56
STUDY001,QS,STUDY001-SUBJ0027,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-03-31,56
STUDY001,QS,STUDY001-SUBJ0027,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-31,56
STUDY001,QS,STUDY001-SUBJ0027,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-31,56
STUDY001,QS,STUDY001-SUBJ0027,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-31,56
STUDY001,QS,STUDY001-SUBJ0027,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-31,56
STUDY001,QS,STUDY001-SUBJ0027,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-03-31,56
STUDY001,QS,STUDY001-SUBJ0027,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-31,56
STUDY001,QS,STUDY001-SUBJ0027,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-03-31,56
STUDY001,QS,STUDY001-SUBJ0027,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-31,56
STUDY001,QS,STUDY001-SUBJ0027,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,75,75,75.0,,,,3,WEEK 8,2025-03-31,56
STUDY001,QS,STUDY001-SUBJ0027,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-28,84
STUDY001,QS,STUDY001-SUBJ0027,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-04-28,84
STUDY001,QS,STUDY001-SUBJ0027,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,4,WEEK 12,2025-04-28,84
STUDY001,QS,STUDY001-SUBJ0027,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-28,84
STUDY001,QS,STUDY001-SUBJ0027,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-28,84
STUDY001,QS,STUDY001-SUBJ0027,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-28,84
STUDY001,QS,STUDY001-SUBJ0027,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-04-28,84
STUDY001,QS,STUDY001-SUBJ0027,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-28,84
STUDY001,QS,STUDY001-SUBJ0027,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,NOT DONE,,,4,WEEK 12,2025-04-28,84
STUDY001,QS,STUDY001-SUBJ0027,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-28,84
STUDY001,QS,STUDY001-SUBJ0027,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,NOT DONE,,,4,WEEK 12,2025-04-28,84
STUDY001,QS,STUDY001-SUBJ0027,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-23,140
STUDY001,QS,STUDY001-SUBJ0027,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-06-23,140
STUDY001,QS,STUDY001-SUBJ0027,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-23,140
STUDY001,QS,STUDY001-SUBJ0027,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-23,140
STUDY001,QS,STUDY001-SUBJ0027,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-23,140
STUDY001,QS,STUDY001-SUBJ0027,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,5,END OF TREATMENT,2025-06-23,140
STUDY001,QS,STUDY001-SUBJ0027,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-06-23,140
STUDY001,QS,STUDY001-SUBJ0027,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-23,140
STUDY001,QS,STUDY001-SUBJ0027,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-06-23,140
STUDY001,QS,STUDY001-SUBJ0027,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-23,140
STUDY001,QS,STUDY001-SUBJ0027,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-06-23,140
STUDY001,QS,STUDY001-SUBJ0028,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0028,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0028,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0028,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0028,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0028,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0028,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0028,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0028,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0028,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0028,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,37,37,37.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0028,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0028,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0028,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0028,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0028,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0028,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0028,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0028,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0028,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0028,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0028,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,61,61,61.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0029,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0029,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0029,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0029,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0029,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0029,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0029,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0029,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0029,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0029,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0029,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,50,50,50.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0029,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0029,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0029,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0029,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0029,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0029,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0029,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0029,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0029,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0029,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0029,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0029,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0029,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0029,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0029,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0029,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0029,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0029,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0029,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0029,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0029,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0029,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,71,71,71.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0029,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0029,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0029,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0029,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0029,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0029,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0029,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0029,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0029,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0029,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0029,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0029,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0029,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0029,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0029,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0029,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0030,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-22,1
STUDY001,QS,STUDY001-SUBJ0030,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-10-22,1
STUDY001,QS,STUDY001-SUBJ0030,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-22,1
STUDY001,QS,STUDY001-SUBJ0030,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-22,1
STUDY001,QS,STUDY001-SUBJ0030,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-22,1
STUDY001,QS,STUDY001-SUBJ0030,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-22,1
STUDY001,QS,STUDY001-SUBJ0030,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-10-22,1
STUDY001,QS,STUDY001-SUBJ0030,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-22,1
STUDY001,QS,STUDY001-SUBJ0030,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-10-22,1
STUDY001,QS,STUDY001-SUBJ0030,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-22,1
STUDY001,QS,STUDY001-SUBJ0030,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,50,50,50.0,,,Y,1,BASELINE,2025-10-22,1
STUDY001,QS,STUDY001-SUBJ0030,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-18,28
STUDY001,QS,STUDY001-SUBJ0030,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-11-18,28
STUDY001,QS,STUDY001-SUBJ0030,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-18,28
STUDY001,QS,STUDY001-SUBJ0030,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-11-18,28
STUDY001,QS,STUDY001-SUBJ0030,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-18,28
STUDY001,QS,STUDY001-SUBJ0030,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-11-18,28
STUDY001,QS,STUDY001-SUBJ0030,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-11-18,28
STUDY001,QS,STUDY001-SUBJ0030,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-11-18,28
STUDY001,QS,STUDY001-SUBJ0030,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-11-18,28
STUDY001,QS,STUDY001-SUBJ0030,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-11-18,28
STUDY001,QS,STUDY001-SUBJ0030,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,57,57,57.0,,,,2,WEEK 4,2025-11-18,28
STUDY001,QS,STUDY001-SUBJ0030,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-16,56
STUDY001,QS,STUDY001-SUBJ0030,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-12-16,56
STUDY001,QS,STUDY001-SUBJ0030,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-16,56
STUDY001,QS,STUDY001-SUBJ0030,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-16,56
STUDY001,QS,STUDY001-SUBJ0030,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-16,56
STUDY001,QS,STUDY001-SUBJ0030,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-16,56
STUDY001,QS,STUDY001-SUBJ0030,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-12-16,56
STUDY001,QS,STUDY001-SUBJ0030,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-16,56
STUDY001,QS,STUDY001-SUBJ0030,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-12-16,56
STUDY001,QS,STUDY001-SUBJ0030,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-16,56
STUDY001,QS,STUDY001-SUBJ0030,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,65,65,65.0,,,,3,WEEK 8,2025-12-16,56
STUDY001,QS,STUDY001-SUBJ0031,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-11-06,1
STUDY001,QS,STUDY001-SUBJ0031,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-11-06,1
STUDY001,QS,STUDY001-SUBJ0031,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-11-06,1
STUDY001,QS,STUDY001-SUBJ0031,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-11-06,1
STUDY001,QS,STUDY001-SUBJ0031,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-11-06,1
STUDY001,QS,STUDY001-SUBJ0031,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-11-06,1
STUDY001,QS,STUDY001-SUBJ0031,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-11-06,1
STUDY001,QS,STUDY001-SUBJ0031,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,Y,1,BASELINE,2025-11-06,1
STUDY001,QS,STUDY001-SUBJ0031,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-11-06,1
STUDY001,QS,STUDY001-SUBJ0031,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-11-06,1
STUDY001,QS,STUDY001-SUBJ0031,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,68,68,68.0,,,Y,1,BASELINE,2025-11-06,1
STUDY001,QS,STUDY001-SUBJ0031,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-03,28
STUDY001,QS,STUDY001-SUBJ0031,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-12-03,28
STUDY001,QS,STUDY001-SUBJ0031,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-03,28
STUDY001,QS,STUDY001-SUBJ0031,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-03,28
STUDY001,QS,STUDY001-SUBJ0031,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,2,WEEK 4,2025-12-03,28
STUDY001,QS,STUDY001-SUBJ0031,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-03,28
STUDY001,QS,STUDY001-SUBJ0031,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-12-03,28
STUDY001,QS,STUDY001-SUBJ0031,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-03,28
STUDY001,QS,STUDY001-SUBJ0031,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-12-03,28
STUDY001,QS,STUDY001-SUBJ0031,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-03,28
STUDY001,QS,STUDY001-SUBJ0031,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,2,WEEK 4,2025-12-03,28
STUDY001,QS,STUDY001-SUBJ0032,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-08-02,1
STUDY001,QS,STUDY001-SUBJ0032,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-08-02,1
STUDY001,QS,STUDY001-SUBJ0032,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-08-02,1
STUDY001,QS,STUDY001-SUBJ0032,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-08-02,1
STUDY001,QS,STUDY001-SUBJ0032,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-08-02,1
STUDY001,QS,STUDY001-SUBJ0032,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-08-02,1
STUDY001,QS,STUDY001-SUBJ0032,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-08-02,1
STUDY001,QS,STUDY001-SUBJ0032,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-08-02,1
STUDY001,QS,STUDY001-SUBJ0032,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-08-02,1
STUDY001,QS,STUDY001-SUBJ0032,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,Y,1,BASELINE,2025-08-02,1
STUDY001,QS,STUDY001-SUBJ0032,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,62,62,62.0,,,Y,1,BASELINE,2025-08-02,1
STUDY001,QS,STUDY001-SUBJ0032,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-08-29,28
STUDY001,QS,STUDY001-SUBJ0032,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-29,28
STUDY001,QS,STUDY001-SUBJ0032,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-29,28
STUDY001,QS,STUDY001-SUBJ0032,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-29,28
STUDY001,QS,STUDY001-SUBJ0032,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-29,28
STUDY001,QS,STUDY001-SUBJ0032,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-26,56
STUDY001,QS,STUDY001-SUBJ0032,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-09-26,56
STUDY001,QS,STUDY001-SUBJ0032,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-26,56
STUDY001,QS,STUDY001-SUBJ0032,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-26,56
STUDY001,QS,STUDY001-SUBJ0032,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-26,56
STUDY001,QS,STUDY001-SUBJ0032,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-26,56
STUDY001,QS,STUDY001-SUBJ0032,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-09-26,56
STUDY001,QS,STUDY001-SUBJ0032,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,3,WEEK 8,2025-09-26,56
STUDY001,QS,STUDY001-SUBJ0032,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-09-26,56
STUDY001,QS,STUDY001-SUBJ0032,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-26,56
STUDY001,QS,STUDY001-SUBJ0032,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,77,77,77.0,,,,3,WEEK 8,2025-09-26,56
STUDY001,QS,STUDY001-SUBJ0032,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-24,84
STUDY001,QS,STUDY001-SUBJ0032,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-10-24,84
STUDY001,QS,STUDY001-SUBJ0032,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-24,84
STUDY001,QS,STUDY001-SUBJ0032,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-24,84
STUDY001,QS,STUDY001-SUBJ0032,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-24,84
STUDY001,QS,STUDY001-SUBJ0032,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-24,84
STUDY001,QS,STUDY001-SUBJ0032,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-10-24,84
STUDY001,QS,STUDY001-SUBJ0032,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-24,84
STUDY001,QS,STUDY001-SUBJ0032,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-10-24,84
STUDY001,QS,STUDY001-SUBJ0032,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-24,84
STUDY001,QS,STUDY001-SUBJ0032,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-10-24,84
STUDY001,QS,STUDY001-SUBJ0032,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,5,END OF TREATMENT,2025-12-19,140
STUDY001,QS,STUDY001-SUBJ0032,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-12-19,140
STUDY001,QS,STUDY001-SUBJ0032,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-19,140
STUDY001,QS,STUDY001-SUBJ0032,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-19,140
STUDY001,QS,STUDY001-SUBJ0032,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-19,140
STUDY001,QS,STUDY001-SUBJ0032,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-19,140
STUDY001,QS,STUDY001-SUBJ0032,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-12-19,140
STUDY001,QS,STUDY001-SUBJ0032,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-19,140
STUDY001,QS,STUDY001-SUBJ0032,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-12-19,140
STUDY001,QS,STUDY001-SUBJ0032,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-19,140
STUDY001,QS,STUDY001-SUBJ0032,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-12-19,140
STUDY001,QS,STUDY001-SUBJ0033,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-06-02,1
STUDY001,QS,STUDY001-SUBJ0033,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-06-02,1
STUDY001,QS,STUDY001-SUBJ0033,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-06-02,1
STUDY001,QS,STUDY001-SUBJ0033,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-02,1
STUDY001,QS,STUDY001-SUBJ0033,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-06-02,1
STUDY001,QS,STUDY001-SUBJ0033,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-02,1
STUDY001,QS,STUDY001-SUBJ0033,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-06-02,1
STUDY001,QS,STUDY001-SUBJ0033,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-02,1
STUDY001,QS,STUDY001-SUBJ0033,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-06-02,1
STUDY001,QS,STUDY001-SUBJ0033,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-02,1
STUDY001,QS,STUDY001-SUBJ0033,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,36,36,36.0,,,Y,1,BASELINE,2025-06-02,1
STUDY001,QS,STUDY001-SUBJ0033,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-06-29,28
STUDY001,QS,STUDY001-SUBJ0033,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-06-29,28
STUDY001,QS,STUDY001-SUBJ0033,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-06-29,28
STUDY001,QS,STUDY001-SUBJ0033,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-29,28
STUDY001,QS,STUDY001-SUBJ0033,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-06-29,28
STUDY001,QS,STUDY001-SUBJ0033,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-29,28
STUDY001,QS,STUDY001-SUBJ0033,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-06-29,28
STUDY001,QS,STUDY001-SUBJ0033,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-29,28
STUDY001,QS,STUDY001-SUBJ0033,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-06-29,28
STUDY001,QS,STUDY001-SUBJ0033,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-29,28
STUDY001,QS,STUDY001-SUBJ0033,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,,,,2,WEEK 4,2025-06-29,28
STUDY001,QS,STUDY001-SUBJ0033,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-27,56
STUDY001,QS,STUDY001-SUBJ0033,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-07-27,56
STUDY001,QS,STUDY001-SUBJ0033,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-27,56
STUDY001,QS,STUDY001-SUBJ0033,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-27,56
STUDY001,QS,STUDY001-SUBJ0033,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-27,56
STUDY001,QS,STUDY001-SUBJ0033,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-27,56
STUDY001,QS,STUDY001-SUBJ0033,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-07-27,56
STUDY001,QS,STUDY001-SUBJ0033,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,3,WEEK 8,2025-07-27,56
STUDY001,QS,STUDY001-SUBJ0033,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-07-27,56
STUDY001,QS,STUDY001-SUBJ0033,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-27,56
STUDY001,QS,STUDY001-SUBJ0033,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,68,68,68.0,,,,3,WEEK 8,2025-07-27,56
STUDY001,QS,STUDY001-SUBJ0033,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-08-24,84
STUDY001,QS,STUDY001-SUBJ0033,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-24,84
STUDY001,QS,STUDY001-SUBJ0033,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,4,WEEK 12,2025-08-24,84
STUDY001,QS,STUDY001-SUBJ0033,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-24,84
STUDY001,QS,STUDY001-SUBJ0033,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-24,84
STUDY001,QS,STUDY001-SUBJ0033,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-19,140
STUDY001,QS,STUDY001-SUBJ0033,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-10-19,140
STUDY001,QS,STUDY001-SUBJ0033,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-19,140
STUDY001,QS,STUDY001-SUBJ0033,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-19,140
STUDY001,QS,STUDY001-SUBJ0033,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-19,140
STUDY001,QS,STUDY001-SUBJ0033,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-19,140
STUDY001,QS,STUDY001-SUBJ0033,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-10-19,140
STUDY001,QS,STUDY001-SUBJ0033,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-19,140
STUDY001,QS,STUDY001-SUBJ0033,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-10-19,140
STUDY001,QS,STUDY001-SUBJ0033,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-19,140
STUDY001,QS,STUDY001-SUBJ0033,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-10-19,140
STUDY001,QS,STUDY001-SUBJ0034,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-01-28,1
STUDY001,QS,STUDY001-SUBJ0034,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-01-28,1
STUDY001,QS,STUDY001-SUBJ0034,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-01-28,1
STUDY001,QS,STUDY001-SUBJ0034,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-01-28,1
STUDY001,QS,STUDY001-SUBJ0034,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-01-28,1
STUDY001,QS,STUDY001-SUBJ0034,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-01-28,1
STUDY001,QS,STUDY001-SUBJ0034,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,NOT DONE,,Y,1,BASELINE,2025-01-28,1
STUDY001,QS,STUDY001-SUBJ0034,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,NOT DONE,,Y,1,BASELINE,2025-01-28,1
STUDY001,QS,STUDY001-SUBJ0034,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-01-28,1
STUDY001,QS,STUDY001-SUBJ0034,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,NOT DONE,,Y,1,BASELINE,2025-01-28,1
STUDY001,QS,STUDY001-SUBJ0034,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,35,35,35.0,,,Y,1,BASELINE,2025-01-28,1
STUDY001,QS,STUDY001-SUBJ0034,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-02-24,28
STUDY001,QS,STUDY001-SUBJ0034,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-02-24,28
STUDY001,QS,STUDY001-SUBJ0034,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-02-24,28
STUDY001,QS,STUDY001-SUBJ0034,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-24,28
STUDY001,QS,STUDY001-SUBJ0034,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-02-24,28
STUDY001,QS,STUDY001-SUBJ0034,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-24,28
STUDY001,QS,STUDY001-SUBJ0034,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-02-24,28
STUDY001,QS,STUDY001-SUBJ0034,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-24,28
STUDY001,QS,STUDY001-SUBJ0034,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-02-24,28
STUDY001,QS,STUDY001-SUBJ0034,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-24,28
STUDY001,QS,STUDY001-SUBJ0034,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,2,WEEK 4,2025-02-24,28
STUDY001,QS,STUDY001-SUBJ0034,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-24,56
STUDY001,QS,STUDY001-SUBJ0034,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-03-24,56
STUDY001,QS,STUDY001-SUBJ0034,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-24,56
STUDY001,QS,STUDY001-SUBJ0034,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-24,56
STUDY001,QS,STUDY001-SUBJ0034,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-24,56
STUDY001,QS,STUDY001-SUBJ0034,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-24,56
STUDY001,QS,STUDY001-SUBJ0034,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-03-24,56
STUDY001,QS,STUDY001-SUBJ0034,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,3,WEEK 8,2025-03-24,56
STUDY001,QS,STUDY001-SUBJ0034,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-03-24,56
STUDY001,QS,STUDY001-SUBJ0034,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-24,56
STUDY001,QS,STUDY001-SUBJ0034,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,70,70,70.0,,,,3,WEEK 8,2025-03-24,56
STUDY001,QS,STUDY001-SUBJ0034,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-21,84
STUDY001,QS,STUDY001-SUBJ0034,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-04-21,84
STUDY001,QS,STUDY001-SUBJ0034,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-21,84
STUDY001,QS,STUDY001-SUBJ0034,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-21,84
STUDY001,QS,STUDY001-SUBJ0034,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-21,84
STUDY001,QS,STUDY001-SUBJ0034,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-21,84
STUDY001,QS,STUDY001-SUBJ0034,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-04-21,84
STUDY001,QS,STUDY001-SUBJ0034,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,4,WEEK 12,2025-04-21,84
STUDY001,QS,STUDY001-SUBJ0034,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-04-21,84
STUDY001,QS,STUDY001-SUBJ0034,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-21,84
STUDY001,QS,STUDY001-SUBJ0034,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,87,87,87.0,,,,4,WEEK 12,2025-04-21,84
STUDY001,QS,STUDY001-SUBJ0034,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-16,140
STUDY001,QS,STUDY001-SUBJ0034,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-06-16,140
STUDY001,QS,STUDY001-SUBJ0034,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-16,140
STUDY001,QS,STUDY001-SUBJ0034,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-16,140
STUDY001,QS,STUDY001-SUBJ0034,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-16,140
STUDY001,QS,STUDY001-SUBJ0034,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-16,140
STUDY001,QS,STUDY001-SUBJ0034,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-06-16,140
STUDY001,QS,STUDY001-SUBJ0034,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-16,140
STUDY001,QS,STUDY001-SUBJ0034,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-06-16,140
STUDY001,QS,STUDY001-SUBJ0034,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-16,140
STUDY001,QS,STUDY001-SUBJ0034,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-06-16,140
STUDY001,QS,STUDY001-SUBJ0035,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-19,1
STUDY001,QS,STUDY001-SUBJ0035,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-04-19,1
STUDY001,QS,STUDY001-SUBJ0035,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-19,1
STUDY001,QS,STUDY001-SUBJ0035,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-19,1
STUDY001,QS,STUDY001-SUBJ0035,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-19,1
STUDY001,QS,STUDY001-SUBJ0035,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-19,1
STUDY001,QS,STUDY001-SUBJ0035,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-04-19,1
STUDY001,QS,STUDY001-SUBJ0035,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-19,1
STUDY001,QS,STUDY001-SUBJ0035,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-04-19,1
STUDY001,QS,STUDY001-SUBJ0035,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-19,1
STUDY001,QS,STUDY001-SUBJ0035,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,55,55,55.0,,,Y,1,BASELINE,2025-04-19,1
STUDY001,QS,STUDY001-SUBJ0035,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-16,28
STUDY001,QS,STUDY001-SUBJ0035,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-05-16,28
STUDY001,QS,STUDY001-SUBJ0035,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-16,28
STUDY001,QS,STUDY001-SUBJ0035,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-16,28
STUDY001,QS,STUDY001-SUBJ0035,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-16,28
STUDY001,QS,STUDY001-SUBJ0035,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-16,28
STUDY001,QS,STUDY001-SUBJ0035,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-05-16,28
STUDY001,QS,STUDY001-SUBJ0035,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-16,28
STUDY001,QS,STUDY001-SUBJ0035,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-05-16,28
STUDY001,QS,STUDY001-SUBJ0035,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-16,28
STUDY001,QS,STUDY001-SUBJ0035,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,58,58,58.0,,,,2,WEEK 4,2025-05-16,28
STUDY001,QS,STUDY001-SUBJ0035,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-13,56
STUDY001,QS,STUDY001-SUBJ0035,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-06-13,56
STUDY001,QS,STUDY001-SUBJ0035,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-13,56
STUDY001,QS,STUDY001-SUBJ0035,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-13,56
STUDY001,QS,STUDY001-SUBJ0035,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-13,56
STUDY001,QS,STUDY001-SUBJ0035,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-13,56
STUDY001,QS,STUDY001-SUBJ0035,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-06-13,56
STUDY001,QS,STUDY001-SUBJ0035,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-13,56
STUDY001,QS,STUDY001-SUBJ0035,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-06-13,56
STUDY001,QS,STUDY001-SUBJ0035,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-13,56
STUDY001,QS,STUDY001-SUBJ0035,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,66,66,66.0,,,,3,WEEK 8,2025-06-13,56
STUDY001,QS,STUDY001-SUBJ0035,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-11,84
STUDY001,QS,STUDY001-SUBJ0035,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-07-11,84
STUDY001,QS,STUDY001-SUBJ0035,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-11,84
STUDY001,QS,STUDY001-SUBJ0035,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-11,84
STUDY001,QS,STUDY001-SUBJ0035,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,4,WEEK 12,2025-07-11,84
STUDY001,QS,STUDY001-SUBJ0035,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-11,84
STUDY001,QS,STUDY001-SUBJ0035,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-07-11,84
STUDY001,QS,STUDY001-SUBJ0035,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-11,84
STUDY001,QS,STUDY001-SUBJ0035,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,NOT DONE,,,4,WEEK 12,2025-07-11,84
STUDY001,QS,STUDY001-SUBJ0035,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-11,84
STUDY001,QS,STUDY001-SUBJ0035,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-07-11,84
STUDY001,QS,STUDY001-SUBJ0035,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-09-05,140
STUDY001,QS,STUDY001-SUBJ0035,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-05,140
STUDY001,QS,STUDY001-SUBJ0035,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-05,140
STUDY001,QS,STUDY001-SUBJ0035,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-05,140
STUDY001,QS,STUDY001-SUBJ0035,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-05,140
STUDY001,QS,STUDY001-SUBJ0036,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-05-25,1
STUDY001,QS,STUDY001-SUBJ0036,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-05-25,1
STUDY001,QS,STUDY001-SUBJ0036,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-05-25,1
STUDY001,QS,STUDY001-SUBJ0036,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-05-25,1
STUDY001,QS,STUDY001-SUBJ0036,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-05-25,1
STUDY001,QS,STUDY001-SUBJ0036,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-06-21,28
STUDY001,QS,STUDY001-SUBJ0036,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-06-21,28
STUDY001,QS,STUDY001-SUBJ0036,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-06-21,28
STUDY001,QS,STUDY001-SUBJ0036,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-06-21,28
STUDY001,QS,STUDY001-SUBJ0036,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-06-21,28
STUDY001,QS,STUDY001-SUBJ0036,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-06-21,28
STUDY001,QS,STUDY001-SUBJ0036,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-06-21,28
STUDY001,QS,STUDY001-SUBJ0036,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-06-21,28
STUDY001,QS,STUDY001-SUBJ0036,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-06-21,28
STUDY001,QS,STUDY001-SUBJ0036,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-06-21,28
STUDY001,QS,STUDY001-SUBJ0036,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,57,57,57.0,,,,2,WEEK 4,2025-06-21,28
STUDY001,QS,STUDY001-SUBJ0036,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-19,56
STUDY001,QS,STUDY001-SUBJ0036,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-07-19,56
STUDY001,QS,STUDY001-SUBJ0036,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-19,56
STUDY001,QS,STUDY001-SUBJ0036,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-19,56
STUDY001,QS,STUDY001-SUBJ0036,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-19,56
STUDY001,QS,STUDY001-SUBJ0036,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-19,56
STUDY001,QS,STUDY001-SUBJ0036,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-07-19,56
STUDY001,QS,STUDY001-SUBJ0036,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-19,56
STUDY001,QS,STUDY001-SUBJ0036,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-07-19,56
STUDY001,QS,STUDY001-SUBJ0036,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-19,56
STUDY001,QS,STUDY001-SUBJ0036,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,75,75,75.0,,,,3,WEEK 8,2025-07-19,56
STUDY001,QS,STUDY001-SUBJ0036,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-08-16,84
STUDY001,QS,STUDY001-SUBJ0036,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-16,84
STUDY001,QS,STUDY001-SUBJ0036,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-16,84
STUDY001,QS,STUDY001-SUBJ0036,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-16,84
STUDY001,QS,STUDY001-SUBJ0036,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-16,84
STUDY001,QS,STUDY001-SUBJ0036,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-11,140
STUDY001,QS,STUDY001-SUBJ0036,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-10-11,140
STUDY001,QS,STUDY001-SUBJ0036,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-11,140
STUDY001,QS,STUDY001-SUBJ0036,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-11,140
STUDY001,QS,STUDY001-SUBJ0036,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-11,140
STUDY001,QS,STUDY001-SUBJ0036,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,5,END OF TREATMENT,2025-10-11,140
STUDY001,QS,STUDY001-SUBJ0036,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-10-11,140
STUDY001,QS,STUDY001-SUBJ0036,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-11,140
STUDY001,QS,STUDY001-SUBJ0036,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,NOT DONE,,,5,END OF TREATMENT,2025-10-11,140
STUDY001,QS,STUDY001-SUBJ0036,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-11,140
STUDY001,QS,STUDY001-SUBJ0036,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-10-11,140
STUDY001,QS,STUDY001-SUBJ0037,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0037,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0037,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0037,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0037,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0037,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,42,42,42.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0037,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-12-13,28
STUDY001,QS,STUDY001-SUBJ0037,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-12-13,28
STUDY001,QS,STUDY001-SUBJ0037,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-12-13,28
STUDY001,QS,STUDY001-SUBJ0037,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-12-13,28
STUDY001,QS,STUDY001-SUBJ0037,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-12-13,28
STUDY001,QS,STUDY001-SUBJ0037,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,58,58,58.0,,,,2,WEEK 4,2025-12-13,28
STUDY001,QS,STUDY001-SUBJ0038,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,NOT DONE,,Y,1,BASELINE,2025-02-05,1
STUDY001,QS,STUDY001-SUBJ0038,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-02-05,1
STUDY001,QS,STUDY001-SUBJ0038,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-02-05,1
STUDY001,QS,STUDY001-SUBJ0038,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-05,1
STUDY001,QS,STUDY001-SUBJ0038,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-02-05,1
STUDY001,QS,STUDY001-SUBJ0038,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-05,1
STUDY001,QS,STUDY001-SUBJ0038,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-02-05,1
STUDY001,QS,STUDY001-SUBJ0038,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-05,1
STUDY001,QS,STUDY001-SUBJ0038,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-02-05,1
STUDY001,QS,STUDY001-SUBJ0038,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-05,1
STUDY001,QS,STUDY001-SUBJ0038,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,34,34,34.0,,,Y,1,BASELINE,2025-02-05,1
STUDY001,QS,STUDY001-SUBJ0038,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-04,28
STUDY001,QS,STUDY001-SUBJ0038,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-03-04,28
STUDY001,QS,STUDY001-SUBJ0038,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-04,28
STUDY001,QS,STUDY001-SUBJ0038,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-04,28
STUDY001,QS,STUDY001-SUBJ0038,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-04,28
STUDY001,QS,STUDY001-SUBJ0038,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-04,28
STUDY001,QS,STUDY001-SUBJ0038,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-03-04,28
STUDY001,QS,STUDY001-SUBJ0038,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-04,28
STUDY001,QS,STUDY001-SUBJ0038,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-03-04,28
STUDY001,QS,STUDY001-SUBJ0038,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-04,28
STUDY001,QS,STUDY001-SUBJ0038,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,2,WEEK 4,2025-03-04,28
STUDY001,QS,STUDY001-SUBJ0038,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-01,56
STUDY001,QS,STUDY001-SUBJ0038,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-04-01,56
STUDY001,QS,STUDY001-SUBJ0038,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-01,56
STUDY001,QS,STUDY001-SUBJ0038,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-01,56
STUDY001,QS,STUDY001-SUBJ0038,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-01,56
STUDY001,QS,STUDY001-SUBJ0038,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-01,56
STUDY001,QS,STUDY001-SUBJ0038,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-04-01,56
STUDY001,QS,STUDY001-SUBJ0038,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-01,56
STUDY001,QS,STUDY001-SUBJ0038,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-04-01,56
STUDY001,QS,STUDY001-SUBJ0038,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-01,56
STUDY001,QS,STUDY001-SUBJ0038,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,3,WEEK 8,2025-04-01,56
STUDY001,QS,STUDY001-SUBJ0038,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,NOT DONE,,,4,WEEK 12,2025-04-29,84
STUDY001,QS,STUDY001-SUBJ0038,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-29,84
STUDY001,QS,STUDY001-SUBJ0038,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-29,84
STUDY001,QS,STUDY001-SUBJ0038,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-29,84
STUDY001,QS,STUDY001-SUBJ0038,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-29,84
STUDY001,QS,STUDY001-SUBJ0038,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-24,140
STUDY001,QS,STUDY001-SUBJ0038,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-24,140
STUDY001,QS,STUDY001-SUBJ0038,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-24,140
STUDY001,QS,STUDY001-SUBJ0038,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,NOT DONE,,,5,END OF TREATMENT,2025-06-24,140
STUDY001,QS,STUDY001-SUBJ0038,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-06-24,140
STUDY001,QS,STUDY001-SUBJ0038,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-06-24,140
STUDY001,QS,STUDY001-SUBJ0039,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-09-19,1
STUDY001,QS,STUDY001-SUBJ0039,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-09-19,1
STUDY001,QS,STUDY001-SUBJ0039,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-09-19,1
STUDY001,QS,STUDY001-SUBJ0039,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-19,1
STUDY001,QS,STUDY001-SUBJ0039,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-09-19,1
STUDY001,QS,STUDY001-SUBJ0039,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-19,1
STUDY001,QS,STUDY001-SUBJ0039,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-09-19,1
STUDY001,QS,STUDY001-SUBJ0039,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-19,1
STUDY001,QS,STUDY001-SUBJ0039,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-09-19,1
STUDY001,QS,STUDY001-SUBJ0039,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-19,1
STUDY001,QS,STUDY001-SUBJ0039,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,35,35,35.0,,,Y,1,BASELINE,2025-09-19,1
STUDY001,QS,STUDY001-SUBJ0039,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-10-16,28
STUDY001,QS,STUDY001-SUBJ0039,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,NOT DONE,,,2,WEEK 4,2025-10-16,28
STUDY001,QS,STUDY001-SUBJ0039,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-10-16,28
STUDY001,QS,STUDY001-SUBJ0039,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-10-16,28
STUDY001,QS,STUDY001-SUBJ0039,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,2,WEEK 4,2025-10-16,28
STUDY001,QS,STUDY001-SUBJ0039,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-10-16,28
STUDY001,QS,STUDY001-SUBJ0039,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-10-16,28
STUDY001,QS,STUDY001-SUBJ0039,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-10-16,28
STUDY001,QS,STUDY001-SUBJ0039,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-10-16,28
STUDY001,QS,STUDY001-SUBJ0039,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-10-16,28
STUDY001,QS,STUDY001-SUBJ0039,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,64,64,64.0,,,,2,WEEK 4,2025-10-16,28
STUDY001,QS,STUDY001-SUBJ0039,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-13,56
STUDY001,QS,STUDY001-SUBJ0039,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-11-13,56
STUDY001,QS,STUDY001-SUBJ0039,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-13,56
STUDY001,QS,STUDY001-SUBJ0039,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-11-13,56
STUDY001,QS,STUDY001-SUBJ0039,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-13,56
STUDY001,QS,STUDY001-SUBJ0039,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-11-13,56
STUDY001,QS,STUDY001-SUBJ0039,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-11-13,56
STUDY001,QS,STUDY001-SUBJ0039,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-11-13,56
STUDY001,QS,STUDY001-SUBJ0039,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-11-13,56
STUDY001,QS,STUDY001-SUBJ0039,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-11-13,56
STUDY001,QS,STUDY001-SUBJ0039,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,67,67,67.0,,,,3,WEEK 8,2025-11-13,56
STUDY001,QS,STUDY001-SUBJ0039,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-12-11,84
STUDY001,QS,STUDY001-SUBJ0039,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-12-11,84
STUDY001,QS,STUDY001-SUBJ0039,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-12-11,84
STUDY001,QS,STUDY001-SUBJ0039,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-12-11,84
STUDY001,QS,STUDY001-SUBJ0039,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-12-11,84
STUDY001,QS,STUDY001-SUBJ0039,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,4,WEEK 12,2025-12-11,84
STUDY001,QS,STUDY001-SUBJ0039,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-12-11,84
STUDY001,QS,STUDY001-SUBJ0039,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-12-11,84
STUDY001,QS,STUDY001-SUBJ0039,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-12-11,84
STUDY001,QS,STUDY001-SUBJ0039,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-12-11,84
STUDY001,QS,STUDY001-SUBJ0039,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,85,85,85.0,,,,4,WEEK 12,2025-12-11,84
STUDY001,QS,STUDY001-SUBJ0040,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-04-29,1
STUDY001,QS,STUDY001-SUBJ0040,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-04-29,1
STUDY001,QS,STUDY001-SUBJ0040,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-04-29,1
STUDY001,QS,STUDY001-SUBJ0040,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-29,1
STUDY001,QS,STUDY001-SUBJ0040,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-04-29,1
STUDY001,QS,STUDY001-SUBJ0040,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-29,1
STUDY001,QS,STUDY001-SUBJ0040,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,NOT DONE,,Y,1,BASELINE,2025-04-29,1
STUDY001,QS,STUDY001-SUBJ0040,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-29,1
STUDY001,QS,STUDY001-SUBJ0040,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,NOT DONE,,Y,1,BASELINE,2025-04-29,1
STUDY001,QS,STUDY001-SUBJ0040,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-29,1
STUDY001,QS,STUDY001-SUBJ0040,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,32,32,32.0,,,Y,1,BASELINE,2025-04-29,1
STUDY001,QS,STUDY001-SUBJ0040,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-26,28
STUDY001,QS,STUDY001-SUBJ0040,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-05-26,28
STUDY001,QS,STUDY001-SUBJ0040,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-26,28
STUDY001,QS,STUDY001-SUBJ0040,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-26,28
STUDY001,QS,STUDY001-SUBJ0040,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-26,28
STUDY001,QS,STUDY001-SUBJ0040,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-26,28
STUDY001,QS,STUDY001-SUBJ0040,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-05-26,28
STUDY001,QS,STUDY001-SUBJ0040,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-26,28
STUDY001,QS,STUDY001-SUBJ0040,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-05-26,28
STUDY001,QS,STUDY001-SUBJ0040,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-26,28
STUDY001,QS,STUDY001-SUBJ0040,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,57,57,57.0,,,,2,WEEK 4,2025-05-26,28
STUDY001,QS,STUDY001-SUBJ0040,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-23,56
STUDY001,QS,STUDY001-SUBJ0040,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-06-23,56
STUDY001,QS,STUDY001-SUBJ0040,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-23,56
STUDY001,QS,STUDY001-SUBJ0040,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-23,56
STUDY001,QS,STUDY001-SUBJ0040,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,3,WEEK 8,2025-06-23,56
STUDY001,QS,STUDY001-SUBJ0040,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-23,56
STUDY001,QS,STUDY001-SUBJ0040,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-06-23,56
STUDY001,QS,STUDY001-SUBJ0040,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-23,56
STUDY001,QS,STUDY001-SUBJ0040,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-06-23,56
STUDY001,QS,STUDY001-SUBJ0040,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-23,56
STUDY001,QS,STUDY001-SUBJ0040,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,74,74,74.0,,,,3,WEEK 8,2025-06-23,56
STUDY001,QS,STUDY001-SUBJ0040,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-21,84
STUDY001,QS,STUDY001-SUBJ0040,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-07-21,84
STUDY001,QS,STUDY001-SUBJ0040,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-21,84
STUDY001,QS,STUDY001-SUBJ0040,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-21,84
STUDY001,QS,STUDY001-SUBJ0040,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-21,84
STUDY001,QS,STUDY001-SUBJ0040,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-21,84
STUDY001,QS,STUDY001-SUBJ0040,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,NOT DONE,,,4,WEEK 12,2025-07-21,84
STUDY001,QS,STUDY001-SUBJ0040,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-21,84
STUDY001,QS,STUDY001-SUBJ0040,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-07-21,84
STUDY001,QS,STUDY001-SUBJ0040,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-21,84
STUDY001,QS,STUDY001-SUBJ0040,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,88,88,88.0,,,,4,WEEK 12,2025-07-21,84
STUDY001,QS,STUDY001-SUBJ0040,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-09-15,140
STUDY001,QS,STUDY001-SUBJ0040,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-15,140
STUDY001,QS,STUDY001-SUBJ0040,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-15,140
STUDY001,QS,STUDY001-SUBJ0040,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-15,140
STUDY001,QS,STUDY001-SUBJ0040,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-15,140
STUDY001,QS,STUDY001-SUBJ0041,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-06-30,1
STUDY001,QS,STUDY001-SUBJ0041,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-06-30,1
STUDY001,QS,STUDY001-SUBJ0041,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-06-30,1
STUDY001,QS,STUDY001-SUBJ0041,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-06-30,1
STUDY001,QS,STUDY001-SUBJ0041,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-06-30,1
STUDY001,QS,STUDY001-SUBJ0041,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-06-30,1
STUDY001,QS,STUDY001-SUBJ0041,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-06-30,1
STUDY001,QS,STUDY001-SUBJ0041,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-06-30,1
STUDY001,QS,STUDY001-SUBJ0041,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-06-30,1
STUDY001,QS,STUDY001-SUBJ0041,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-06-30,1
STUDY001,QS,STUDY001-SUBJ0041,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,65,65,65.0,,,Y,1,BASELINE,2025-06-30,1
STUDY001,QS,STUDY001-SUBJ0041,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-27,28
STUDY001,QS,STUDY001-SUBJ0041,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-07-27,28
STUDY001,QS,STUDY001-SUBJ0041,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-27,28
STUDY001,QS,STUDY001-SUBJ0041,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-27,28
STUDY001,QS,STUDY001-SUBJ0041,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-27,28
STUDY001,QS,STUDY001-SUBJ0041,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-27,28
STUDY001,QS,STUDY001-SUBJ0041,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-07-27,28
STUDY001,QS,STUDY001-SUBJ0041,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-27,28
STUDY001,QS,STUDY001-SUBJ0041,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-07-27,28
STUDY001,QS,STUDY001-SUBJ0041,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-27,28
STUDY001,QS,STUDY001-SUBJ0041,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,57,57,57.0,,,,2,WEEK 4,2025-07-27,28
STUDY001,QS,STUDY001-SUBJ0041,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,3,WEEK 8,2025-08-24,56
STUDY001,QS,STUDY001-SUBJ0041,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-08-24,56
STUDY001,QS,STUDY001-SUBJ0041,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-24,56
STUDY001,QS,STUDY001-SUBJ0041,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-08-24,56
STUDY001,QS,STUDY001-SUBJ0041,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-24,56
STUDY001,QS,STUDY001-SUBJ0041,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-08-24,56
STUDY001,QS,STUDY001-SUBJ0041,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-08-24,56
STUDY001,QS,STUDY001-SUBJ0041,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-08-24,56
STUDY001,QS,STUDY001-SUBJ0041,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-08-24,56
STUDY001,QS,STUDY001-SUBJ0041,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-08-24,56
STUDY001,QS,STUDY001-SUBJ0041,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,NOT DONE,,,3,WEEK 8,2025-08-24,56
STUDY001,QS,STUDY001-SUBJ0041,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,4,WEEK 12,2025-09-21,84
STUDY001,QS,STUDY001-SUBJ0041,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-09-21,84
STUDY001,QS,STUDY001-SUBJ0041,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-21,84
STUDY001,QS,STUDY001-SUBJ0041,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-21,84
STUDY001,QS,STUDY001-SUBJ0041,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-21,84
STUDY001,QS,STUDY001-SUBJ0041,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,4,WEEK 12,2025-09-21,84
STUDY001,QS,STUDY001-SUBJ0041,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-09-21,84
STUDY001,QS,STUDY001-SUBJ0041,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-21,84
STUDY001,QS,STUDY001-SUBJ0041,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-09-21,84
STUDY001,QS,STUDY001-SUBJ0041,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-21,84
STUDY001,QS,STUDY001-SUBJ0041,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,87,87,87.0,,,,4,WEEK 12,2025-09-21,84
STUDY001,QS,STUDY001-SUBJ0041,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-16,140
STUDY001,QS,STUDY001-SUBJ0041,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-16,140
STUDY001,QS,STUDY001-SUBJ0041,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-16,140
STUDY001,QS,STUDY001-SUBJ0041,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-11-16,140
STUDY001,QS,STUDY001-SUBJ0041,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-11-16,140
STUDY001,QS,STUDY001-SUBJ0041,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-11-16,140
STUDY001,QS,STUDY001-SUBJ0042,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-12-02,1
STUDY001,QS,STUDY001-SUBJ0042,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-12-02,1
STUDY001,QS,STUDY001-SUBJ0042,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-12-02,1
STUDY001,QS,STUDY001-SUBJ0042,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-12-02,1
STUDY001,QS,STUDY001-SUBJ0042,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-12-02,1
STUDY001,QS,STUDY001-SUBJ0042,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-12-02,1
STUDY001,QS,STUDY001-SUBJ0042,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-12-02,1
STUDY001,QS,STUDY001-SUBJ0042,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-12-02,1
STUDY001,QS,STUDY001-SUBJ0042,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-12-02,1
STUDY001,QS,STUDY001-SUBJ0042,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-12-02,1
STUDY001,QS,STUDY001-SUBJ0042,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,31,31,31.0,,,Y,1,BASELINE,2025-12-02,1
STUDY001,QS,STUDY001-SUBJ0042,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-29,28
STUDY001,QS,STUDY001-SUBJ0042,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-29,28
STUDY001,QS,STUDY001-SUBJ0042,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-29,28
STUDY001,QS,STUDY001-SUBJ0042,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-12-29,28
STUDY001,QS,STUDY001-SUBJ0042,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,NOT DONE,,,2,WEEK 4,2025-12-29,28
STUDY001,QS,STUDY001-SUBJ0042,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,2,WEEK 4,2025-12-29,28
STUDY001,QS,STUDY001-SUBJ0043,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-13,1
STUDY001,QS,STUDY001-SUBJ0043,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-13,1
STUDY001,QS,STUDY001-SUBJ0043,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-13,1
STUDY001,QS,STUDY001-SUBJ0043,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-04-13,1
STUDY001,QS,STUDY001-SUBJ0043,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-04-13,1
STUDY001,QS,STUDY001-SUBJ0043,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,43,43,43.0,,,Y,1,BASELINE,2025-04-13,1
STUDY001,QS,STUDY001-SUBJ0043,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-10,28
STUDY001,QS,STUDY001-SUBJ0043,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-05-10,28
STUDY001,QS,STUDY001-SUBJ0043,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-10,28
STUDY001,QS,STUDY001-SUBJ0043,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-10,28
STUDY001,QS,STUDY001-SUBJ0043,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-10,28
STUDY001,QS,STUDY001-SUBJ0043,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-10,28
STUDY001,QS,STUDY001-SUBJ0043,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-05-10,28
STUDY001,QS,STUDY001-SUBJ0043,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-10,28
STUDY001,QS,STUDY001-SUBJ0043,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-05-10,28
STUDY001,QS,STUDY001-SUBJ0043,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-10,28
STUDY001,QS,STUDY001-SUBJ0043,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,57,57,57.0,,,,2,WEEK 4,2025-05-10,28
STUDY001,QS,STUDY001-SUBJ0043,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-06-07,56
STUDY001,QS,STUDY001-SUBJ0043,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-07,56
STUDY001,QS,STUDY001-SUBJ0043,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-07,56
STUDY001,QS,STUDY001-SUBJ0043,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-07,56
STUDY001,QS,STUDY001-SUBJ0043,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-07,56
STUDY001,QS,STUDY001-SUBJ0043,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-07-05,84
STUDY001,QS,STUDY001-SUBJ0043,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-05,84
STUDY001,QS,STUDY001-SUBJ0043,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-05,84
STUDY001,QS,STUDY001-SUBJ0043,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-05,84
STUDY001,QS,STUDY001-SUBJ0043,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-05,84
STUDY001,QS,STUDY001-SUBJ0043,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-30,140
STUDY001,QS,STUDY001-SUBJ0043,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-08-30,140
STUDY001,QS,STUDY001-SUBJ0043,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-30,140
STUDY001,QS,STUDY001-SUBJ0043,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-30,140
STUDY001,QS,STUDY001-SUBJ0043,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-30,140
STUDY001,QS,STUDY001-SUBJ0043,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-30,140
STUDY001,QS,STUDY001-SUBJ0043,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-08-30,140
STUDY001,QS,STUDY001-SUBJ0043,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-30,140
STUDY001,QS,STUDY001-SUBJ0043,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-08-30,140
STUDY001,QS,STUDY001-SUBJ0043,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-30,140
STUDY001,QS,STUDY001-SUBJ0043,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-08-30,140
STUDY001,QS,STUDY001-SUBJ0044,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-11-22,1
STUDY001,QS,STUDY001-SUBJ0044,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-22,1
STUDY001,QS,STUDY001-SUBJ0044,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-22,1
STUDY001,QS,STUDY001-SUBJ0044,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-22,1
STUDY001,QS,STUDY001-SUBJ0044,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-22,1
STUDY001,QS,STUDY001-SUBJ0044,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-19,28
STUDY001,QS,STUDY001-SUBJ0044,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-19,28
STUDY001,QS,STUDY001-SUBJ0044,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-19,28
STUDY001,QS,STUDY001-SUBJ0044,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-12-19,28
STUDY001,QS,STUDY001-SUBJ0044,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-12-19,28
STUDY001,QS,STUDY001-SUBJ0044,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,2,WEEK 4,2025-12-19,28
STUDY001,QS,STUDY001-SUBJ0045,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-08-24,1
STUDY001,QS,STUDY001-SUBJ0045,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-08-24,1
STUDY001,QS,STUDY001-SUBJ0045,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-08-24,1
STUDY001,QS,STUDY001-SUBJ0045,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-08-24,1
STUDY001,QS,STUDY001-SUBJ0045,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-08-24,1
STUDY001,QS,STUDY001-SUBJ0045,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,66,66,66.0,NOT DONE,,Y,1,BASELINE,2025-08-24,1
STUDY001,QS,STUDY001-SUBJ0045,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-09-20,28
STUDY001,QS,STUDY001-SUBJ0045,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-09-20,28
STUDY001,QS,STUDY001-SUBJ0045,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-09-20,28
STUDY001,QS,STUDY001-SUBJ0045,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-20,28
STUDY001,QS,STUDY001-SUBJ0045,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-09-20,28
STUDY001,QS,STUDY001-SUBJ0045,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-20,28
STUDY001,QS,STUDY001-SUBJ0045,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-09-20,28
STUDY001,QS,STUDY001-SUBJ0045,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,2,WEEK 4,2025-09-20,28
STUDY001,QS,STUDY001-SUBJ0045,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-09-20,28
STUDY001,QS,STUDY001-SUBJ0045,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-20,28
STUDY001,QS,STUDY001-SUBJ0045,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,,,,2,WEEK 4,2025-09-20,28
STUDY001,QS,STUDY001-SUBJ0045,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-18,56
STUDY001,QS,STUDY001-SUBJ0045,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-18,56
STUDY001,QS,STUDY001-SUBJ0045,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-18,56
STUDY001,QS,STUDY001-SUBJ0045,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-10-18,56
STUDY001,QS,STUDY001-SUBJ0045,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-10-18,56
STUDY001,QS,STUDY001-SUBJ0045,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,65,65,65.0,,,,3,WEEK 8,2025-10-18,56
STUDY001,QS,STUDY001-SUBJ0045,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-11-15,84
STUDY001,QS,STUDY001-SUBJ0045,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,4,WEEK 12,2025-11-15,84
STUDY001,QS,STUDY001-SUBJ0045,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-11-15,84
STUDY001,QS,STUDY001-SUBJ0045,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-11-15,84
STUDY001,QS,STUDY001-SUBJ0045,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-11-15,84
STUDY001,QS,STUDY001-SUBJ0045,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-11-15,84
STUDY001,QS,STUDY001-SUBJ0045,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,4,WEEK 12,2025-11-15,84
STUDY001,QS,STUDY001-SUBJ0045,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-11-15,84
STUDY001,QS,STUDY001-SUBJ0045,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,4,WEEK 12,2025-11-15,84
STUDY001,QS,STUDY001-SUBJ0045,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,4,WEEK 12,2025-11-15,84
STUDY001,QS,STUDY001-SUBJ0045,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,71,71,71.0,,,,4,WEEK 12,2025-11-15,84
STUDY001,QS,STUDY001-SUBJ0046,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-01-14,1
STUDY001,QS,STUDY001-SUBJ0046,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-01-14,1
STUDY001,QS,STUDY001-SUBJ0046,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-01-14,1
STUDY001,QS,STUDY001-SUBJ0046,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-01-14,1
STUDY001,QS,STUDY001-SUBJ0046,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-01-14,1
STUDY001,QS,STUDY001-SUBJ0046,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-01-14,1
STUDY001,QS,STUDY001-SUBJ0046,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-01-14,1
STUDY001,QS,STUDY001-SUBJ0046,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-01-14,1
STUDY001,QS,STUDY001-SUBJ0046,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-01-14,1
STUDY001,QS,STUDY001-SUBJ0046,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-01-14,1
STUDY001,QS,STUDY001-SUBJ0046,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,45,45,45.0,,,Y,1,BASELINE,2025-01-14,1
STUDY001,QS,STUDY001-SUBJ0046,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-02-10,28
STUDY001,QS,STUDY001-SUBJ0046,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-02-10,28
STUDY001,QS,STUDY001-SUBJ0046,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-02-10,28
STUDY001,QS,STUDY001-SUBJ0046,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-02-10,28
STUDY001,QS,STUDY001-SUBJ0046,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-02-10,28
STUDY001,QS,STUDY001-SUBJ0046,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-02-10,28
STUDY001,QS,STUDY001-SUBJ0046,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-02-10,28
STUDY001,QS,STUDY001-SUBJ0046,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-02-10,28
STUDY001,QS,STUDY001-SUBJ0046,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-02-10,28
STUDY001,QS,STUDY001-SUBJ0046,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,2,WEEK 4,2025-02-10,28
STUDY001,QS,STUDY001-SUBJ0046,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,58,58,58.0,,,,2,WEEK 4,2025-02-10,28
STUDY001,QS,STUDY001-SUBJ0046,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-10,56
STUDY001,QS,STUDY001-SUBJ0046,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-03-10,56
STUDY001,QS,STUDY001-SUBJ0046,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-10,56
STUDY001,QS,STUDY001-SUBJ0046,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-10,56
STUDY001,QS,STUDY001-SUBJ0046,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-10,56
STUDY001,QS,STUDY001-SUBJ0046,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-10,56
STUDY001,QS,STUDY001-SUBJ0046,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-03-10,56
STUDY001,QS,STUDY001-SUBJ0046,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-10,56
STUDY001,QS,STUDY001-SUBJ0046,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-03-10,56
STUDY001,QS,STUDY001-SUBJ0046,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-10,56
STUDY001,QS,STUDY001-SUBJ0046,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,70,70,70.0,,,,3,WEEK 8,2025-03-10,56
STUDY001,QS,STUDY001-SUBJ0046,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-07,84
STUDY001,QS,STUDY001-SUBJ0046,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-04-07,84
STUDY001,QS,STUDY001-SUBJ0046,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,4,WEEK 12,2025-04-07,84
STUDY001,QS,STUDY001-SUBJ0046,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-07,84
STUDY001,QS,STUDY001-SUBJ0046,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-07,84
STUDY001,QS,STUDY001-SUBJ0046,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-07,84
STUDY001,QS,STUDY001-SUBJ0046,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,NOT DONE,,,4,WEEK 12,2025-04-07,84
STUDY001,QS,STUDY001-SUBJ0046,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-07,84
STUDY001,QS,STUDY001-SUBJ0046,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-04-07,84
STUDY001,QS,STUDY001-SUBJ0046,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-07,84
STUDY001,QS,STUDY001-SUBJ0046,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-04-07,84
STUDY001,QS,STUDY001-SUBJ0046,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-02,140
STUDY001,QS,STUDY001-SUBJ0046,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-06-02,140
STUDY001,QS,STUDY001-SUBJ0046,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-02,140
STUDY001,QS,STUDY001-SUBJ0046,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-02,140
STUDY001,QS,STUDY001-SUBJ0046,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-02,140
STUDY001,QS,STUDY001-SUBJ0046,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,5,END OF TREATMENT,2025-06-02,140
STUDY001,QS,STUDY001-SUBJ0046,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-06-02,140
STUDY001,QS,STUDY001-SUBJ0046,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-02,140
STUDY001,QS,STUDY001-SUBJ0046,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-06-02,140
STUDY001,QS,STUDY001-SUBJ0046,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-02,140
STUDY001,QS,STUDY001-SUBJ0046,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-06-02,140
STUDY001,QS,STUDY001-SUBJ0047,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,Y,1,BASELINE,2025-09-09,1
STUDY001,QS,STUDY001-SUBJ0047,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-09-09,1
STUDY001,QS,STUDY001-SUBJ0047,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-09-09,1
STUDY001,QS,STUDY001-SUBJ0047,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,NOT DONE,,Y,1,BASELINE,2025-09-09,1
STUDY001,QS,STUDY001-SUBJ0047,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-09-09,1
STUDY001,QS,STUDY001-SUBJ0047,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,69,69,69.0,,,Y,1,BASELINE,2025-09-09,1
STUDY001,QS,STUDY001-SUBJ0047,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-10-06,28
STUDY001,QS,STUDY001-SUBJ0047,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-10-06,28
STUDY001,QS,STUDY001-SUBJ0047,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-10-06,28
STUDY001,QS,STUDY001-SUBJ0047,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-06,28
STUDY001,QS,STUDY001-SUBJ0047,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-10-06,28
STUDY001,QS,STUDY001-SUBJ0047,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-06,28
STUDY001,QS,STUDY001-SUBJ0047,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-10-06,28
STUDY001,QS,STUDY001-SUBJ0047,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-06,28
STUDY001,QS,STUDY001-SUBJ0047,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-10-06,28
STUDY001,QS,STUDY001-SUBJ0047,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-06,28
STUDY001,QS,STUDY001-SUBJ0047,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,62,62,62.0,,,,2,WEEK 4,2025-10-06,28
STUDY001,QS,STUDY001-SUBJ0047,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-03,56
STUDY001,QS,STUDY001-SUBJ0047,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-03,56
STUDY001,QS,STUDY001-SUBJ0047,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,3,WEEK 8,2025-11-03,56
STUDY001,QS,STUDY001-SUBJ0047,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-11-03,56
STUDY001,QS,STUDY001-SUBJ0047,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-11-03,56
STUDY001,QS,STUDY001-SUBJ0047,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,76,76,76.0,,,,3,WEEK 8,2025-11-03,56
STUDY001,QS,STUDY001-SUBJ0047,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-12-01,84
STUDY001,QS,STUDY001-SUBJ0047,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-12-01,84
STUDY001,QS,STUDY001-SUBJ0047,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-12-01,84
STUDY001,QS,STUDY001-SUBJ0047,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-12-01,84
STUDY001,QS,STUDY001-SUBJ0047,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-12-01,84
STUDY001,QS,STUDY001-SUBJ0047,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-12-01,84
STUDY001,QS,STUDY001-SUBJ0047,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-12-01,84
STUDY001,QS,STUDY001-SUBJ0047,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-12-01,84
STUDY001,QS,STUDY001-SUBJ0047,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-12-01,84
STUDY001,QS,STUDY001-SUBJ0047,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-12-01,84
STUDY001,QS,STUDY001-SUBJ0047,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,87,87,87.0,,,,4,WEEK 12,2025-12-01,84
STUDY001,QS,STUDY001-SUBJ0048,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,NOT DONE,,Y,1,BASELINE,2025-06-11,1
STUDY001,QS,STUDY001-SUBJ0048,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-06-11,1
STUDY001,QS,STUDY001-SUBJ0048,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-06-11,1
STUDY001,QS,STUDY001-SUBJ0048,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-06-11,1
STUDY001,QS,STUDY001-SUBJ0048,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-06-11,1
STUDY001,QS,STUDY001-SUBJ0048,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-06-11,1
STUDY001,QS,STUDY001-SUBJ0048,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,NOT DONE,,Y,1,BASELINE,2025-06-11,1
STUDY001,QS,STUDY001-SUBJ0048,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-06-11,1
STUDY001,QS,STUDY001-SUBJ0048,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-06-11,1
STUDY001,QS,STUDY001-SUBJ0048,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-06-11,1
STUDY001,QS,STUDY001-SUBJ0048,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,32,32,32.0,,,Y,1,BASELINE,2025-06-11,1
STUDY001,QS,STUDY001-SUBJ0048,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-08,28
STUDY001,QS,STUDY001-SUBJ0048,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-07-08,28
STUDY001,QS,STUDY001-SUBJ0048,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-08,28
STUDY001,QS,STUDY001-SUBJ0048,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-08,28
STUDY001,QS,STUDY001-SUBJ0048,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-08,28
STUDY001,QS,STUDY001-SUBJ0048,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-08,28
STUDY001,QS,STUDY001-SUBJ0048,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,NOT DONE,,,2,WEEK 4,2025-07-08,28
STUDY001,QS,STUDY001-SUBJ0048,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-08,28
STUDY001,QS,STUDY001-SUBJ0048,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-07-08,28
STUDY001,QS,STUDY001-SUBJ0048,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-08,28
STUDY001,QS,STUDY001-SUBJ0048,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,55,55,55.0,,,,2,WEEK 4,2025-07-08,28
STUDY001,QS,STUDY001-SUBJ0048,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-05,56
STUDY001,QS,STUDY001-SUBJ0048,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-08-05,56
STUDY001,QS,STUDY001-SUBJ0048,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-05,56
STUDY001,QS,STUDY001-SUBJ0048,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-05,56
STUDY001,QS,STUDY001-SUBJ0048,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-05,56
STUDY001,QS,STUDY001-SUBJ0048,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-05,56
STUDY001,QS,STUDY001-SUBJ0048,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-08-05,56
STUDY001,QS,STUDY001-SUBJ0048,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-05,56
STUDY001,QS,STUDY001-SUBJ0048,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-08-05,56
STUDY001,QS,STUDY001-SUBJ0048,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-05,56
STUDY001,QS,STUDY001-SUBJ0048,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,75,75,75.0,,,,3,WEEK 8,2025-08-05,56
STUDY001,QS,STUDY001-SUBJ0048,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-02,84
STUDY001,QS,STUDY001-SUBJ0048,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-09-02,84
STUDY001,QS,STUDY001-SUBJ0048,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-02,84
STUDY001,QS,STUDY001-SUBJ0048,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-02,84
STUDY001,QS,STUDY001-SUBJ0048,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-02,84
STUDY001,QS,STUDY001-SUBJ0048,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-02,84
STUDY001,QS,STUDY001-SUBJ0048,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-09-02,84
STUDY001,QS,STUDY001-SUBJ0048,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-02,84
STUDY001,QS,STUDY001-SUBJ0048,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-09-02,84
STUDY001,QS,STUDY001-SUBJ0048,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-02,84
STUDY001,QS,STUDY001-SUBJ0048,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-09-02,84
STUDY001,QS,STUDY001-SUBJ0048,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-28,140
STUDY001,QS,STUDY001-SUBJ0048,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-10-28,140
STUDY001,QS,STUDY001-SUBJ0048,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-28,140
STUDY001,QS,STUDY001-SUBJ0048,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-28,140
STUDY001,QS,STUDY001-SUBJ0048,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-28,140
STUDY001,QS,STUDY001-SUBJ0048,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-28,140
STUDY001,QS,STUDY001-SUBJ0048,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-10-28,140
STUDY001,QS,STUDY001-SUBJ0048,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-28,140
STUDY001,QS,STUDY001-SUBJ0048,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-10-28,140
STUDY001,QS,STUDY001-SUBJ0048,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-28,140
STUDY001,QS,STUDY001-SUBJ0048,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-10-28,140
STUDY001,QS,STUDY001-SUBJ0049,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-11-13,1
STUDY001,QS,STUDY001-SUBJ0049,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-13,1
STUDY001,QS,STUDY001-SUBJ0049,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-13,1
STUDY001,QS,STUDY001-SUBJ0049,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-13,1
STUDY001,QS,STUDY001-SUBJ0049,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-13,1
STUDY001,QS,STUDY001-SUBJ0049,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-10,28
STUDY001,QS,STUDY001-SUBJ0049,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-10,28
STUDY001,QS,STUDY001-SUBJ0049,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-10,28
STUDY001,QS,STUDY001-SUBJ0049,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-12-10,28
STUDY001,QS,STUDY001-SUBJ0049,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-12-10,28
STUDY001,QS,STUDY001-SUBJ0049,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,62,62,62.0,,,,2,WEEK 4,2025-12-10,28
STUDY001,QS,STUDY001-SUBJ0050,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-03,1
STUDY001,QS,STUDY001-SUBJ0050,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-11-03,1
STUDY001,QS,STUDY001-SUBJ0050,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-03,1
STUDY001,QS,STUDY001-SUBJ0050,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-03,1
STUDY001,QS,STUDY001-SUBJ0050,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-03,1
STUDY001,QS,STUDY001-SUBJ0050,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-03,1
STUDY001,QS,STUDY001-SUBJ0050,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-11-03,1
STUDY001,QS,STUDY001-SUBJ0050,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-03,1
STUDY001,QS,STUDY001-SUBJ0050,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-11-03,1
STUDY001,QS,STUDY001-SUBJ0050,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-03,1
STUDY001,QS,STUDY001-SUBJ0050,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,51,51,51.0,,,Y,1,BASELINE,2025-11-03,1
STUDY001,QS,STUDY001-SUBJ0050,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-30,28
STUDY001,QS,STUDY001-SUBJ0050,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-11-30,28
STUDY001,QS,STUDY001-SUBJ0050,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-30,28
STUDY001,QS,STUDY001-SUBJ0050,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-11-30,28
STUDY001,QS,STUDY001-SUBJ0050,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-30,28
STUDY001,QS,STUDY001-SUBJ0050,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-11-30,28
STUDY001,QS,STUDY001-SUBJ0050,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-11-30,28
STUDY001,QS,STUDY001-SUBJ0050,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-11-30,28
STUDY001,QS,STUDY001-SUBJ0050,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-11-30,28
STUDY001,QS,STUDY001-SUBJ0050,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-11-30,28
STUDY001,QS,STUDY001-SUBJ0050,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,61,61,61.0,,,,2,WEEK 4,2025-11-30,28
STUDY001,QS,STUDY001-SUBJ0051,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-03-18,1
STUDY001,QS,STUDY001-SUBJ0051,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-03-18,1
STUDY001,QS,STUDY001-SUBJ0051,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-03-18,1
STUDY001,QS,STUDY001-SUBJ0051,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-18,1
STUDY001,QS,STUDY001-SUBJ0051,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-03-18,1
STUDY001,QS,STUDY001-SUBJ0051,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-18,1
STUDY001,QS,STUDY001-SUBJ0051,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-03-18,1
STUDY001,QS,STUDY001-SUBJ0051,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-18,1
STUDY001,QS,STUDY001-SUBJ0051,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-03-18,1
STUDY001,QS,STUDY001-SUBJ0051,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-18,1
STUDY001,QS,STUDY001-SUBJ0051,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,55,55,55.0,,,Y,1,BASELINE,2025-03-18,1
STUDY001,QS,STUDY001-SUBJ0051,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-04-14,28
STUDY001,QS,STUDY001-SUBJ0051,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-14,28
STUDY001,QS,STUDY001-SUBJ0051,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-14,28
STUDY001,QS,STUDY001-SUBJ0051,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-14,28
STUDY001,QS,STUDY001-SUBJ0051,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-14,28
STUDY001,QS,STUDY001-SUBJ0051,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-12,56
STUDY001,QS,STUDY001-SUBJ0051,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-05-12,56
STUDY001,QS,STUDY001-SUBJ0051,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-12,56
STUDY001,QS,STUDY001-SUBJ0051,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-12,56
STUDY001,QS,STUDY001-SUBJ0051,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-12,56
STUDY001,QS,STUDY001-SUBJ0051,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-12,56
STUDY001,QS,STUDY001-SUBJ0051,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-05-12,56
STUDY001,QS,STUDY001-SUBJ0051,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-12,56
STUDY001,QS,STUDY001-SUBJ0051,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-05-12,56
STUDY001,QS,STUDY001-SUBJ0051,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-12,56
STUDY001,QS,STUDY001-SUBJ0051,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,66,66,66.0,,,,3,WEEK 8,2025-05-12,56
STUDY001,QS,STUDY001-SUBJ0051,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-06-09,84
STUDY001,QS,STUDY001-SUBJ0051,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-06-09,84
STUDY001,QS,STUDY001-SUBJ0051,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-06-09,84
STUDY001,QS,STUDY001-SUBJ0051,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-09,84
STUDY001,QS,STUDY001-SUBJ0051,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-06-09,84
STUDY001,QS,STUDY001-SUBJ0051,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-09,84
STUDY001,QS,STUDY001-SUBJ0051,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-06-09,84
STUDY001,QS,STUDY001-SUBJ0051,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-09,84
STUDY001,QS,STUDY001-SUBJ0051,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-06-09,84
STUDY001,QS,STUDY001-SUBJ0051,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-09,84
STUDY001,QS,STUDY001-SUBJ0051,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,87,87,87.0,,,,4,WEEK 12,2025-06-09,84
STUDY001,QS,STUDY001-SUBJ0051,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-04,140
STUDY001,QS,STUDY001-SUBJ0051,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-08-04,140
STUDY001,QS,STUDY001-SUBJ0051,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-04,140
STUDY001,QS,STUDY001-SUBJ0051,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-04,140
STUDY001,QS,STUDY001-SUBJ0051,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-04,140
STUDY001,QS,STUDY001-SUBJ0051,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-04,140
STUDY001,QS,STUDY001-SUBJ0051,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-08-04,140
STUDY001,QS,STUDY001-SUBJ0051,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-04,140
STUDY001,QS,STUDY001-SUBJ0051,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,NOT DONE,,,5,END OF TREATMENT,2025-08-04,140
STUDY001,QS,STUDY001-SUBJ0051,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-04,140
STUDY001,QS,STUDY001-SUBJ0051,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-08-04,140
STUDY001,QS,STUDY001-SUBJ0052,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-05-02,1
STUDY001,QS,STUDY001-SUBJ0052,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-05-02,1
STUDY001,QS,STUDY001-SUBJ0052,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-05-02,1
STUDY001,QS,STUDY001-SUBJ0052,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-05-02,1
STUDY001,QS,STUDY001-SUBJ0052,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-05-02,1
STUDY001,QS,STUDY001-SUBJ0052,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-05-02,1
STUDY001,QS,STUDY001-SUBJ0052,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-05-02,1
STUDY001,QS,STUDY001-SUBJ0052,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-05-02,1
STUDY001,QS,STUDY001-SUBJ0052,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-05-02,1
STUDY001,QS,STUDY001-SUBJ0052,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-05-02,1
STUDY001,QS,STUDY001-SUBJ0052,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,55,55,55.0,,,Y,1,BASELINE,2025-05-02,1
STUDY001,QS,STUDY001-SUBJ0052,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-05-29,28
STUDY001,QS,STUDY001-SUBJ0052,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-05-29,28
STUDY001,QS,STUDY001-SUBJ0052,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-05-29,28
STUDY001,QS,STUDY001-SUBJ0052,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-29,28
STUDY001,QS,STUDY001-SUBJ0052,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-05-29,28
STUDY001,QS,STUDY001-SUBJ0052,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-29,28
STUDY001,QS,STUDY001-SUBJ0052,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-05-29,28
STUDY001,QS,STUDY001-SUBJ0052,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-29,28
STUDY001,QS,STUDY001-SUBJ0052,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-05-29,28
STUDY001,QS,STUDY001-SUBJ0052,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-29,28
STUDY001,QS,STUDY001-SUBJ0052,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,61,61,61.0,,,,2,WEEK 4,2025-05-29,28
STUDY001,QS,STUDY001-SUBJ0052,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-26,56
STUDY001,QS,STUDY001-SUBJ0052,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-06-26,56
STUDY001,QS,STUDY001-SUBJ0052,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-26,56
STUDY001,QS,STUDY001-SUBJ0052,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-26,56
STUDY001,QS,STUDY001-SUBJ0052,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,3,WEEK 8,2025-06-26,56
STUDY001,QS,STUDY001-SUBJ0052,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-26,56
STUDY001,QS,STUDY001-SUBJ0052,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,NOT DONE,,,3,WEEK 8,2025-06-26,56
STUDY001,QS,STUDY001-SUBJ0052,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-26,56
STUDY001,QS,STUDY001-SUBJ0052,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-06-26,56
STUDY001,QS,STUDY001-SUBJ0052,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-26,56
STUDY001,QS,STUDY001-SUBJ0052,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,75,75,75.0,,,,3,WEEK 8,2025-06-26,56
STUDY001,QS,STUDY001-SUBJ0052,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-24,84
STUDY001,QS,STUDY001-SUBJ0052,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-07-24,84
STUDY001,QS,STUDY001-SUBJ0052,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-24,84
STUDY001,QS,STUDY001-SUBJ0052,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-24,84
STUDY001,QS,STUDY001-SUBJ0052,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-24,84
STUDY001,QS,STUDY001-SUBJ0052,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-24,84
STUDY001,QS,STUDY001-SUBJ0052,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-07-24,84
STUDY001,QS,STUDY001-SUBJ0052,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-24,84
STUDY001,QS,STUDY001-SUBJ0052,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-07-24,84
STUDY001,QS,STUDY001-SUBJ0052,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-24,84
STUDY001,QS,STUDY001-SUBJ0052,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-07-24,84
STUDY001,QS,STUDY001-SUBJ0052,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-18,140
STUDY001,QS,STUDY001-SUBJ0052,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-09-18,140
STUDY001,QS,STUDY001-SUBJ0052,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-18,140
STUDY001,QS,STUDY001-SUBJ0052,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-18,140
STUDY001,QS,STUDY001-SUBJ0052,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-18,140
STUDY001,QS,STUDY001-SUBJ0052,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-18,140
STUDY001,QS,STUDY001-SUBJ0052,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-09-18,140
STUDY001,QS,STUDY001-SUBJ0052,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-18,140
STUDY001,QS,STUDY001-SUBJ0052,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-09-18,140
STUDY001,QS,STUDY001-SUBJ0052,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-18,140
STUDY001,QS,STUDY001-SUBJ0052,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-09-18,140
STUDY001,QS,STUDY001-SUBJ0053,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-10-26,1
STUDY001,QS,STUDY001-SUBJ0053,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-10-26,1
STUDY001,QS,STUDY001-SUBJ0053,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-10-26,1
STUDY001,QS,STUDY001-SUBJ0053,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-26,1
STUDY001,QS,STUDY001-SUBJ0053,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-10-26,1
STUDY001,QS,STUDY001-SUBJ0053,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-26,1
STUDY001,QS,STUDY001-SUBJ0053,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-10-26,1
STUDY001,QS,STUDY001-SUBJ0053,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,NOT DONE,,Y,1,BASELINE,2025-10-26,1
STUDY001,QS,STUDY001-SUBJ0053,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-10-26,1
STUDY001,QS,STUDY001-SUBJ0053,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-26,1
STUDY001,QS,STUDY001-SUBJ0053,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,64,64,64.0,,,Y,1,BASELINE,2025-10-26,1
STUDY001,QS,STUDY001-SUBJ0053,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-22,28
STUDY001,QS,STUDY001-SUBJ0053,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-11-22,28
STUDY001,QS,STUDY001-SUBJ0053,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-22,28
STUDY001,QS,STUDY001-SUBJ0053,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-22,28
STUDY001,QS,STUDY001-SUBJ0053,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-22,28
STUDY001,QS,STUDY001-SUBJ0053,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-22,28
STUDY001,QS,STUDY001-SUBJ0053,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-11-22,28
STUDY001,QS,STUDY001-SUBJ0053,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-22,28
STUDY001,QS,STUDY001-SUBJ0053,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-11-22,28
STUDY001,QS,STUDY001-SUBJ0053,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-22,28
STUDY001,QS,STUDY001-SUBJ0053,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,2,WEEK 4,2025-11-22,28
STUDY001,QS,STUDY001-SUBJ0054,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-03-29,1
STUDY001,QS,STUDY001-SUBJ0054,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-03-29,1
STUDY001,QS,STUDY001-SUBJ0054,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-03-29,1
STUDY001,QS,STUDY001-SUBJ0054,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-29,1
STUDY001,QS,STUDY001-SUBJ0054,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,Y,1,BASELINE,2025-03-29,1
STUDY001,QS,STUDY001-SUBJ0054,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-29,1
STUDY001,QS,STUDY001-SUBJ0054,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-03-29,1
STUDY001,QS,STUDY001-SUBJ0054,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-29,1
STUDY001,QS,STUDY001-SUBJ0054,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-03-29,1
STUDY001,QS,STUDY001-SUBJ0054,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-29,1
STUDY001,QS,STUDY001-SUBJ0054,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,67,67,67.0,,,Y,1,BASELINE,2025-03-29,1
STUDY001,QS,STUDY001-SUBJ0054,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-04-25,28
STUDY001,QS,STUDY001-SUBJ0054,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-04-25,28
STUDY001,QS,STUDY001-SUBJ0054,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-04-25,28
STUDY001,QS,STUDY001-SUBJ0054,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-04-25,28
STUDY001,QS,STUDY001-SUBJ0054,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,NOT DONE,,,2,WEEK 4,2025-04-25,28
STUDY001,QS,STUDY001-SUBJ0054,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-25,28
STUDY001,QS,STUDY001-SUBJ0054,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-04-25,28
STUDY001,QS,STUDY001-SUBJ0054,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-25,28
STUDY001,QS,STUDY001-SUBJ0054,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-04-25,28
STUDY001,QS,STUDY001-SUBJ0054,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-04-25,28
STUDY001,QS,STUDY001-SUBJ0054,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,59,59,59.0,,,,2,WEEK 4,2025-04-25,28
STUDY001,QS,STUDY001-SUBJ0054,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-23,56
STUDY001,QS,STUDY001-SUBJ0054,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-23,56
STUDY001,QS,STUDY001-SUBJ0054,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-23,56
STUDY001,QS,STUDY001-SUBJ0054,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-05-23,56
STUDY001,QS,STUDY001-SUBJ0054,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-05-23,56
STUDY001,QS,STUDY001-SUBJ0054,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,69,69,69.0,,,,3,WEEK 8,2025-05-23,56
STUDY001,QS,STUDY001-SUBJ0054,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,4,WEEK 12,2025-06-20,84
STUDY001,QS,STUDY001-SUBJ0054,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-06-20,84
STUDY001,QS,STUDY001-SUBJ0054,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-06-20,84
STUDY001,QS,STUDY001-SUBJ0054,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-06-20,84
STUDY001,QS,STUDY001-SUBJ0054,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-06-20,84
STUDY001,QS,STUDY001-SUBJ0054,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-15,140
STUDY001,QS,STUDY001-SUBJ0054,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-08-15,140
STUDY001,QS,STUDY001-SUBJ0054,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-15,140
STUDY001,QS,STUDY001-SUBJ0054,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-15,140
STUDY001,QS,STUDY001-SUBJ0054,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-15,140
STUDY001,QS,STUDY001-SUBJ0054,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,5,END OF TREATMENT,2025-08-15,140
STUDY001,QS,STUDY001-SUBJ0054,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-08-15,140
STUDY001,QS,STUDY001-SUBJ0054,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-15,140
STUDY001,QS,STUDY001-SUBJ0054,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-08-15,140
STUDY001,QS,STUDY001-SUBJ0054,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-15,140
STUDY001,QS,STUDY001-SUBJ0054,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-08-15,140
STUDY001,QS,STUDY001-SUBJ0055,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-07-11,1
STUDY001,QS,STUDY001-SUBJ0055,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,NOT DONE,,Y,1,BASELINE,2025-07-11,1
STUDY001,QS,STUDY001-SUBJ0055,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-07-11,1
STUDY001,QS,STUDY001-SUBJ0055,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-11,1
STUDY001,QS,STUDY001-SUBJ0055,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-07-11,1
STUDY001,QS,STUDY001-SUBJ0055,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-11,1
STUDY001,QS,STUDY001-SUBJ0055,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-07-11,1
STUDY001,QS,STUDY001-SUBJ0055,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-11,1
STUDY001,QS,STUDY001-SUBJ0055,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,NOT DONE,,Y,1,BASELINE,2025-07-11,1
STUDY001,QS,STUDY001-SUBJ0055,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-11,1
STUDY001,QS,STUDY001-SUBJ0055,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,45,45,45.0,,,Y,1,BASELINE,2025-07-11,1
STUDY001,QS,STUDY001-SUBJ0055,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-08-07,28
STUDY001,QS,STUDY001-SUBJ0055,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-08-07,28
STUDY001,QS,STUDY001-SUBJ0055,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-08-07,28
STUDY001,QS,STUDY001-SUBJ0055,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-07,28
STUDY001,QS,STUDY001-SUBJ0055,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-08-07,28
STUDY001,QS,STUDY001-SUBJ0055,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-07,28
STUDY001,QS,STUDY001-SUBJ0055,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-08-07,28
STUDY001,QS,STUDY001-SUBJ0055,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-07,28
STUDY001,QS,STUDY001-SUBJ0055,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-08-07,28
STUDY001,QS,STUDY001-SUBJ0055,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-07,28
STUDY001,QS,STUDY001-SUBJ0055,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,59,59,59.0,,,,2,WEEK 4,2025-08-07,28
STUDY001,QS,STUDY001-SUBJ0055,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-04,56
STUDY001,QS,STUDY001-SUBJ0055,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-09-04,56
STUDY001,QS,STUDY001-SUBJ0055,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-04,56
STUDY001,QS,STUDY001-SUBJ0055,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-04,56
STUDY001,QS,STUDY001-SUBJ0055,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-04,56
STUDY001,QS,STUDY001-SUBJ0055,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-04,56
STUDY001,QS,STUDY001-SUBJ0055,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-09-04,56
STUDY001,QS,STUDY001-SUBJ0055,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-04,56
STUDY001,QS,STUDY001-SUBJ0055,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-09-04,56
STUDY001,QS,STUDY001-SUBJ0055,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,3,WEEK 8,2025-09-04,56
STUDY001,QS,STUDY001-SUBJ0055,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,69,69,69.0,,,,3,WEEK 8,2025-09-04,56
STUDY001,QS,STUDY001-SUBJ0055,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-02,84
STUDY001,QS,STUDY001-SUBJ0055,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-10-02,84
STUDY001,QS,STUDY001-SUBJ0055,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-02,84
STUDY001,QS,STUDY001-SUBJ0055,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-02,84
STUDY001,QS,STUDY001-SUBJ0055,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,4,WEEK 12,2025-10-02,84
STUDY001,QS,STUDY001-SUBJ0055,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-02,84
STUDY001,QS,STUDY001-SUBJ0055,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-10-02,84
STUDY001,QS,STUDY001-SUBJ0055,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-02,84
STUDY001,QS,STUDY001-SUBJ0055,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-10-02,84
STUDY001,QS,STUDY001-SUBJ0055,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-02,84
STUDY001,QS,STUDY001-SUBJ0055,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,87,87,87.0,,,,4,WEEK 12,2025-10-02,84
STUDY001,QS,STUDY001-SUBJ0055,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-27,140
STUDY001,QS,STUDY001-SUBJ0055,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-11-27,140
STUDY001,QS,STUDY001-SUBJ0055,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-27,140
STUDY001,QS,STUDY001-SUBJ0055,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-27,140
STUDY001,QS,STUDY001-SUBJ0055,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-27,140
STUDY001,QS,STUDY001-SUBJ0055,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-27,140
STUDY001,QS,STUDY001-SUBJ0055,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-11-27,140
STUDY001,QS,STUDY001-SUBJ0055,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-27,140
STUDY001,QS,STUDY001-SUBJ0055,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-11-27,140
STUDY001,QS,STUDY001-SUBJ0055,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-27,140
STUDY001,QS,STUDY001-SUBJ0055,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-11-27,140
STUDY001,QS,STUDY001-SUBJ0056,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-08,1
STUDY001,QS,STUDY001-SUBJ0056,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-11-08,1
STUDY001,QS,STUDY001-SUBJ0056,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-08,1
STUDY001,QS,STUDY001-SUBJ0056,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-08,1
STUDY001,QS,STUDY001-SUBJ0056,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-08,1
STUDY001,QS,STUDY001-SUBJ0056,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-08,1
STUDY001,QS,STUDY001-SUBJ0056,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-11-08,1
STUDY001,QS,STUDY001-SUBJ0056,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-08,1
STUDY001,QS,STUDY001-SUBJ0056,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-11-08,1
STUDY001,QS,STUDY001-SUBJ0056,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-08,1
STUDY001,QS,STUDY001-SUBJ0056,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,48,48,48.0,,,Y,1,BASELINE,2025-11-08,1
STUDY001,QS,STUDY001-SUBJ0056,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-05,28
STUDY001,QS,STUDY001-SUBJ0056,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-12-05,28
STUDY001,QS,STUDY001-SUBJ0056,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-05,28
STUDY001,QS,STUDY001-SUBJ0056,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,2,WEEK 4,2025-12-05,28
STUDY001,QS,STUDY001-SUBJ0056,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-05,28
STUDY001,QS,STUDY001-SUBJ0056,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-05,28
STUDY001,QS,STUDY001-SUBJ0056,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-12-05,28
STUDY001,QS,STUDY001-SUBJ0056,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-05,28
STUDY001,QS,STUDY001-SUBJ0056,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-12-05,28
STUDY001,QS,STUDY001-SUBJ0056,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-05,28
STUDY001,QS,STUDY001-SUBJ0056,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,62,62,62.0,,,,2,WEEK 4,2025-12-05,28
STUDY001,QS,STUDY001-SUBJ0057,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-09-18,1
STUDY001,QS,STUDY001-SUBJ0057,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-09-18,1
STUDY001,QS,STUDY001-SUBJ0057,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-09-18,1
STUDY001,QS,STUDY001-SUBJ0057,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-09-18,1
STUDY001,QS,STUDY001-SUBJ0057,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-09-18,1
STUDY001,QS,STUDY001-SUBJ0057,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-09-18,1
STUDY001,QS,STUDY001-SUBJ0057,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-09-18,1
STUDY001,QS,STUDY001-SUBJ0057,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-09-18,1
STUDY001,QS,STUDY001-SUBJ0057,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-09-18,1
STUDY001,QS,STUDY001-SUBJ0057,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-09-18,1
STUDY001,QS,STUDY001-SUBJ0057,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,60,60,60.0,,,Y,1,BASELINE,2025-09-18,1
STUDY001,QS,STUDY001-SUBJ0057,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-10-15,28
STUDY001,QS,STUDY001-SUBJ0057,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-10-15,28
STUDY001,QS,STUDY001-SUBJ0057,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-10-15,28
STUDY001,QS,STUDY001-SUBJ0057,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-15,28
STUDY001,QS,STUDY001-SUBJ0057,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-10-15,28
STUDY001,QS,STUDY001-SUBJ0057,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-15,28
STUDY001,QS,STUDY001-SUBJ0057,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-10-15,28
STUDY001,QS,STUDY001-SUBJ0057,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-15,28
STUDY001,QS,STUDY001-SUBJ0057,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,NOT DONE,,,2,WEEK 4,2025-10-15,28
STUDY001,QS,STUDY001-SUBJ0057,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-15,28
STUDY001,QS,STUDY001-SUBJ0057,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,61,61,61.0,,,,2,WEEK 4,2025-10-15,28
STUDY001,QS,STUDY001-SUBJ0057,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-12,56
STUDY001,QS,STUDY001-SUBJ0057,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-11-12,56
STUDY001,QS,STUDY001-SUBJ0057,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-12,56
STUDY001,QS,STUDY001-SUBJ0057,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-11-12,56
STUDY001,QS,STUDY001-SUBJ0057,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-12,56
STUDY001,QS,STUDY001-SUBJ0057,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-11-12,56
STUDY001,QS,STUDY001-SUBJ0057,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-11-12,56
STUDY001,QS,STUDY001-SUBJ0057,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-11-12,56
STUDY001,QS,STUDY001-SUBJ0057,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-11-12,56
STUDY001,QS,STUDY001-SUBJ0057,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-11-12,56
STUDY001,QS,STUDY001-SUBJ0057,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,65,65,65.0,,,,3,WEEK 8,2025-11-12,56
STUDY001,QS,STUDY001-SUBJ0057,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-12-10,84
STUDY001,QS,STUDY001-SUBJ0057,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-12-10,84
STUDY001,QS,STUDY001-SUBJ0057,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-12-10,84
STUDY001,QS,STUDY001-SUBJ0057,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-12-10,84
STUDY001,QS,STUDY001-SUBJ0057,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,4,WEEK 12,2025-12-10,84
STUDY001,QS,STUDY001-SUBJ0058,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-03-11,1
STUDY001,QS,STUDY001-SUBJ0058,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-03-11,1
STUDY001,QS,STUDY001-SUBJ0058,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-03-11,1
STUDY001,QS,STUDY001-SUBJ0058,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-11,1
STUDY001,QS,STUDY001-SUBJ0058,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-03-11,1
STUDY001,QS,STUDY001-SUBJ0058,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-11,1
STUDY001,QS,STUDY001-SUBJ0058,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-03-11,1
STUDY001,QS,STUDY001-SUBJ0058,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-11,1
STUDY001,QS,STUDY001-SUBJ0058,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-03-11,1
STUDY001,QS,STUDY001-SUBJ0058,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-11,1
STUDY001,QS,STUDY001-SUBJ0058,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,54,54,54.0,,,Y,1,BASELINE,2025-03-11,1
STUDY001,QS,STUDY001-SUBJ0058,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-04-07,28
STUDY001,QS,STUDY001-SUBJ0058,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-04-07,28
STUDY001,QS,STUDY001-SUBJ0058,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-04-07,28
STUDY001,QS,STUDY001-SUBJ0058,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-04-07,28
STUDY001,QS,STUDY001-SUBJ0058,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-04-07,28
STUDY001,QS,STUDY001-SUBJ0058,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,62,62,62.0,NOT DONE,,,2,WEEK 4,2025-04-07,28
STUDY001,QS,STUDY001-SUBJ0058,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-05,56
STUDY001,QS,STUDY001-SUBJ0058,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-05-05,56
STUDY001,QS,STUDY001-SUBJ0058,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-05,56
STUDY001,QS,STUDY001-SUBJ0058,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-05,56
STUDY001,QS,STUDY001-SUBJ0058,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-05,56
STUDY001,QS,STUDY001-SUBJ0058,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-05,56
STUDY001,QS,STUDY001-SUBJ0058,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-05-05,56
STUDY001,QS,STUDY001-SUBJ0058,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-05,56
STUDY001,QS,STUDY001-SUBJ0058,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-05-05,56
STUDY001,QS,STUDY001-SUBJ0058,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-05,56
STUDY001,QS,STUDY001-SUBJ0058,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,76,76,76.0,,,,3,WEEK 8,2025-05-05,56
STUDY001,QS,STUDY001-SUBJ0058,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-06-02,84
STUDY001,QS,STUDY001-SUBJ0058,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-02,84
STUDY001,QS,STUDY001-SUBJ0058,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-02,84
STUDY001,QS,STUDY001-SUBJ0058,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-02,84
STUDY001,QS,STUDY001-SUBJ0058,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-02,84
STUDY001,QS,STUDY001-SUBJ0058,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-28,140
STUDY001,QS,STUDY001-SUBJ0058,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-07-28,140
STUDY001,QS,STUDY001-SUBJ0058,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-28,140
STUDY001,QS,STUDY001-SUBJ0058,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-28,140
STUDY001,QS,STUDY001-SUBJ0058,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-28,140
STUDY001,QS,STUDY001-SUBJ0058,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-28,140
STUDY001,QS,STUDY001-SUBJ0058,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-07-28,140
STUDY001,QS,STUDY001-SUBJ0058,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-28,140
STUDY001,QS,STUDY001-SUBJ0058,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-07-28,140
STUDY001,QS,STUDY001-SUBJ0058,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-28,140
STUDY001,QS,STUDY001-SUBJ0058,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-07-28,140
STUDY001,QS,STUDY001-SUBJ0059,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0059,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0059,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0059,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0059,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0059,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0059,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0059,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,NOT DONE,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0059,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0059,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0059,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,48,48,48.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0059,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0059,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,NOT DONE,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0059,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0059,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0059,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0059,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0059,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0059,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0059,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0059,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0059,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,61,61,61.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0059,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0059,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0059,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0059,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0059,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0059,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0059,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0059,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0059,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0059,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0059,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,69,69,69.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0059,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0059,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0059,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0059,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0059,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0059,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,88,88,88.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0059,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0059,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0059,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0059,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0059,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0059,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0059,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0059,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0059,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0059,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0059,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0060,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-09-14,1
STUDY001,QS,STUDY001-SUBJ0060,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-09-14,1
STUDY001,QS,STUDY001-SUBJ0060,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-09-14,1
STUDY001,QS,STUDY001-SUBJ0060,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-14,1
STUDY001,QS,STUDY001-SUBJ0060,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-09-14,1
STUDY001,QS,STUDY001-SUBJ0060,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-14,1
STUDY001,QS,STUDY001-SUBJ0060,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-09-14,1
STUDY001,QS,STUDY001-SUBJ0060,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-14,1
STUDY001,QS,STUDY001-SUBJ0060,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-09-14,1
STUDY001,QS,STUDY001-SUBJ0060,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-14,1
STUDY001,QS,STUDY001-SUBJ0060,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,Y,1,BASELINE,2025-09-14,1
STUDY001,QS,STUDY001-SUBJ0060,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-10-11,28
STUDY001,QS,STUDY001-SUBJ0060,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,NOT DONE,,,2,WEEK 4,2025-10-11,28
STUDY001,QS,STUDY001-SUBJ0060,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-10-11,28
STUDY001,QS,STUDY001-SUBJ0060,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-11,28
STUDY001,QS,STUDY001-SUBJ0060,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-10-11,28
STUDY001,QS,STUDY001-SUBJ0060,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-11,28
STUDY001,QS,STUDY001-SUBJ0060,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-10-11,28
STUDY001,QS,STUDY001-SUBJ0060,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-11,28
STUDY001,QS,STUDY001-SUBJ0060,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-10-11,28
STUDY001,QS,STUDY001-SUBJ0060,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,2,WEEK 4,2025-10-11,28
STUDY001,QS,STUDY001-SUBJ0060,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,58,58,58.0,,,,2,WEEK 4,2025-10-11,28
STUDY001,QS,STUDY001-SUBJ0060,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-12-06,84
STUDY001,QS,STUDY001-SUBJ0060,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,4,WEEK 12,2025-12-06,84
STUDY001,QS,STUDY001-SUBJ0060,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-12-06,84
STUDY001,QS,STUDY001-SUBJ0060,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-12-06,84
STUDY001,QS,STUDY001-SUBJ0060,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-12-06,84
STUDY001,QS,STUDY001-SUBJ0060,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,4,WEEK 12,2025-12-06,84
STUDY001,QS,STUDY001-SUBJ0060,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,4,WEEK 12,2025-12-06,84
STUDY001,QS,STUDY001-SUBJ0060,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-12-06,84
STUDY001,QS,STUDY001-SUBJ0060,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,4,WEEK 12,2025-12-06,84
STUDY001,QS,STUDY001-SUBJ0060,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-12-06,84
STUDY001,QS,STUDY001-SUBJ0060,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,68,68,68.0,,,,4,WEEK 12,2025-12-06,84
STUDY001,QS,STUDY001-SUBJ0061,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-05,1
STUDY001,QS,STUDY001-SUBJ0061,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-10-05,1
STUDY001,QS,STUDY001-SUBJ0061,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-05,1
STUDY001,QS,STUDY001-SUBJ0061,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-05,1
STUDY001,QS,STUDY001-SUBJ0061,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-05,1
STUDY001,QS,STUDY001-SUBJ0061,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-05,1
STUDY001,QS,STUDY001-SUBJ0061,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-10-05,1
STUDY001,QS,STUDY001-SUBJ0061,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-05,1
STUDY001,QS,STUDY001-SUBJ0061,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-10-05,1
STUDY001,QS,STUDY001-SUBJ0061,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-05,1
STUDY001,QS,STUDY001-SUBJ0061,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,48,48,48.0,,,Y,1,BASELINE,2025-10-05,1
STUDY001,QS,STUDY001-SUBJ0061,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-01,28
STUDY001,QS,STUDY001-SUBJ0061,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-11-01,28
STUDY001,QS,STUDY001-SUBJ0061,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-01,28
STUDY001,QS,STUDY001-SUBJ0061,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-01,28
STUDY001,QS,STUDY001-SUBJ0061,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-01,28
STUDY001,QS,STUDY001-SUBJ0061,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-01,28
STUDY001,QS,STUDY001-SUBJ0061,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-11-01,28
STUDY001,QS,STUDY001-SUBJ0061,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-01,28
STUDY001,QS,STUDY001-SUBJ0061,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,NOT DONE,,,2,WEEK 4,2025-11-01,28
STUDY001,QS,STUDY001-SUBJ0061,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-01,28
STUDY001,QS,STUDY001-SUBJ0061,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,64,64,64.0,,,,2,WEEK 4,2025-11-01,28
STUDY001,QS,STUDY001-SUBJ0061,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-29,56
STUDY001,QS,STUDY001-SUBJ0061,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-11-29,56
STUDY001,QS,STUDY001-SUBJ0061,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-29,56
STUDY001,QS,STUDY001-SUBJ0061,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-29,56
STUDY001,QS,STUDY001-SUBJ0061,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-29,56
STUDY001,QS,STUDY001-SUBJ0061,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-29,56
STUDY001,QS,STUDY001-SUBJ0061,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-11-29,56
STUDY001,QS,STUDY001-SUBJ0061,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-29,56
STUDY001,QS,STUDY001-SUBJ0061,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-11-29,56
STUDY001,QS,STUDY001-SUBJ0061,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-29,56
STUDY001,QS,STUDY001-SUBJ0061,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,72,72,72.0,,,,3,WEEK 8,2025-11-29,56
STUDY001,QS,STUDY001-SUBJ0062,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0062,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0062,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0062,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0062,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0062,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0062,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0062,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0062,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0062,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0062,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,42,42,42.0,NOT DONE,,Y,1,BASELINE,2025-11-16,1
STUDY001,QS,STUDY001-SUBJ0063,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-04-18,1
STUDY001,QS,STUDY001-SUBJ0063,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-04-18,1
STUDY001,QS,STUDY001-SUBJ0063,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-04-18,1
STUDY001,QS,STUDY001-SUBJ0063,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-18,1
STUDY001,QS,STUDY001-SUBJ0063,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-04-18,1
STUDY001,QS,STUDY001-SUBJ0063,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-18,1
STUDY001,QS,STUDY001-SUBJ0063,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-04-18,1
STUDY001,QS,STUDY001-SUBJ0063,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-18,1
STUDY001,QS,STUDY001-SUBJ0063,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-04-18,1
STUDY001,QS,STUDY001-SUBJ0063,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-18,1
STUDY001,QS,STUDY001-SUBJ0063,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,38,38,38.0,,,Y,1,BASELINE,2025-04-18,1
STUDY001,QS,STUDY001-SUBJ0063,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-15,28
STUDY001,QS,STUDY001-SUBJ0063,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-05-15,28
STUDY001,QS,STUDY001-SUBJ0063,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-15,28
STUDY001,QS,STUDY001-SUBJ0063,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-05-15,28
STUDY001,QS,STUDY001-SUBJ0063,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-15,28
STUDY001,QS,STUDY001-SUBJ0063,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-15,28
STUDY001,QS,STUDY001-SUBJ0063,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-05-15,28
STUDY001,QS,STUDY001-SUBJ0063,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-15,28
STUDY001,QS,STUDY001-SUBJ0063,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-05-15,28
STUDY001,QS,STUDY001-SUBJ0063,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-15,28
STUDY001,QS,STUDY001-SUBJ0063,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,57,57,57.0,,,,2,WEEK 4,2025-05-15,28
STUDY001,QS,STUDY001-SUBJ0063,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-12,56
STUDY001,QS,STUDY001-SUBJ0063,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,NOT DONE,,,3,WEEK 8,2025-06-12,56
STUDY001,QS,STUDY001-SUBJ0063,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-12,56
STUDY001,QS,STUDY001-SUBJ0063,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-12,56
STUDY001,QS,STUDY001-SUBJ0063,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-12,56
STUDY001,QS,STUDY001-SUBJ0063,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-12,56
STUDY001,QS,STUDY001-SUBJ0063,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-06-12,56
STUDY001,QS,STUDY001-SUBJ0063,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-12,56
STUDY001,QS,STUDY001-SUBJ0063,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-06-12,56
STUDY001,QS,STUDY001-SUBJ0063,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-06-12,56
STUDY001,QS,STUDY001-SUBJ0063,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,68,68,68.0,,,,3,WEEK 8,2025-06-12,56
STUDY001,QS,STUDY001-SUBJ0063,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-10,84
STUDY001,QS,STUDY001-SUBJ0063,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-07-10,84
STUDY001,QS,STUDY001-SUBJ0063,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-10,84
STUDY001,QS,STUDY001-SUBJ0063,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-10,84
STUDY001,QS,STUDY001-SUBJ0063,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-10,84
STUDY001,QS,STUDY001-SUBJ0063,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-10,84
STUDY001,QS,STUDY001-SUBJ0063,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-07-10,84
STUDY001,QS,STUDY001-SUBJ0063,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-10,84
STUDY001,QS,STUDY001-SUBJ0063,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-07-10,84
STUDY001,QS,STUDY001-SUBJ0063,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-10,84
STUDY001,QS,STUDY001-SUBJ0063,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,83,83,83.0,,,,4,WEEK 12,2025-07-10,84
STUDY001,QS,STUDY001-SUBJ0063,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-04,140
STUDY001,QS,STUDY001-SUBJ0063,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-09-04,140
STUDY001,QS,STUDY001-SUBJ0063,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-04,140
STUDY001,QS,STUDY001-SUBJ0063,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-04,140
STUDY001,QS,STUDY001-SUBJ0063,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-04,140
STUDY001,QS,STUDY001-SUBJ0063,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-04,140
STUDY001,QS,STUDY001-SUBJ0063,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-09-04,140
STUDY001,QS,STUDY001-SUBJ0063,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-04,140
STUDY001,QS,STUDY001-SUBJ0063,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-09-04,140
STUDY001,QS,STUDY001-SUBJ0063,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-04,140
STUDY001,QS,STUDY001-SUBJ0063,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-09-04,140
STUDY001,QS,STUDY001-SUBJ0064,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-10-21,1
STUDY001,QS,STUDY001-SUBJ0064,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-10-21,1
STUDY001,QS,STUDY001-SUBJ0064,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-10-21,1
STUDY001,QS,STUDY001-SUBJ0064,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-21,1
STUDY001,QS,STUDY001-SUBJ0064,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-10-21,1
STUDY001,QS,STUDY001-SUBJ0064,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-21,1
STUDY001,QS,STUDY001-SUBJ0064,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-10-21,1
STUDY001,QS,STUDY001-SUBJ0064,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-21,1
STUDY001,QS,STUDY001-SUBJ0064,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-10-21,1
STUDY001,QS,STUDY001-SUBJ0064,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-10-21,1
STUDY001,QS,STUDY001-SUBJ0064,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,60,60,60.0,,,Y,1,BASELINE,2025-10-21,1
STUDY001,QS,STUDY001-SUBJ0064,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-17,28
STUDY001,QS,STUDY001-SUBJ0064,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-11-17,28
STUDY001,QS,STUDY001-SUBJ0064,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-17,28
STUDY001,QS,STUDY001-SUBJ0064,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-17,28
STUDY001,QS,STUDY001-SUBJ0064,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,NOT DONE,,,2,WEEK 4,2025-11-17,28
STUDY001,QS,STUDY001-SUBJ0064,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-17,28
STUDY001,QS,STUDY001-SUBJ0064,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-11-17,28
STUDY001,QS,STUDY001-SUBJ0064,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-17,28
STUDY001,QS,STUDY001-SUBJ0064,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-11-17,28
STUDY001,QS,STUDY001-SUBJ0064,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-17,28
STUDY001,QS,STUDY001-SUBJ0064,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,57,57,57.0,,,,2,WEEK 4,2025-11-17,28
STUDY001,QS,STUDY001-SUBJ0064,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-12-15,56
STUDY001,QS,STUDY001-SUBJ0064,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-15,56
STUDY001,QS,STUDY001-SUBJ0064,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-15,56
STUDY001,QS,STUDY001-SUBJ0064,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-15,56
STUDY001,QS,STUDY001-SUBJ0064,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-15,56
STUDY001,QS,STUDY001-SUBJ0065,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-09-21,1
STUDY001,QS,STUDY001-SUBJ0065,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-09-21,1
STUDY001,QS,STUDY001-SUBJ0065,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,Y,1,BASELINE,2025-09-21,1
STUDY001,QS,STUDY001-SUBJ0065,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-09-21,1
STUDY001,QS,STUDY001-SUBJ0065,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-09-21,1
STUDY001,QS,STUDY001-SUBJ0065,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-09-21,1
STUDY001,QS,STUDY001-SUBJ0065,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-09-21,1
STUDY001,QS,STUDY001-SUBJ0065,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-09-21,1
STUDY001,QS,STUDY001-SUBJ0065,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-09-21,1
STUDY001,QS,STUDY001-SUBJ0065,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-09-21,1
STUDY001,QS,STUDY001-SUBJ0065,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,66,66,66.0,,,Y,1,BASELINE,2025-09-21,1
STUDY001,QS,STUDY001-SUBJ0065,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-10-18,28
STUDY001,QS,STUDY001-SUBJ0065,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-10-18,28
STUDY001,QS,STUDY001-SUBJ0065,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-10-18,28
STUDY001,QS,STUDY001-SUBJ0065,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-18,28
STUDY001,QS,STUDY001-SUBJ0065,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-10-18,28
STUDY001,QS,STUDY001-SUBJ0065,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-18,28
STUDY001,QS,STUDY001-SUBJ0065,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-10-18,28
STUDY001,QS,STUDY001-SUBJ0065,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-18,28
STUDY001,QS,STUDY001-SUBJ0065,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-10-18,28
STUDY001,QS,STUDY001-SUBJ0065,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-10-18,28
STUDY001,QS,STUDY001-SUBJ0065,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,60,60,60.0,,,,2,WEEK 4,2025-10-18,28
STUDY001,QS,STUDY001-SUBJ0065,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-15,56
STUDY001,QS,STUDY001-SUBJ0065,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-11-15,56
STUDY001,QS,STUDY001-SUBJ0065,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-15,56
STUDY001,QS,STUDY001-SUBJ0065,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-15,56
STUDY001,QS,STUDY001-SUBJ0065,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-15,56
STUDY001,QS,STUDY001-SUBJ0065,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-15,56
STUDY001,QS,STUDY001-SUBJ0065,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-11-15,56
STUDY001,QS,STUDY001-SUBJ0065,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-15,56
STUDY001,QS,STUDY001-SUBJ0065,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-11-15,56
STUDY001,QS,STUDY001-SUBJ0065,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-15,56
STUDY001,QS,STUDY001-SUBJ0065,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,71,71,71.0,,,,3,WEEK 8,2025-11-15,56
STUDY001,QS,STUDY001-SUBJ0066,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0066,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0066,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0066,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0066,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0066,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0066,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0066,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0066,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0066,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0066,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,50,50,50.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0066,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0066,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0066,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0066,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0066,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0066,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0066,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0066,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0066,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0066,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0066,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0066,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0066,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0066,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0066,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0066,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0066,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0066,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0066,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0066,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0066,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0066,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,71,71,71.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0066,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0066,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0066,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0066,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0066,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0066,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0066,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0066,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0066,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0066,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0066,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,86,86,86.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0067,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0067,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0067,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0067,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0067,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0067,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0067,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0067,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0067,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0067,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0067,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,42,42,42.0,,,Y,1,BASELINE,2025-11-09,1
STUDY001,QS,STUDY001-SUBJ0067,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0067,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0067,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0067,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0067,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0067,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0067,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0067,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0067,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0067,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0067,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,64,64,64.0,,,,2,WEEK 4,2025-12-06,28
STUDY001,QS,STUDY001-SUBJ0068,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-02,1
STUDY001,QS,STUDY001-SUBJ0068,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-11-02,1
STUDY001,QS,STUDY001-SUBJ0068,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-02,1
STUDY001,QS,STUDY001-SUBJ0068,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-02,1
STUDY001,QS,STUDY001-SUBJ0068,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-11-02,1
STUDY001,QS,STUDY001-SUBJ0068,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-02,1
STUDY001,QS,STUDY001-SUBJ0068,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-11-02,1
STUDY001,QS,STUDY001-SUBJ0068,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-02,1
STUDY001,QS,STUDY001-SUBJ0068,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-11-02,1
STUDY001,QS,STUDY001-SUBJ0068,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-11-02,1
STUDY001,QS,STUDY001-SUBJ0068,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,47,47,47.0,,,Y,1,BASELINE,2025-11-02,1
STUDY001,QS,STUDY001-SUBJ0068,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-29,28
STUDY001,QS,STUDY001-SUBJ0068,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-11-29,28
STUDY001,QS,STUDY001-SUBJ0068,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-29,28
STUDY001,QS,STUDY001-SUBJ0068,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-11-29,28
STUDY001,QS,STUDY001-SUBJ0068,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-29,28
STUDY001,QS,STUDY001-SUBJ0068,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-11-29,28
STUDY001,QS,STUDY001-SUBJ0068,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-11-29,28
STUDY001,QS,STUDY001-SUBJ0068,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-11-29,28
STUDY001,QS,STUDY001-SUBJ0068,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-11-29,28
STUDY001,QS,STUDY001-SUBJ0068,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-11-29,28
STUDY001,QS,STUDY001-SUBJ0068,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,61,61,61.0,,,,2,WEEK 4,2025-11-29,28
STUDY001,QS,STUDY001-SUBJ0068,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-27,56
STUDY001,QS,STUDY001-SUBJ0068,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-12-27,56
STUDY001,QS,STUDY001-SUBJ0068,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-27,56
STUDY001,QS,STUDY001-SUBJ0068,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-27,56
STUDY001,QS,STUDY001-SUBJ0068,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-27,56
STUDY001,QS,STUDY001-SUBJ0068,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-27,56
STUDY001,QS,STUDY001-SUBJ0068,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-12-27,56
STUDY001,QS,STUDY001-SUBJ0068,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-27,56
STUDY001,QS,STUDY001-SUBJ0068,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-12-27,56
STUDY001,QS,STUDY001-SUBJ0068,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-27,56
STUDY001,QS,STUDY001-SUBJ0068,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,66,66,66.0,NOT DONE,,,3,WEEK 8,2025-12-27,56
STUDY001,QS,STUDY001-SUBJ0069,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-05-26,1
STUDY001,QS,STUDY001-SUBJ0069,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-05-26,1
STUDY001,QS,STUDY001-SUBJ0069,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-05-26,1
STUDY001,QS,STUDY001-SUBJ0069,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-05-26,1
STUDY001,QS,STUDY001-SUBJ0069,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-05-26,1
STUDY001,QS,STUDY001-SUBJ0069,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,33,33,33.0,,,Y,1,BASELINE,2025-05-26,1
STUDY001,QS,STUDY001-SUBJ0069,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-06-22,28
STUDY001,QS,STUDY001-SUBJ0069,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-06-22,28
STUDY001,QS,STUDY001-SUBJ0069,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-06-22,28
STUDY001,QS,STUDY001-SUBJ0069,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-22,28
STUDY001,QS,STUDY001-SUBJ0069,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-06-22,28
STUDY001,QS,STUDY001-SUBJ0069,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-22,28
STUDY001,QS,STUDY001-SUBJ0069,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-06-22,28
STUDY001,QS,STUDY001-SUBJ0069,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-22,28
STUDY001,QS,STUDY001-SUBJ0069,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-06-22,28
STUDY001,QS,STUDY001-SUBJ0069,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-06-22,28
STUDY001,QS,STUDY001-SUBJ0069,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,60,60,60.0,NOT DONE,,,2,WEEK 4,2025-06-22,28
STUDY001,QS,STUDY001-SUBJ0069,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-20,56
STUDY001,QS,STUDY001-SUBJ0069,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-07-20,56
STUDY001,QS,STUDY001-SUBJ0069,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-20,56
STUDY001,QS,STUDY001-SUBJ0069,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-20,56
STUDY001,QS,STUDY001-SUBJ0069,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-07-20,56
STUDY001,QS,STUDY001-SUBJ0069,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-20,56
STUDY001,QS,STUDY001-SUBJ0069,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-07-20,56
STUDY001,QS,STUDY001-SUBJ0069,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,3,WEEK 8,2025-07-20,56
STUDY001,QS,STUDY001-SUBJ0069,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-07-20,56
STUDY001,QS,STUDY001-SUBJ0069,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-07-20,56
STUDY001,QS,STUDY001-SUBJ0069,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,70,70,70.0,NOT DONE,,,3,WEEK 8,2025-07-20,56
STUDY001,QS,STUDY001-SUBJ0069,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-08-17,84
STUDY001,QS,STUDY001-SUBJ0069,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-08-17,84
STUDY001,QS,STUDY001-SUBJ0069,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-08-17,84
STUDY001,QS,STUDY001-SUBJ0069,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-17,84
STUDY001,QS,STUDY001-SUBJ0069,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-08-17,84
STUDY001,QS,STUDY001-SUBJ0069,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-17,84
STUDY001,QS,STUDY001-SUBJ0069,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-08-17,84
STUDY001,QS,STUDY001-SUBJ0069,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-17,84
STUDY001,QS,STUDY001-SUBJ0069,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-08-17,84
STUDY001,QS,STUDY001-SUBJ0069,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-08-17,84
STUDY001,QS,STUDY001-SUBJ0069,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-08-17,84
STUDY001,QS,STUDY001-SUBJ0069,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-12,140
STUDY001,QS,STUDY001-SUBJ0069,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-10-12,140
STUDY001,QS,STUDY001-SUBJ0069,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-12,140
STUDY001,QS,STUDY001-SUBJ0069,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-12,140
STUDY001,QS,STUDY001-SUBJ0069,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-10-12,140
STUDY001,QS,STUDY001-SUBJ0069,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-12,140
STUDY001,QS,STUDY001-SUBJ0069,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-10-12,140
STUDY001,QS,STUDY001-SUBJ0069,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-12,140
STUDY001,QS,STUDY001-SUBJ0069,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,NOT DONE,,,5,END OF TREATMENT,2025-10-12,140
STUDY001,QS,STUDY001-SUBJ0069,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-10-12,140
STUDY001,QS,STUDY001-SUBJ0069,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-10-12,140
STUDY001,QS,STUDY001-SUBJ0070,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-07-02,1
STUDY001,QS,STUDY001-SUBJ0070,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-07-02,1
STUDY001,QS,STUDY001-SUBJ0070,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,Y,1,BASELINE,2025-07-02,1
STUDY001,QS,STUDY001-SUBJ0070,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-02,1
STUDY001,QS,STUDY001-SUBJ0070,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-07-02,1
STUDY001,QS,STUDY001-SUBJ0070,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-02,1
STUDY001,QS,STUDY001-SUBJ0070,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-07-02,1
STUDY001,QS,STUDY001-SUBJ0070,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-02,1
STUDY001,QS,STUDY001-SUBJ0070,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-07-02,1
STUDY001,QS,STUDY001-SUBJ0070,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-02,1
STUDY001,QS,STUDY001-SUBJ0070,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,61,61,61.0,,,Y,1,BASELINE,2025-07-02,1
STUDY001,QS,STUDY001-SUBJ0070,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-29,28
STUDY001,QS,STUDY001-SUBJ0070,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-07-29,28
STUDY001,QS,STUDY001-SUBJ0070,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-29,28
STUDY001,QS,STUDY001-SUBJ0070,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-29,28
STUDY001,QS,STUDY001-SUBJ0070,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-29,28
STUDY001,QS,STUDY001-SUBJ0070,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-29,28
STUDY001,QS,STUDY001-SUBJ0070,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-07-29,28
STUDY001,QS,STUDY001-SUBJ0070,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-29,28
STUDY001,QS,STUDY001-SUBJ0070,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-07-29,28
STUDY001,QS,STUDY001-SUBJ0070,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-29,28
STUDY001,QS,STUDY001-SUBJ0070,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,,,,2,WEEK 4,2025-07-29,28
STUDY001,QS,STUDY001-SUBJ0070,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-26,56
STUDY001,QS,STUDY001-SUBJ0070,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-08-26,56
STUDY001,QS,STUDY001-SUBJ0070,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-26,56
STUDY001,QS,STUDY001-SUBJ0070,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-26,56
STUDY001,QS,STUDY001-SUBJ0070,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-26,56
STUDY001,QS,STUDY001-SUBJ0070,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-26,56
STUDY001,QS,STUDY001-SUBJ0070,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-08-26,56
STUDY001,QS,STUDY001-SUBJ0070,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-26,56
STUDY001,QS,STUDY001-SUBJ0070,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-08-26,56
STUDY001,QS,STUDY001-SUBJ0070,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-26,56
STUDY001,QS,STUDY001-SUBJ0070,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,75,75,75.0,,,,3,WEEK 8,2025-08-26,56
STUDY001,QS,STUDY001-SUBJ0070,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-23,84
STUDY001,QS,STUDY001-SUBJ0070,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-09-23,84
STUDY001,QS,STUDY001-SUBJ0070,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-23,84
STUDY001,QS,STUDY001-SUBJ0070,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-23,84
STUDY001,QS,STUDY001-SUBJ0070,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-23,84
STUDY001,QS,STUDY001-SUBJ0070,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-23,84
STUDY001,QS,STUDY001-SUBJ0070,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-09-23,84
STUDY001,QS,STUDY001-SUBJ0070,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-23,84
STUDY001,QS,STUDY001-SUBJ0070,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-09-23,84
STUDY001,QS,STUDY001-SUBJ0070,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-23,84
STUDY001,QS,STUDY001-SUBJ0070,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-09-23,84
STUDY001,QS,STUDY001-SUBJ0070,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-18,140
STUDY001,QS,STUDY001-SUBJ0070,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-11-18,140
STUDY001,QS,STUDY001-SUBJ0070,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-18,140
STUDY001,QS,STUDY001-SUBJ0070,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-18,140
STUDY001,QS,STUDY001-SUBJ0070,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-18,140
STUDY001,QS,STUDY001-SUBJ0070,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-18,140
STUDY001,QS,STUDY001-SUBJ0070,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-11-18,140
STUDY001,QS,STUDY001-SUBJ0070,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-18,140
STUDY001,QS,STUDY001-SUBJ0070,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-11-18,140
STUDY001,QS,STUDY001-SUBJ0070,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-18,140
STUDY001,QS,STUDY001-SUBJ0070,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-11-18,140
STUDY001,QS,STUDY001-SUBJ0071,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-06-24,1
STUDY001,QS,STUDY001-SUBJ0071,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-06-24,1
STUDY001,QS,STUDY001-SUBJ0071,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-06-24,1
STUDY001,QS,STUDY001-SUBJ0071,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-24,1
STUDY001,QS,STUDY001-SUBJ0071,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-06-24,1
STUDY001,QS,STUDY001-SUBJ0071,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-24,1
STUDY001,QS,STUDY001-SUBJ0071,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-06-24,1
STUDY001,QS,STUDY001-SUBJ0071,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-24,1
STUDY001,QS,STUDY001-SUBJ0071,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-06-24,1
STUDY001,QS,STUDY001-SUBJ0071,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-24,1
STUDY001,QS,STUDY001-SUBJ0071,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,53,53,53.0,,,Y,1,BASELINE,2025-06-24,1
STUDY001,QS,STUDY001-SUBJ0071,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-07-21,28
STUDY001,QS,STUDY001-SUBJ0071,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-21,28
STUDY001,QS,STUDY001-SUBJ0071,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-21,28
STUDY001,QS,STUDY001-SUBJ0071,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-21,28
STUDY001,QS,STUDY001-SUBJ0071,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-21,28
STUDY001,QS,STUDY001-SUBJ0071,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-18,56
STUDY001,QS,STUDY001-SUBJ0071,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-08-18,56
STUDY001,QS,STUDY001-SUBJ0071,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-18,56
STUDY001,QS,STUDY001-SUBJ0071,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-18,56
STUDY001,QS,STUDY001-SUBJ0071,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-18,56
STUDY001,QS,STUDY001-SUBJ0071,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-18,56
STUDY001,QS,STUDY001-SUBJ0071,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-08-18,56
STUDY001,QS,STUDY001-SUBJ0071,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-18,56
STUDY001,QS,STUDY001-SUBJ0071,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-08-18,56
STUDY001,QS,STUDY001-SUBJ0071,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-18,56
STUDY001,QS,STUDY001-SUBJ0071,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,76,76,76.0,,,,3,WEEK 8,2025-08-18,56
STUDY001,QS,STUDY001-SUBJ0071,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-15,84
STUDY001,QS,STUDY001-SUBJ0071,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-09-15,84
STUDY001,QS,STUDY001-SUBJ0071,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-15,84
STUDY001,QS,STUDY001-SUBJ0071,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-15,84
STUDY001,QS,STUDY001-SUBJ0071,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-15,84
STUDY001,QS,STUDY001-SUBJ0071,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-15,84
STUDY001,QS,STUDY001-SUBJ0071,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-09-15,84
STUDY001,QS,STUDY001-SUBJ0071,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-15,84
STUDY001,QS,STUDY001-SUBJ0071,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-09-15,84
STUDY001,QS,STUDY001-SUBJ0071,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-15,84
STUDY001,QS,STUDY001-SUBJ0071,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-09-15,84
STUDY001,QS,STUDY001-SUBJ0071,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-10,140
STUDY001,QS,STUDY001-SUBJ0071,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-11-10,140
STUDY001,QS,STUDY001-SUBJ0071,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-10,140
STUDY001,QS,STUDY001-SUBJ0071,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-10,140
STUDY001,QS,STUDY001-SUBJ0071,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-10,140
STUDY001,QS,STUDY001-SUBJ0071,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-10,140
STUDY001,QS,STUDY001-SUBJ0071,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-11-10,140
STUDY001,QS,STUDY001-SUBJ0071,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-10,140
STUDY001,QS,STUDY001-SUBJ0071,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-11-10,140
STUDY001,QS,STUDY001-SUBJ0071,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,5,END OF TREATMENT,2025-11-10,140
STUDY001,QS,STUDY001-SUBJ0071,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-11-10,140
STUDY001,QS,STUDY001-SUBJ0072,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-16,1
STUDY001,QS,STUDY001-SUBJ0072,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-04-16,1
STUDY001,QS,STUDY001-SUBJ0072,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,NOT DONE,,Y,1,BASELINE,2025-04-16,1
STUDY001,QS,STUDY001-SUBJ0072,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-04-16,1
STUDY001,QS,STUDY001-SUBJ0072,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-16,1
STUDY001,QS,STUDY001-SUBJ0072,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-04-16,1
STUDY001,QS,STUDY001-SUBJ0072,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,NOT DONE,,Y,1,BASELINE,2025-04-16,1
STUDY001,QS,STUDY001-SUBJ0072,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-04-16,1
STUDY001,QS,STUDY001-SUBJ0072,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-04-16,1
STUDY001,QS,STUDY001-SUBJ0072,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,NOT DONE,,Y,1,BASELINE,2025-04-16,1
STUDY001,QS,STUDY001-SUBJ0072,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,44,44,44.0,NOT DONE,,Y,1,BASELINE,2025-04-16,1
STUDY001,QS,STUDY001-SUBJ0072,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-13,28
STUDY001,QS,STUDY001-SUBJ0072,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-05-13,28
STUDY001,QS,STUDY001-SUBJ0072,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,NOT DONE,,,2,WEEK 4,2025-05-13,28
STUDY001,QS,STUDY001-SUBJ0072,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-13,28
STUDY001,QS,STUDY001-SUBJ0072,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-05-13,28
STUDY001,QS,STUDY001-SUBJ0072,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-13,28
STUDY001,QS,STUDY001-SUBJ0072,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-05-13,28
STUDY001,QS,STUDY001-SUBJ0072,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-13,28
STUDY001,QS,STUDY001-SUBJ0072,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-05-13,28
STUDY001,QS,STUDY001-SUBJ0072,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-13,28
STUDY001,QS,STUDY001-SUBJ0072,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,55,55,55.0,,,,2,WEEK 4,2025-05-13,28
STUDY001,QS,STUDY001-SUBJ0072,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-10,56
STUDY001,QS,STUDY001-SUBJ0072,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-06-10,56
STUDY001,QS,STUDY001-SUBJ0072,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-10,56
STUDY001,QS,STUDY001-SUBJ0072,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-10,56
STUDY001,QS,STUDY001-SUBJ0072,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-10,56
STUDY001,QS,STUDY001-SUBJ0072,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-10,56
STUDY001,QS,STUDY001-SUBJ0072,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-06-10,56
STUDY001,QS,STUDY001-SUBJ0072,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-10,56
STUDY001,QS,STUDY001-SUBJ0072,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-06-10,56
STUDY001,QS,STUDY001-SUBJ0072,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-10,56
STUDY001,QS,STUDY001-SUBJ0072,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,70,70,70.0,,,,3,WEEK 8,2025-06-10,56
STUDY001,QS,STUDY001-SUBJ0072,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-08,84
STUDY001,QS,STUDY001-SUBJ0072,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-07-08,84
STUDY001,QS,STUDY001-SUBJ0072,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-08,84
STUDY001,QS,STUDY001-SUBJ0072,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,4,WEEK 12,2025-07-08,84
STUDY001,QS,STUDY001-SUBJ0072,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-08,84
STUDY001,QS,STUDY001-SUBJ0072,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-08,84
STUDY001,QS,STUDY001-SUBJ0072,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-07-08,84
STUDY001,QS,STUDY001-SUBJ0072,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-08,84
STUDY001,QS,STUDY001-SUBJ0072,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-07-08,84
STUDY001,QS,STUDY001-SUBJ0072,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-08,84
STUDY001,QS,STUDY001-SUBJ0072,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-07-08,84
STUDY001,QS,STUDY001-SUBJ0072,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-02,140
STUDY001,QS,STUDY001-SUBJ0072,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-09-02,140
STUDY001,QS,STUDY001-SUBJ0072,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-02,140
STUDY001,QS,STUDY001-SUBJ0072,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-02,140
STUDY001,QS,STUDY001-SUBJ0072,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-02,140
STUDY001,QS,STUDY001-SUBJ0072,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-02,140
STUDY001,QS,STUDY001-SUBJ0072,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-09-02,140
STUDY001,QS,STUDY001-SUBJ0072,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-02,140
STUDY001,QS,STUDY001-SUBJ0072,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-09-02,140
STUDY001,QS,STUDY001-SUBJ0072,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-02,140
STUDY001,QS,STUDY001-SUBJ0072,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-09-02,140
STUDY001,QS,STUDY001-SUBJ0073,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,NOT DONE,,Y,1,BASELINE,2025-06-19,1
STUDY001,QS,STUDY001-SUBJ0073,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-06-19,1
STUDY001,QS,STUDY001-SUBJ0073,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-06-19,1
STUDY001,QS,STUDY001-SUBJ0073,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-06-19,1
STUDY001,QS,STUDY001-SUBJ0073,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-06-19,1
STUDY001,QS,STUDY001-SUBJ0073,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,55,55,55.0,,,Y,1,BASELINE,2025-06-19,1
STUDY001,QS,STUDY001-SUBJ0073,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-07-16,28
STUDY001,QS,STUDY001-SUBJ0073,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-16,28
STUDY001,QS,STUDY001-SUBJ0073,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-16,28
STUDY001,QS,STUDY001-SUBJ0073,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-16,28
STUDY001,QS,STUDY001-SUBJ0073,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-16,28
STUDY001,QS,STUDY001-SUBJ0073,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-13,56
STUDY001,QS,STUDY001-SUBJ0073,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-08-13,56
STUDY001,QS,STUDY001-SUBJ0073,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-13,56
STUDY001,QS,STUDY001-SUBJ0073,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-13,56
STUDY001,QS,STUDY001-SUBJ0073,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,3,WEEK 8,2025-08-13,56
STUDY001,QS,STUDY001-SUBJ0073,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-13,56
STUDY001,QS,STUDY001-SUBJ0073,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,NOT DONE,,,3,WEEK 8,2025-08-13,56
STUDY001,QS,STUDY001-SUBJ0073,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-13,56
STUDY001,QS,STUDY001-SUBJ0073,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-08-13,56
STUDY001,QS,STUDY001-SUBJ0073,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-13,56
STUDY001,QS,STUDY001-SUBJ0073,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,68,68,68.0,,,,3,WEEK 8,2025-08-13,56
STUDY001,QS,STUDY001-SUBJ0073,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-10,84
STUDY001,QS,STUDY001-SUBJ0073,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,NOT DONE,,,4,WEEK 12,2025-09-10,84
STUDY001,QS,STUDY001-SUBJ0073,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-10,84
STUDY001,QS,STUDY001-SUBJ0073,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-10,84
STUDY001,QS,STUDY001-SUBJ0073,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-10,84
STUDY001,QS,STUDY001-SUBJ0073,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-10,84
STUDY001,QS,STUDY001-SUBJ0073,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-09-10,84
STUDY001,QS,STUDY001-SUBJ0073,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-10,84
STUDY001,QS,STUDY001-SUBJ0073,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-09-10,84
STUDY001,QS,STUDY001-SUBJ0073,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-10,84
STUDY001,QS,STUDY001-SUBJ0073,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-09-10,84
STUDY001,QS,STUDY001-SUBJ0073,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-05,140
STUDY001,QS,STUDY001-SUBJ0073,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-11-05,140
STUDY001,QS,STUDY001-SUBJ0073,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-05,140
STUDY001,QS,STUDY001-SUBJ0073,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-05,140
STUDY001,QS,STUDY001-SUBJ0073,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-05,140
STUDY001,QS,STUDY001-SUBJ0073,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-05,140
STUDY001,QS,STUDY001-SUBJ0073,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-11-05,140
STUDY001,QS,STUDY001-SUBJ0073,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-05,140
STUDY001,QS,STUDY001-SUBJ0073,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-11-05,140
STUDY001,QS,STUDY001-SUBJ0073,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-05,140
STUDY001,QS,STUDY001-SUBJ0073,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-11-05,140
STUDY001,QS,STUDY001-SUBJ0074,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0074,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0074,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0074,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0074,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0074,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0074,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0074,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0074,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0074,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0074,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,51,51,51.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0074,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0074,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0074,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0074,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0074,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0074,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0074,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0074,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0074,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0074,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0074,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0074,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0074,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0074,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0074,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0074,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0074,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0074,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0074,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0074,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0074,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0074,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,64,64,64.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0074,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0074,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,NOT DONE,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0074,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0074,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0074,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0074,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0074,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0074,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0074,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0074,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0074,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,82,82,82.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0074,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0074,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0074,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0074,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0074,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0074,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0075,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-09-06,1
STUDY001,QS,STUDY001-SUBJ0075,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-09-06,1
STUDY001,QS,STUDY001-SUBJ0075,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-09-06,1
STUDY001,QS,STUDY001-SUBJ0075,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-06,1
STUDY001,QS,STUDY001-SUBJ0075,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-09-06,1
STUDY001,QS,STUDY001-SUBJ0075,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-06,1
STUDY001,QS,STUDY001-SUBJ0075,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-09-06,1
STUDY001,QS,STUDY001-SUBJ0075,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-06,1
STUDY001,QS,STUDY001-SUBJ0075,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-09-06,1
STUDY001,QS,STUDY001-SUBJ0075,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-09-06,1
STUDY001,QS,STUDY001-SUBJ0075,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,62,62,62.0,,,Y,1,BASELINE,2025-09-06,1
STUDY001,QS,STUDY001-SUBJ0075,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-10-03,28
STUDY001,QS,STUDY001-SUBJ0075,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-10-03,28
STUDY001,QS,STUDY001-SUBJ0075,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-10-03,28
STUDY001,QS,STUDY001-SUBJ0075,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-10-03,28
STUDY001,QS,STUDY001-SUBJ0075,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-10-03,28
STUDY001,QS,STUDY001-SUBJ0075,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-10-03,28
STUDY001,QS,STUDY001-SUBJ0075,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-10-03,28
STUDY001,QS,STUDY001-SUBJ0075,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-10-03,28
STUDY001,QS,STUDY001-SUBJ0075,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-10-03,28
STUDY001,QS,STUDY001-SUBJ0075,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-10-03,28
STUDY001,QS,STUDY001-SUBJ0075,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,,,,2,WEEK 4,2025-10-03,28
STUDY001,QS,STUDY001-SUBJ0075,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-31,56
STUDY001,QS,STUDY001-SUBJ0075,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,NOT DONE,,,3,WEEK 8,2025-10-31,56
STUDY001,QS,STUDY001-SUBJ0075,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-31,56
STUDY001,QS,STUDY001-SUBJ0075,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-10-31,56
STUDY001,QS,STUDY001-SUBJ0075,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-31,56
STUDY001,QS,STUDY001-SUBJ0075,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-10-31,56
STUDY001,QS,STUDY001-SUBJ0075,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-10-31,56
STUDY001,QS,STUDY001-SUBJ0075,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-10-31,56
STUDY001,QS,STUDY001-SUBJ0075,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-10-31,56
STUDY001,QS,STUDY001-SUBJ0075,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-10-31,56
STUDY001,QS,STUDY001-SUBJ0075,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,72,72,72.0,,,,3,WEEK 8,2025-10-31,56
STUDY001,QS,STUDY001-SUBJ0076,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-06-27,1
STUDY001,QS,STUDY001-SUBJ0076,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-06-27,1
STUDY001,QS,STUDY001-SUBJ0076,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,NOT DONE,,Y,1,BASELINE,2025-06-27,1
STUDY001,QS,STUDY001-SUBJ0076,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-06-27,1
STUDY001,QS,STUDY001-SUBJ0076,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-06-27,1
STUDY001,QS,STUDY001-SUBJ0076,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-06-27,1
STUDY001,QS,STUDY001-SUBJ0076,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-06-27,1
STUDY001,QS,STUDY001-SUBJ0076,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-06-27,1
STUDY001,QS,STUDY001-SUBJ0076,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-06-27,1
STUDY001,QS,STUDY001-SUBJ0076,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-06-27,1
STUDY001,QS,STUDY001-SUBJ0076,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,43,43,43.0,,,Y,1,BASELINE,2025-06-27,1
STUDY001,QS,STUDY001-SUBJ0076,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-24,28
STUDY001,QS,STUDY001-SUBJ0076,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-07-24,28
STUDY001,QS,STUDY001-SUBJ0076,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-24,28
STUDY001,QS,STUDY001-SUBJ0076,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-24,28
STUDY001,QS,STUDY001-SUBJ0076,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-07-24,28
STUDY001,QS,STUDY001-SUBJ0076,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-24,28
STUDY001,QS,STUDY001-SUBJ0076,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-07-24,28
STUDY001,QS,STUDY001-SUBJ0076,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-24,28
STUDY001,QS,STUDY001-SUBJ0076,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-07-24,28
STUDY001,QS,STUDY001-SUBJ0076,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-07-24,28
STUDY001,QS,STUDY001-SUBJ0076,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,,,,2,WEEK 4,2025-07-24,28
STUDY001,QS,STUDY001-SUBJ0076,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-21,56
STUDY001,QS,STUDY001-SUBJ0076,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-08-21,56
STUDY001,QS,STUDY001-SUBJ0076,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-21,56
STUDY001,QS,STUDY001-SUBJ0076,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-21,56
STUDY001,QS,STUDY001-SUBJ0076,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-21,56
STUDY001,QS,STUDY001-SUBJ0076,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-21,56
STUDY001,QS,STUDY001-SUBJ0076,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-08-21,56
STUDY001,QS,STUDY001-SUBJ0076,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-21,56
STUDY001,QS,STUDY001-SUBJ0076,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-08-21,56
STUDY001,QS,STUDY001-SUBJ0076,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-08-21,56
STUDY001,QS,STUDY001-SUBJ0076,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,73,73,73.0,,,,3,WEEK 8,2025-08-21,56
STUDY001,QS,STUDY001-SUBJ0076,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-18,84
STUDY001,QS,STUDY001-SUBJ0076,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-09-18,84
STUDY001,QS,STUDY001-SUBJ0076,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-18,84
STUDY001,QS,STUDY001-SUBJ0076,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-18,84
STUDY001,QS,STUDY001-SUBJ0076,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-09-18,84
STUDY001,QS,STUDY001-SUBJ0076,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-18,84
STUDY001,QS,STUDY001-SUBJ0076,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-09-18,84
STUDY001,QS,STUDY001-SUBJ0076,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-18,84
STUDY001,QS,STUDY001-SUBJ0076,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-09-18,84
STUDY001,QS,STUDY001-SUBJ0076,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-18,84
STUDY001,QS,STUDY001-SUBJ0076,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,86,86,86.0,,,,4,WEEK 12,2025-09-18,84
STUDY001,QS,STUDY001-SUBJ0076,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-13,140
STUDY001,QS,STUDY001-SUBJ0076,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-11-13,140
STUDY001,QS,STUDY001-SUBJ0076,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,5,END OF TREATMENT,2025-11-13,140
STUDY001,QS,STUDY001-SUBJ0076,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-13,140
STUDY001,QS,STUDY001-SUBJ0076,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-13,140
STUDY001,QS,STUDY001-SUBJ0076,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-13,140
STUDY001,QS,STUDY001-SUBJ0076,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-11-13,140
STUDY001,QS,STUDY001-SUBJ0076,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-13,140
STUDY001,QS,STUDY001-SUBJ0076,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-11-13,140
STUDY001,QS,STUDY001-SUBJ0076,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-13,140
STUDY001,QS,STUDY001-SUBJ0076,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-11-13,140
STUDY001,QS,STUDY001-SUBJ0077,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-04-15,1
STUDY001,QS,STUDY001-SUBJ0077,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-04-15,1
STUDY001,QS,STUDY001-SUBJ0077,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-04-15,1
STUDY001,QS,STUDY001-SUBJ0077,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-04-15,1
STUDY001,QS,STUDY001-SUBJ0077,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-04-15,1
STUDY001,QS,STUDY001-SUBJ0077,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-04-15,1
STUDY001,QS,STUDY001-SUBJ0077,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-04-15,1
STUDY001,QS,STUDY001-SUBJ0077,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-04-15,1
STUDY001,QS,STUDY001-SUBJ0077,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-04-15,1
STUDY001,QS,STUDY001-SUBJ0077,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-04-15,1
STUDY001,QS,STUDY001-SUBJ0077,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,60,60,60.0,,,Y,1,BASELINE,2025-04-15,1
STUDY001,QS,STUDY001-SUBJ0077,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-05-12,28
STUDY001,QS,STUDY001-SUBJ0077,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-12,28
STUDY001,QS,STUDY001-SUBJ0077,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-12,28
STUDY001,QS,STUDY001-SUBJ0077,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-12,28
STUDY001,QS,STUDY001-SUBJ0077,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-12,28
STUDY001,QS,STUDY001-SUBJ0077,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,3,WEEK 8,2025-06-09,56
STUDY001,QS,STUDY001-SUBJ0077,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-06-09,56
STUDY001,QS,STUDY001-SUBJ0077,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-09,56
STUDY001,QS,STUDY001-SUBJ0077,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-09,56
STUDY001,QS,STUDY001-SUBJ0077,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-09,56
STUDY001,QS,STUDY001-SUBJ0077,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-09,56
STUDY001,QS,STUDY001-SUBJ0077,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-06-09,56
STUDY001,QS,STUDY001-SUBJ0077,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-09,56
STUDY001,QS,STUDY001-SUBJ0077,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-06-09,56
STUDY001,QS,STUDY001-SUBJ0077,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-09,56
STUDY001,QS,STUDY001-SUBJ0077,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,71,71,71.0,,,,3,WEEK 8,2025-06-09,56
STUDY001,QS,STUDY001-SUBJ0077,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-07,84
STUDY001,QS,STUDY001-SUBJ0077,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-07-07,84
STUDY001,QS,STUDY001-SUBJ0077,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-07,84
STUDY001,QS,STUDY001-SUBJ0077,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-07,84
STUDY001,QS,STUDY001-SUBJ0077,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-07,84
STUDY001,QS,STUDY001-SUBJ0077,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-07,84
STUDY001,QS,STUDY001-SUBJ0077,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-07-07,84
STUDY001,QS,STUDY001-SUBJ0077,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-07,84
STUDY001,QS,STUDY001-SUBJ0077,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-07-07,84
STUDY001,QS,STUDY001-SUBJ0077,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-07,84
STUDY001,QS,STUDY001-SUBJ0077,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-07-07,84
STUDY001,QS,STUDY001-SUBJ0078,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-03-22,1
STUDY001,QS,STUDY001-SUBJ0078,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-03-22,1
STUDY001,QS,STUDY001-SUBJ0078,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-03-22,1
STUDY001,QS,STUDY001-SUBJ0078,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-22,1
STUDY001,QS,STUDY001-SUBJ0078,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-03-22,1
STUDY001,QS,STUDY001-SUBJ0078,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-22,1
STUDY001,QS,STUDY001-SUBJ0078,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-03-22,1
STUDY001,QS,STUDY001-SUBJ0078,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-22,1
STUDY001,QS,STUDY001-SUBJ0078,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-03-22,1
STUDY001,QS,STUDY001-SUBJ0078,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-03-22,1
STUDY001,QS,STUDY001-SUBJ0078,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,45,45,45.0,,,Y,1,BASELINE,2025-03-22,1
STUDY001,QS,STUDY001-SUBJ0078,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-04-18,28
STUDY001,QS,STUDY001-SUBJ0078,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-04-18,28
STUDY001,QS,STUDY001-SUBJ0078,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,NOT DONE,,,2,WEEK 4,2025-04-18,28
STUDY001,QS,STUDY001-SUBJ0078,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-18,28
STUDY001,QS,STUDY001-SUBJ0078,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-04-18,28
STUDY001,QS,STUDY001-SUBJ0078,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-18,28
STUDY001,QS,STUDY001-SUBJ0078,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-04-18,28
STUDY001,QS,STUDY001-SUBJ0078,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-18,28
STUDY001,QS,STUDY001-SUBJ0078,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-04-18,28
STUDY001,QS,STUDY001-SUBJ0078,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-04-18,28
STUDY001,QS,STUDY001-SUBJ0078,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,,,,2,WEEK 4,2025-04-18,28
STUDY001,QS,STUDY001-SUBJ0078,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-16,56
STUDY001,QS,STUDY001-SUBJ0078,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-05-16,56
STUDY001,QS,STUDY001-SUBJ0078,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-16,56
STUDY001,QS,STUDY001-SUBJ0078,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,3,WEEK 8,2025-05-16,56
STUDY001,QS,STUDY001-SUBJ0078,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-16,56
STUDY001,QS,STUDY001-SUBJ0078,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-05-16,56
STUDY001,QS,STUDY001-SUBJ0078,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-05-16,56
STUDY001,QS,STUDY001-SUBJ0078,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-05-16,56
STUDY001,QS,STUDY001-SUBJ0078,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-05-16,56
STUDY001,QS,STUDY001-SUBJ0078,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-05-16,56
STUDY001,QS,STUDY001-SUBJ0078,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,62,62,62.0,,,,3,WEEK 8,2025-05-16,56
STUDY001,QS,STUDY001-SUBJ0078,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-06-13,84
STUDY001,QS,STUDY001-SUBJ0078,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,NOT DONE,,,4,WEEK 12,2025-06-13,84
STUDY001,QS,STUDY001-SUBJ0078,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,4,WEEK 12,2025-06-13,84
STUDY001,QS,STUDY001-SUBJ0078,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-13,84
STUDY001,QS,STUDY001-SUBJ0078,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-06-13,84
STUDY001,QS,STUDY001-SUBJ0078,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-13,84
STUDY001,QS,STUDY001-SUBJ0078,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-06-13,84
STUDY001,QS,STUDY001-SUBJ0078,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-13,84
STUDY001,QS,STUDY001-SUBJ0078,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-06-13,84
STUDY001,QS,STUDY001-SUBJ0078,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-06-13,84
STUDY001,QS,STUDY001-SUBJ0078,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,89,89,89.0,,,,4,WEEK 12,2025-06-13,84
STUDY001,QS,STUDY001-SUBJ0078,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-08,140
STUDY001,QS,STUDY001-SUBJ0078,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-08-08,140
STUDY001,QS,STUDY001-SUBJ0078,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-08,140
STUDY001,QS,STUDY001-SUBJ0078,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-08,140
STUDY001,QS,STUDY001-SUBJ0078,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-08,140
STUDY001,QS,STUDY001-SUBJ0078,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-08,140
STUDY001,QS,STUDY001-SUBJ0078,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-08-08,140
STUDY001,QS,STUDY001-SUBJ0078,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-08,140
STUDY001,QS,STUDY001-SUBJ0078,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-08-08,140
STUDY001,QS,STUDY001-SUBJ0078,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-08,140
STUDY001,QS,STUDY001-SUBJ0078,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-08-08,140
STUDY001,QS,STUDY001-SUBJ0079,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-08-18,1
STUDY001,QS,STUDY001-SUBJ0079,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-08-18,1
STUDY001,QS,STUDY001-SUBJ0079,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-08-18,1
STUDY001,QS,STUDY001-SUBJ0079,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-08-18,1
STUDY001,QS,STUDY001-SUBJ0079,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-08-18,1
STUDY001,QS,STUDY001-SUBJ0079,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-08-18,1
STUDY001,QS,STUDY001-SUBJ0079,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-08-18,1
STUDY001,QS,STUDY001-SUBJ0079,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-08-18,1
STUDY001,QS,STUDY001-SUBJ0079,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-08-18,1
STUDY001,QS,STUDY001-SUBJ0079,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-08-18,1
STUDY001,QS,STUDY001-SUBJ0079,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,41,41,41.0,,,Y,1,BASELINE,2025-08-18,1
STUDY001,QS,STUDY001-SUBJ0079,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-09-14,28
STUDY001,QS,STUDY001-SUBJ0079,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-09-14,28
STUDY001,QS,STUDY001-SUBJ0079,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-09-14,28
STUDY001,QS,STUDY001-SUBJ0079,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-14,28
STUDY001,QS,STUDY001-SUBJ0079,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-09-14,28
STUDY001,QS,STUDY001-SUBJ0079,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-14,28
STUDY001,QS,STUDY001-SUBJ0079,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-09-14,28
STUDY001,QS,STUDY001-SUBJ0079,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-14,28
STUDY001,QS,STUDY001-SUBJ0079,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-09-14,28
STUDY001,QS,STUDY001-SUBJ0079,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-14,28
STUDY001,QS,STUDY001-SUBJ0079,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,59,59,59.0,,,,2,WEEK 4,2025-09-14,28
STUDY001,QS,STUDY001-SUBJ0079,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-12,56
STUDY001,QS,STUDY001-SUBJ0079,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-10-12,56
STUDY001,QS,STUDY001-SUBJ0079,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-12,56
STUDY001,QS,STUDY001-SUBJ0079,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-10-12,56
STUDY001,QS,STUDY001-SUBJ0079,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-12,56
STUDY001,QS,STUDY001-SUBJ0079,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-10-12,56
STUDY001,QS,STUDY001-SUBJ0079,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-10-12,56
STUDY001,QS,STUDY001-SUBJ0079,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-10-12,56
STUDY001,QS,STUDY001-SUBJ0079,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-10-12,56
STUDY001,QS,STUDY001-SUBJ0079,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-10-12,56
STUDY001,QS,STUDY001-SUBJ0079,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,70,70,70.0,,,,3,WEEK 8,2025-10-12,56
STUDY001,QS,STUDY001-SUBJ0079,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-11-09,84
STUDY001,QS,STUDY001-SUBJ0079,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-11-09,84
STUDY001,QS,STUDY001-SUBJ0079,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,4,WEEK 12,2025-11-09,84
STUDY001,QS,STUDY001-SUBJ0079,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-09,84
STUDY001,QS,STUDY001-SUBJ0079,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-11-09,84
STUDY001,QS,STUDY001-SUBJ0079,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-09,84
STUDY001,QS,STUDY001-SUBJ0079,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-11-09,84
STUDY001,QS,STUDY001-SUBJ0079,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-09,84
STUDY001,QS,STUDY001-SUBJ0079,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-11-09,84
STUDY001,QS,STUDY001-SUBJ0079,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-09,84
STUDY001,QS,STUDY001-SUBJ0079,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,84,84,84.0,,,,4,WEEK 12,2025-11-09,84
STUDY001,QS,STUDY001-SUBJ0080,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0080,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0080,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0080,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0080,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0080,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0080,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0080,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0080,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0080,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0080,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,39,39,39.0,,,Y,1,BASELINE,2025-07-10,1
STUDY001,QS,STUDY001-SUBJ0080,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0080,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0080,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0080,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0080,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0080,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0080,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,NOT DONE,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0080,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0080,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0080,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0080,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,64,64,64.0,,,,2,WEEK 4,2025-08-06,28
STUDY001,QS,STUDY001-SUBJ0080,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0080,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0080,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0080,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0080,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0080,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0080,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0080,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0080,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0080,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0080,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,67,67,67.0,,,,3,WEEK 8,2025-09-03,56
STUDY001,QS,STUDY001-SUBJ0080,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0080,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0080,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0080,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0080,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0080,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,83,83,83.0,,,,4,WEEK 12,2025-10-01,84
STUDY001,QS,STUDY001-SUBJ0080,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0080,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0080,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0080,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0080,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0080,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0080,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0080,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0080,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0080,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0080,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-11-26,140
STUDY001,QS,STUDY001-SUBJ0081,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-10-06,1
STUDY001,QS,STUDY001-SUBJ0081,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-10-06,1
STUDY001,QS,STUDY001-SUBJ0081,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-10-06,1
STUDY001,QS,STUDY001-SUBJ0081,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-10-06,1
STUDY001,QS,STUDY001-SUBJ0081,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,Y,1,BASELINE,2025-10-06,1
STUDY001,QS,STUDY001-SUBJ0081,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-10-06,1
STUDY001,QS,STUDY001-SUBJ0081,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-10-06,1
STUDY001,QS,STUDY001-SUBJ0081,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-10-06,1
STUDY001,QS,STUDY001-SUBJ0081,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-10-06,1
STUDY001,QS,STUDY001-SUBJ0081,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-10-06,1
STUDY001,QS,STUDY001-SUBJ0081,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,68,68,68.0,,,Y,1,BASELINE,2025-10-06,1
STUDY001,QS,STUDY001-SUBJ0081,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-02,28
STUDY001,QS,STUDY001-SUBJ0081,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-11-02,28
STUDY001,QS,STUDY001-SUBJ0081,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-02,28
STUDY001,QS,STUDY001-SUBJ0081,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-02,28
STUDY001,QS,STUDY001-SUBJ0081,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-11-02,28
STUDY001,QS,STUDY001-SUBJ0081,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-02,28
STUDY001,QS,STUDY001-SUBJ0081,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-11-02,28
STUDY001,QS,STUDY001-SUBJ0081,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-02,28
STUDY001,QS,STUDY001-SUBJ0081,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-11-02,28
STUDY001,QS,STUDY001-SUBJ0081,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-11-02,28
STUDY001,QS,STUDY001-SUBJ0081,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,62,62,62.0,,,,2,WEEK 4,2025-11-02,28
STUDY001,QS,STUDY001-SUBJ0081,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,3,WEEK 8,2025-11-30,56
STUDY001,QS,STUDY001-SUBJ0081,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-11-30,56
STUDY001,QS,STUDY001-SUBJ0081,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,3,WEEK 8,2025-11-30,56
STUDY001,QS,STUDY001-SUBJ0081,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-30,56
STUDY001,QS,STUDY001-SUBJ0081,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-11-30,56
STUDY001,QS,STUDY001-SUBJ0081,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-30,56
STUDY001,QS,STUDY001-SUBJ0081,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-11-30,56
STUDY001,QS,STUDY001-SUBJ0081,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-30,56
STUDY001,QS,STUDY001-SUBJ0081,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-11-30,56
STUDY001,QS,STUDY001-SUBJ0081,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-11-30,56
STUDY001,QS,STUDY001-SUBJ0081,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,71,71,71.0,,,,3,WEEK 8,2025-11-30,56
STUDY001,QS,STUDY001-SUBJ0082,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-12-01,1
STUDY001,QS,STUDY001-SUBJ0082,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-12-01,1
STUDY001,QS,STUDY001-SUBJ0082,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-12-01,1
STUDY001,QS,STUDY001-SUBJ0082,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-12-01,1
STUDY001,QS,STUDY001-SUBJ0082,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-12-01,1
STUDY001,QS,STUDY001-SUBJ0082,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-12-01,1
STUDY001,QS,STUDY001-SUBJ0082,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-12-01,1
STUDY001,QS,STUDY001-SUBJ0082,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,NOT DONE,,Y,1,BASELINE,2025-12-01,1
STUDY001,QS,STUDY001-SUBJ0082,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-12-01,1
STUDY001,QS,STUDY001-SUBJ0082,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-12-01,1
STUDY001,QS,STUDY001-SUBJ0082,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,32,32,32.0,,,Y,1,BASELINE,2025-12-01,1
STUDY001,QS,STUDY001-SUBJ0083,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-12-04,1
STUDY001,QS,STUDY001-SUBJ0083,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-12-04,1
STUDY001,QS,STUDY001-SUBJ0083,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-12-04,1
STUDY001,QS,STUDY001-SUBJ0083,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-12-04,1
STUDY001,QS,STUDY001-SUBJ0083,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-12-04,1
STUDY001,QS,STUDY001-SUBJ0083,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,58,58,58.0,,,Y,1,BASELINE,2025-12-04,1
STUDY001,QS,STUDY001-SUBJ0083,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-12-31,28
STUDY001,QS,STUDY001-SUBJ0083,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-12-31,28
STUDY001,QS,STUDY001-SUBJ0083,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,NOT DONE,,,2,WEEK 4,2025-12-31,28
STUDY001,QS,STUDY001-SUBJ0083,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-31,28
STUDY001,QS,STUDY001-SUBJ0083,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-12-31,28
STUDY001,QS,STUDY001-SUBJ0083,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-31,28
STUDY001,QS,STUDY001-SUBJ0083,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-12-31,28
STUDY001,QS,STUDY001-SUBJ0083,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-31,28
STUDY001,QS,STUDY001-SUBJ0083,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-12-31,28
STUDY001,QS,STUDY001-SUBJ0083,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-12-31,28
STUDY001,QS,STUDY001-SUBJ0083,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,57,57,57.0,,,,2,WEEK 4,2025-12-31,28
STUDY001,QS,STUDY001-SUBJ0084,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0084,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0084,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0084,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0084,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0084,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0084,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0084,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0084,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0084,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0084,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,60,60,60.0,,,Y,1,BASELINE,2025-01-23,1
STUDY001,QS,STUDY001-SUBJ0084,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0084,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0084,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0084,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0084,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-19,28
STUDY001,QS,STUDY001-SUBJ0084,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0084,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0084,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0084,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0084,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0084,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0084,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0084,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0084,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0084,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0084,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,3,WEEK 8,2025-03-19,56
STUDY001,QS,STUDY001-SUBJ0084,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0084,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0084,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0084,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0084,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0084,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0084,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0084,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0084,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0084,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0084,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,77,77,77.0,,,,4,WEEK 12,2025-04-16,84
STUDY001,QS,STUDY001-SUBJ0084,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0084,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0084,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0084,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0084,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0084,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0084,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0084,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0084,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0084,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0084,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-06-11,140
STUDY001,QS,STUDY001-SUBJ0085,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-03,1
STUDY001,QS,STUDY001-SUBJ0085,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-02-03,1
STUDY001,QS,STUDY001-SUBJ0085,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,NOT DONE,,Y,1,BASELINE,2025-02-03,1
STUDY001,QS,STUDY001-SUBJ0085,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,Y,1,BASELINE,2025-02-03,1
STUDY001,QS,STUDY001-SUBJ0085,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-03,1
STUDY001,QS,STUDY001-SUBJ0085,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-03,1
STUDY001,QS,STUDY001-SUBJ0085,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-02-03,1
STUDY001,QS,STUDY001-SUBJ0085,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-03,1
STUDY001,QS,STUDY001-SUBJ0085,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-02-03,1
STUDY001,QS,STUDY001-SUBJ0085,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-03,1
STUDY001,QS,STUDY001-SUBJ0085,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,54,54,54.0,,,Y,1,BASELINE,2025-02-03,1
STUDY001,QS,STUDY001-SUBJ0085,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-03-02,28
STUDY001,QS,STUDY001-SUBJ0085,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-03-02,28
STUDY001,QS,STUDY001-SUBJ0085,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-03-02,28
STUDY001,QS,STUDY001-SUBJ0085,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-02,28
STUDY001,QS,STUDY001-SUBJ0085,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-03-02,28
STUDY001,QS,STUDY001-SUBJ0085,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-02,28
STUDY001,QS,STUDY001-SUBJ0085,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-03-02,28
STUDY001,QS,STUDY001-SUBJ0085,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-02,28
STUDY001,QS,STUDY001-SUBJ0085,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-03-02,28
STUDY001,QS,STUDY001-SUBJ0085,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-02,28
STUDY001,QS,STUDY001-SUBJ0085,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,57,57,57.0,,,,2,WEEK 4,2025-03-02,28
STUDY001,QS,STUDY001-SUBJ0085,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-30,56
STUDY001,QS,STUDY001-SUBJ0085,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-03-30,56
STUDY001,QS,STUDY001-SUBJ0085,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-30,56
STUDY001,QS,STUDY001-SUBJ0085,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-30,56
STUDY001,QS,STUDY001-SUBJ0085,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-30,56
STUDY001,QS,STUDY001-SUBJ0085,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-30,56
STUDY001,QS,STUDY001-SUBJ0085,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-03-30,56
STUDY001,QS,STUDY001-SUBJ0085,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-30,56
STUDY001,QS,STUDY001-SUBJ0085,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-03-30,56
STUDY001,QS,STUDY001-SUBJ0085,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-03-30,56
STUDY001,QS,STUDY001-SUBJ0085,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,65,65,65.0,,,,3,WEEK 8,2025-03-30,56
STUDY001,QS,STUDY001-SUBJ0085,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-27,84
STUDY001,QS,STUDY001-SUBJ0085,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-27,84
STUDY001,QS,STUDY001-SUBJ0085,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-27,84
STUDY001,QS,STUDY001-SUBJ0085,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-04-27,84
STUDY001,QS,STUDY001-SUBJ0085,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-04-27,84
STUDY001,QS,STUDY001-SUBJ0085,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,84,84,84.0,,,,4,WEEK 12,2025-04-27,84
STUDY001,QS,STUDY001-SUBJ0085,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,5,END OF TREATMENT,2025-06-22,140
STUDY001,QS,STUDY001-SUBJ0085,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-06-22,140
STUDY001,QS,STUDY001-SUBJ0085,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-22,140
STUDY001,QS,STUDY001-SUBJ0085,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-22,140
STUDY001,QS,STUDY001-SUBJ0085,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-22,140
STUDY001,QS,STUDY001-SUBJ0085,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-22,140
STUDY001,QS,STUDY001-SUBJ0085,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-06-22,140
STUDY001,QS,STUDY001-SUBJ0085,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,5,END OF TREATMENT,2025-06-22,140
STUDY001,QS,STUDY001-SUBJ0085,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-06-22,140
STUDY001,QS,STUDY001-SUBJ0085,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-22,140
STUDY001,QS,STUDY001-SUBJ0085,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-06-22,140
STUDY001,QS,STUDY001-SUBJ0086,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,Y,1,BASELINE,2025-06-21,1
STUDY001,QS,STUDY001-SUBJ0086,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-06-21,1
STUDY001,QS,STUDY001-SUBJ0086,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-06-21,1
STUDY001,QS,STUDY001-SUBJ0086,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-21,1
STUDY001,QS,STUDY001-SUBJ0086,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-06-21,1
STUDY001,QS,STUDY001-SUBJ0086,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-21,1
STUDY001,QS,STUDY001-SUBJ0086,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-06-21,1
STUDY001,QS,STUDY001-SUBJ0086,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-21,1
STUDY001,QS,STUDY001-SUBJ0086,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-06-21,1
STUDY001,QS,STUDY001-SUBJ0086,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-06-21,1
STUDY001,QS,STUDY001-SUBJ0086,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,69,69,69.0,,,Y,1,BASELINE,2025-06-21,1
STUDY001,QS,STUDY001-SUBJ0086,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-07-18,28
STUDY001,QS,STUDY001-SUBJ0086,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-07-18,28
STUDY001,QS,STUDY001-SUBJ0086,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-07-18,28
STUDY001,QS,STUDY001-SUBJ0086,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-18,28
STUDY001,QS,STUDY001-SUBJ0086,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-07-18,28
STUDY001,QS,STUDY001-SUBJ0086,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-18,28
STUDY001,QS,STUDY001-SUBJ0086,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-07-18,28
STUDY001,QS,STUDY001-SUBJ0086,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-18,28
STUDY001,QS,STUDY001-SUBJ0086,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-07-18,28
STUDY001,QS,STUDY001-SUBJ0086,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-07-18,28
STUDY001,QS,STUDY001-SUBJ0086,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,64,64,64.0,,,,2,WEEK 4,2025-07-18,28
STUDY001,QS,STUDY001-SUBJ0086,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-15,56
STUDY001,QS,STUDY001-SUBJ0086,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-08-15,56
STUDY001,QS,STUDY001-SUBJ0086,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-15,56
STUDY001,QS,STUDY001-SUBJ0086,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-08-15,56
STUDY001,QS,STUDY001-SUBJ0086,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-08-15,56
STUDY001,QS,STUDY001-SUBJ0086,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-08-15,56
STUDY001,QS,STUDY001-SUBJ0086,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-08-15,56
STUDY001,QS,STUDY001-SUBJ0086,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-08-15,56
STUDY001,QS,STUDY001-SUBJ0086,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-08-15,56
STUDY001,QS,STUDY001-SUBJ0086,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-08-15,56
STUDY001,QS,STUDY001-SUBJ0086,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,NOT DONE,,,3,WEEK 8,2025-08-15,56
STUDY001,QS,STUDY001-SUBJ0086,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-09-12,84
STUDY001,QS,STUDY001-SUBJ0086,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-09-12,84
STUDY001,QS,STUDY001-SUBJ0086,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-09-12,84
STUDY001,QS,STUDY001-SUBJ0086,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,4,WEEK 12,2025-09-12,84
STUDY001,QS,STUDY001-SUBJ0086,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-09-12,84
STUDY001,QS,STUDY001-SUBJ0086,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-12,84
STUDY001,QS,STUDY001-SUBJ0086,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,4,WEEK 12,2025-09-12,84
STUDY001,QS,STUDY001-SUBJ0086,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-12,84
STUDY001,QS,STUDY001-SUBJ0086,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,4,WEEK 12,2025-09-12,84
STUDY001,QS,STUDY001-SUBJ0086,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-09-12,84
STUDY001,QS,STUDY001-SUBJ0086,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,77,77,77.0,,,,4,WEEK 12,2025-09-12,84
STUDY001,QS,STUDY001-SUBJ0086,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-07,140
STUDY001,QS,STUDY001-SUBJ0086,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-11-07,140
STUDY001,QS,STUDY001-SUBJ0086,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-07,140
STUDY001,QS,STUDY001-SUBJ0086,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-07,140
STUDY001,QS,STUDY001-SUBJ0086,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-11-07,140
STUDY001,QS,STUDY001-SUBJ0086,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-07,140
STUDY001,QS,STUDY001-SUBJ0086,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-11-07,140
STUDY001,QS,STUDY001-SUBJ0086,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-07,140
STUDY001,QS,STUDY001-SUBJ0086,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-11-07,140
STUDY001,QS,STUDY001-SUBJ0086,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-11-07,140
STUDY001,QS,STUDY001-SUBJ0086,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-11-07,140
STUDY001,QS,STUDY001-SUBJ0087,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0087,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,NOT DONE,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0087,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0087,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0087,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0087,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0087,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0087,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0087,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0087,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0087,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,52,52,52.0,,,Y,1,BASELINE,2025-02-08,1
STUDY001,QS,STUDY001-SUBJ0087,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0087,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0087,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0087,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0087,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0087,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0087,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0087,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0087,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,NOT DONE,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0087,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0087,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,,2,WEEK 4,2025-03-07,28
STUDY001,QS,STUDY001-SUBJ0087,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0087,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0087,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0087,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0087,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0087,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0087,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0087,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0087,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,NOT DONE,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0087,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0087,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,62,62,62.0,,,,3,WEEK 8,2025-04-04,56
STUDY001,QS,STUDY001-SUBJ0087,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,NOT DONE,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0087,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0087,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0087,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0087,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,4,WEEK 12,2025-05-02,84
STUDY001,QS,STUDY001-SUBJ0087,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0087,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0087,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0087,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0087,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0087,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0087,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0087,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0087,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0087,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0087,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,87,87,87.0,,,,5,END OF TREATMENT,2025-06-27,140
STUDY001,QS,STUDY001-SUBJ0088,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-16,1
STUDY001,QS,STUDY001-SUBJ0088,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-10-16,1
STUDY001,QS,STUDY001-SUBJ0088,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-16,1
STUDY001,QS,STUDY001-SUBJ0088,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-10-16,1
STUDY001,QS,STUDY001-SUBJ0088,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-10-16,1
STUDY001,QS,STUDY001-SUBJ0088,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-10-16,1
STUDY001,QS,STUDY001-SUBJ0088,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-10-16,1
STUDY001,QS,STUDY001-SUBJ0088,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-10-16,1
STUDY001,QS,STUDY001-SUBJ0088,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-10-16,1
STUDY001,QS,STUDY001-SUBJ0088,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-10-16,1
STUDY001,QS,STUDY001-SUBJ0088,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,53,53,53.0,,,Y,1,BASELINE,2025-10-16,1
STUDY001,QS,STUDY001-SUBJ0088,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-12,28
STUDY001,QS,STUDY001-SUBJ0088,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-12,28
STUDY001,QS,STUDY001-SUBJ0088,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-11-12,28
STUDY001,QS,STUDY001-SUBJ0088,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-11-12,28
STUDY001,QS,STUDY001-SUBJ0088,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-11-12,28
STUDY001,QS,STUDY001-SUBJ0088,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,55,55,55.0,,,,2,WEEK 4,2025-11-12,28
STUDY001,QS,STUDY001-SUBJ0088,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-10,56
STUDY001,QS,STUDY001-SUBJ0088,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-12-10,56
STUDY001,QS,STUDY001-SUBJ0088,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-10,56
STUDY001,QS,STUDY001-SUBJ0088,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-10,56
STUDY001,QS,STUDY001-SUBJ0088,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-12-10,56
STUDY001,QS,STUDY001-SUBJ0088,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,3,WEEK 8,2025-12-10,56
STUDY001,QS,STUDY001-SUBJ0088,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-12-10,56
STUDY001,QS,STUDY001-SUBJ0088,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-10,56
STUDY001,QS,STUDY001-SUBJ0088,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-12-10,56
STUDY001,QS,STUDY001-SUBJ0088,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-12-10,56
STUDY001,QS,STUDY001-SUBJ0088,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,64,64,64.0,,,,3,WEEK 8,2025-12-10,56
STUDY001,QS,STUDY001-SUBJ0089,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-08-22,1
STUDY001,QS,STUDY001-SUBJ0089,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-08-22,1
STUDY001,QS,STUDY001-SUBJ0089,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-08-22,1
STUDY001,QS,STUDY001-SUBJ0089,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-08-22,1
STUDY001,QS,STUDY001-SUBJ0089,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-08-22,1
STUDY001,QS,STUDY001-SUBJ0089,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,34,34,34.0,,,Y,1,BASELINE,2025-08-22,1
STUDY001,QS,STUDY001-SUBJ0089,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-09-18,28
STUDY001,QS,STUDY001-SUBJ0089,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-18,28
STUDY001,QS,STUDY001-SUBJ0089,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-18,28
STUDY001,QS,STUDY001-SUBJ0089,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-18,28
STUDY001,QS,STUDY001-SUBJ0089,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-18,28
STUDY001,QS,STUDY001-SUBJ0089,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,3,WEEK 8,2025-10-16,56
STUDY001,QS,STUDY001-SUBJ0089,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-10-16,56
STUDY001,QS,STUDY001-SUBJ0089,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-16,56
STUDY001,QS,STUDY001-SUBJ0089,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-10-16,56
STUDY001,QS,STUDY001-SUBJ0089,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-16,56
STUDY001,QS,STUDY001-SUBJ0089,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,NOT DONE,,,3,WEEK 8,2025-10-16,56
STUDY001,QS,STUDY001-SUBJ0089,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-10-16,56
STUDY001,QS,STUDY001-SUBJ0089,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-10-16,56
STUDY001,QS,STUDY001-SUBJ0089,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-10-16,56
STUDY001,QS,STUDY001-SUBJ0089,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-10-16,56
STUDY001,QS,STUDY001-SUBJ0089,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,69,69,69.0,NOT DONE,,,3,WEEK 8,2025-10-16,56
STUDY001,QS,STUDY001-SUBJ0089,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,4,WEEK 12,2025-11-13,84
STUDY001,QS,STUDY001-SUBJ0089,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-11-13,84
STUDY001,QS,STUDY001-SUBJ0089,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-11-13,84
STUDY001,QS,STUDY001-SUBJ0089,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-13,84
STUDY001,QS,STUDY001-SUBJ0089,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-11-13,84
STUDY001,QS,STUDY001-SUBJ0089,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-13,84
STUDY001,QS,STUDY001-SUBJ0089,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-11-13,84
STUDY001,QS,STUDY001-SUBJ0089,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-13,84
STUDY001,QS,STUDY001-SUBJ0089,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-11-13,84
STUDY001,QS,STUDY001-SUBJ0089,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-13,84
STUDY001,QS,STUDY001-SUBJ0089,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,82,82,82.0,NOT DONE,,,4,WEEK 12,2025-11-13,84
STUDY001,QS,STUDY001-SUBJ0090,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-04-03,1
STUDY001,QS,STUDY001-SUBJ0090,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-04-03,1
STUDY001,QS,STUDY001-SUBJ0090,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-04-03,1
STUDY001,QS,STUDY001-SUBJ0090,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,NOT DONE,,Y,1,BASELINE,2025-04-03,1
STUDY001,QS,STUDY001-SUBJ0090,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-04-03,1
STUDY001,QS,STUDY001-SUBJ0090,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-04-03,1
STUDY001,QS,STUDY001-SUBJ0090,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-04-03,1
STUDY001,QS,STUDY001-SUBJ0090,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-04-03,1
STUDY001,QS,STUDY001-SUBJ0090,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-04-03,1
STUDY001,QS,STUDY001-SUBJ0090,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-04-03,1
STUDY001,QS,STUDY001-SUBJ0090,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,60,60,60.0,NOT DONE,,Y,1,BASELINE,2025-04-03,1
STUDY001,QS,STUDY001-SUBJ0090,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-04-30,28
STUDY001,QS,STUDY001-SUBJ0090,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-04-30,28
STUDY001,QS,STUDY001-SUBJ0090,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-04-30,28
STUDY001,QS,STUDY001-SUBJ0090,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-04-30,28
STUDY001,QS,STUDY001-SUBJ0090,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-04-30,28
STUDY001,QS,STUDY001-SUBJ0090,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-28,56
STUDY001,QS,STUDY001-SUBJ0090,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-05-28,56
STUDY001,QS,STUDY001-SUBJ0090,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-28,56
STUDY001,QS,STUDY001-SUBJ0090,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-28,56
STUDY001,QS,STUDY001-SUBJ0090,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-05-28,56
STUDY001,QS,STUDY001-SUBJ0090,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-28,56
STUDY001,QS,STUDY001-SUBJ0090,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-05-28,56
STUDY001,QS,STUDY001-SUBJ0090,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,3,WEEK 8,2025-05-28,56
STUDY001,QS,STUDY001-SUBJ0090,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-05-28,56
STUDY001,QS,STUDY001-SUBJ0090,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-05-28,56
STUDY001,QS,STUDY001-SUBJ0090,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,70,70,70.0,,,,3,WEEK 8,2025-05-28,56
STUDY001,QS,STUDY001-SUBJ0090,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,5,END OF TREATMENT,2025-08-20,140
STUDY001,QS,STUDY001-SUBJ0090,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-08-20,140
STUDY001,QS,STUDY001-SUBJ0090,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-20,140
STUDY001,QS,STUDY001-SUBJ0090,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-20,140
STUDY001,QS,STUDY001-SUBJ0090,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-08-20,140
STUDY001,QS,STUDY001-SUBJ0090,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-20,140
STUDY001,QS,STUDY001-SUBJ0090,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-08-20,140
STUDY001,QS,STUDY001-SUBJ0090,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-20,140
STUDY001,QS,STUDY001-SUBJ0090,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-08-20,140
STUDY001,QS,STUDY001-SUBJ0090,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-08-20,140
STUDY001,QS,STUDY001-SUBJ0090,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-08-20,140
STUDY001,QS,STUDY001-SUBJ0091,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-08-17,1
STUDY001,QS,STUDY001-SUBJ0091,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-08-17,1
STUDY001,QS,STUDY001-SUBJ0091,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-08-17,1
STUDY001,QS,STUDY001-SUBJ0091,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-08-17,1
STUDY001,QS,STUDY001-SUBJ0091,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-08-17,1
STUDY001,QS,STUDY001-SUBJ0091,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-08-17,1
STUDY001,QS,STUDY001-SUBJ0091,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-08-17,1
STUDY001,QS,STUDY001-SUBJ0091,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-08-17,1
STUDY001,QS,STUDY001-SUBJ0091,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-08-17,1
STUDY001,QS,STUDY001-SUBJ0091,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-08-17,1
STUDY001,QS,STUDY001-SUBJ0091,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,63,63,63.0,,,Y,1,BASELINE,2025-08-17,1
STUDY001,QS,STUDY001-SUBJ0091,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,2,WEEK 4,2025-09-13,28
STUDY001,QS,STUDY001-SUBJ0091,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-09-13,28
STUDY001,QS,STUDY001-SUBJ0091,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-09-13,28
STUDY001,QS,STUDY001-SUBJ0091,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-13,28
STUDY001,QS,STUDY001-SUBJ0091,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-09-13,28
STUDY001,QS,STUDY001-SUBJ0091,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-13,28
STUDY001,QS,STUDY001-SUBJ0091,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-09-13,28
STUDY001,QS,STUDY001-SUBJ0091,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-13,28
STUDY001,QS,STUDY001-SUBJ0091,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-09-13,28
STUDY001,QS,STUDY001-SUBJ0091,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-09-13,28
STUDY001,QS,STUDY001-SUBJ0091,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,61,61,61.0,,,,2,WEEK 4,2025-09-13,28
STUDY001,QS,STUDY001-SUBJ0091,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-11,56
STUDY001,QS,STUDY001-SUBJ0091,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-10-11,56
STUDY001,QS,STUDY001-SUBJ0091,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-11,56
STUDY001,QS,STUDY001-SUBJ0091,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-10-11,56
STUDY001,QS,STUDY001-SUBJ0091,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-11,56
STUDY001,QS,STUDY001-SUBJ0091,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-10-11,56
STUDY001,QS,STUDY001-SUBJ0091,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-10-11,56
STUDY001,QS,STUDY001-SUBJ0091,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-10-11,56
STUDY001,QS,STUDY001-SUBJ0091,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-10-11,56
STUDY001,QS,STUDY001-SUBJ0091,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-10-11,56
STUDY001,QS,STUDY001-SUBJ0091,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,69,69,69.0,,,,3,WEEK 8,2025-10-11,56
STUDY001,QS,STUDY001-SUBJ0091,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-11-08,84
STUDY001,QS,STUDY001-SUBJ0091,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-11-08,84
STUDY001,QS,STUDY001-SUBJ0091,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-11-08,84
STUDY001,QS,STUDY001-SUBJ0091,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-11-08,84
STUDY001,QS,STUDY001-SUBJ0091,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-11-08,84
STUDY001,QS,STUDY001-SUBJ0091,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,89,89,89.0,,,,4,WEEK 12,2025-11-08,84
STUDY001,QS,STUDY001-SUBJ0092,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-01-18,1
STUDY001,QS,STUDY001-SUBJ0092,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-01-18,1
STUDY001,QS,STUDY001-SUBJ0092,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-01-18,1
STUDY001,QS,STUDY001-SUBJ0092,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-01-18,1
STUDY001,QS,STUDY001-SUBJ0092,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-01-18,1
STUDY001,QS,STUDY001-SUBJ0092,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,36,36,36.0,,,Y,1,BASELINE,2025-01-18,1
STUDY001,QS,STUDY001-SUBJ0092,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-02-14,28
STUDY001,QS,STUDY001-SUBJ0092,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-02-14,28
STUDY001,QS,STUDY001-SUBJ0092,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-02-14,28
STUDY001,QS,STUDY001-SUBJ0092,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-14,28
STUDY001,QS,STUDY001-SUBJ0092,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-02-14,28
STUDY001,QS,STUDY001-SUBJ0092,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-14,28
STUDY001,QS,STUDY001-SUBJ0092,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-02-14,28
STUDY001,QS,STUDY001-SUBJ0092,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-14,28
STUDY001,QS,STUDY001-SUBJ0092,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-02-14,28
STUDY001,QS,STUDY001-SUBJ0092,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-02-14,28
STUDY001,QS,STUDY001-SUBJ0092,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,57,57,57.0,,,,2,WEEK 4,2025-02-14,28
STUDY001,QS,STUDY001-SUBJ0092,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-14,56
STUDY001,QS,STUDY001-SUBJ0092,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-03-14,56
STUDY001,QS,STUDY001-SUBJ0092,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-14,56
STUDY001,QS,STUDY001-SUBJ0092,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-14,56
STUDY001,QS,STUDY001-SUBJ0092,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-03-14,56
STUDY001,QS,STUDY001-SUBJ0092,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-14,56
STUDY001,QS,STUDY001-SUBJ0092,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-03-14,56
STUDY001,QS,STUDY001-SUBJ0092,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-14,56
STUDY001,QS,STUDY001-SUBJ0092,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-03-14,56
STUDY001,QS,STUDY001-SUBJ0092,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-03-14,56
STUDY001,QS,STUDY001-SUBJ0092,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,70,70,70.0,,,,3,WEEK 8,2025-03-14,56
STUDY001,QS,STUDY001-SUBJ0092,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-11,84
STUDY001,QS,STUDY001-SUBJ0092,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-04-11,84
STUDY001,QS,STUDY001-SUBJ0092,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-11,84
STUDY001,QS,STUDY001-SUBJ0092,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-11,84
STUDY001,QS,STUDY001-SUBJ0092,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-04-11,84
STUDY001,QS,STUDY001-SUBJ0092,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-11,84
STUDY001,QS,STUDY001-SUBJ0092,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-04-11,84
STUDY001,QS,STUDY001-SUBJ0092,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-11,84
STUDY001,QS,STUDY001-SUBJ0092,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-04-11,84
STUDY001,QS,STUDY001-SUBJ0092,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-04-11,84
STUDY001,QS,STUDY001-SUBJ0092,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-04-11,84
STUDY001,QS,STUDY001-SUBJ0092,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-06,140
STUDY001,QS,STUDY001-SUBJ0092,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-06-06,140
STUDY001,QS,STUDY001-SUBJ0092,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-06,140
STUDY001,QS,STUDY001-SUBJ0092,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-06,140
STUDY001,QS,STUDY001-SUBJ0092,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-06-06,140
STUDY001,QS,STUDY001-SUBJ0092,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-06,140
STUDY001,QS,STUDY001-SUBJ0092,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-06-06,140
STUDY001,QS,STUDY001-SUBJ0092,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-06,140
STUDY001,QS,STUDY001-SUBJ0092,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-06-06,140
STUDY001,QS,STUDY001-SUBJ0092,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-06-06,140
STUDY001,QS,STUDY001-SUBJ0092,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-06-06,140
STUDY001,QS,STUDY001-SUBJ0093,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-08-20,1
STUDY001,QS,STUDY001-SUBJ0093,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-08-20,1
STUDY001,QS,STUDY001-SUBJ0093,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-08-20,1
STUDY001,QS,STUDY001-SUBJ0093,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-08-20,1
STUDY001,QS,STUDY001-SUBJ0093,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,Y,1,BASELINE,2025-08-20,1
STUDY001,QS,STUDY001-SUBJ0093,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-08-20,1
STUDY001,QS,STUDY001-SUBJ0093,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,Y,1,BASELINE,2025-08-20,1
STUDY001,QS,STUDY001-SUBJ0093,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-08-20,1
STUDY001,QS,STUDY001-SUBJ0093,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,Y,1,BASELINE,2025-08-20,1
STUDY001,QS,STUDY001-SUBJ0093,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-08-20,1
STUDY001,QS,STUDY001-SUBJ0093,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,65,65,65.0,,,Y,1,BASELINE,2025-08-20,1
STUDY001,QS,STUDY001-SUBJ0093,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-09-16,28
STUDY001,QS,STUDY001-SUBJ0093,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,NOT DONE,,,2,WEEK 4,2025-09-16,28
STUDY001,QS,STUDY001-SUBJ0093,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-09-16,28
STUDY001,QS,STUDY001-SUBJ0093,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-09-16,28
STUDY001,QS,STUDY001-SUBJ0093,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-09-16,28
STUDY001,QS,STUDY001-SUBJ0093,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-09-16,28
STUDY001,QS,STUDY001-SUBJ0093,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-09-16,28
STUDY001,QS,STUDY001-SUBJ0093,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-09-16,28
STUDY001,QS,STUDY001-SUBJ0093,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-09-16,28
STUDY001,QS,STUDY001-SUBJ0093,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-09-16,28
STUDY001,QS,STUDY001-SUBJ0093,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,61,61,61.0,,,,2,WEEK 4,2025-09-16,28
STUDY001,QS,STUDY001-SUBJ0093,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-14,56
STUDY001,QS,STUDY001-SUBJ0093,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-10-14,56
STUDY001,QS,STUDY001-SUBJ0093,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-14,56
STUDY001,QS,STUDY001-SUBJ0093,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-10-14,56
STUDY001,QS,STUDY001-SUBJ0093,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-14,56
STUDY001,QS,STUDY001-SUBJ0093,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-10-14,56
STUDY001,QS,STUDY001-SUBJ0093,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-10-14,56
STUDY001,QS,STUDY001-SUBJ0093,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-10-14,56
STUDY001,QS,STUDY001-SUBJ0093,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-10-14,56
STUDY001,QS,STUDY001-SUBJ0093,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-10-14,56
STUDY001,QS,STUDY001-SUBJ0093,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,68,68,68.0,,,,3,WEEK 8,2025-10-14,56
STUDY001,QS,STUDY001-SUBJ0093,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-11-11,84
STUDY001,QS,STUDY001-SUBJ0093,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-11-11,84
STUDY001,QS,STUDY001-SUBJ0093,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-11-11,84
STUDY001,QS,STUDY001-SUBJ0093,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-11,84
STUDY001,QS,STUDY001-SUBJ0093,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-11-11,84
STUDY001,QS,STUDY001-SUBJ0093,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,4,WEEK 12,2025-11-11,84
STUDY001,QS,STUDY001-SUBJ0093,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-11-11,84
STUDY001,QS,STUDY001-SUBJ0093,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-11,84
STUDY001,QS,STUDY001-SUBJ0093,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-11-11,84
STUDY001,QS,STUDY001-SUBJ0093,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-11,84
STUDY001,QS,STUDY001-SUBJ0093,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,83,83,83.0,,,,4,WEEK 12,2025-11-11,84
STUDY001,QS,STUDY001-SUBJ0094,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-02-17,1
STUDY001,QS,STUDY001-SUBJ0094,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-02-17,1
STUDY001,QS,STUDY001-SUBJ0094,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-02-17,1
STUDY001,QS,STUDY001-SUBJ0094,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-02-17,1
STUDY001,QS,STUDY001-SUBJ0094,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-02-17,1
STUDY001,QS,STUDY001-SUBJ0094,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-02-17,1
STUDY001,QS,STUDY001-SUBJ0094,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,,,Y,1,BASELINE,2025-02-17,1
STUDY001,QS,STUDY001-SUBJ0094,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-02-17,1
STUDY001,QS,STUDY001-SUBJ0094,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-02-17,1
STUDY001,QS,STUDY001-SUBJ0094,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-02-17,1
STUDY001,QS,STUDY001-SUBJ0094,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,31,31,31.0,,,Y,1,BASELINE,2025-02-17,1
STUDY001,QS,STUDY001-SUBJ0094,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-03-16,28
STUDY001,QS,STUDY001-SUBJ0094,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-16,28
STUDY001,QS,STUDY001-SUBJ0094,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-16,28
STUDY001,QS,STUDY001-SUBJ0094,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-03-16,28
STUDY001,QS,STUDY001-SUBJ0094,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,NOT DONE,,,2,WEEK 4,2025-03-16,28
STUDY001,QS,STUDY001-SUBJ0094,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-13,56
STUDY001,QS,STUDY001-SUBJ0094,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-04-13,56
STUDY001,QS,STUDY001-SUBJ0094,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-13,56
STUDY001,QS,STUDY001-SUBJ0094,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-13,56
STUDY001,QS,STUDY001-SUBJ0094,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-04-13,56
STUDY001,QS,STUDY001-SUBJ0094,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-13,56
STUDY001,QS,STUDY001-SUBJ0094,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-04-13,56
STUDY001,QS,STUDY001-SUBJ0094,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-13,56
STUDY001,QS,STUDY001-SUBJ0094,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-04-13,56
STUDY001,QS,STUDY001-SUBJ0094,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-04-13,56
STUDY001,QS,STUDY001-SUBJ0094,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,64,64,64.0,,,,3,WEEK 8,2025-04-13,56
STUDY001,QS,STUDY001-SUBJ0094,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-11,84
STUDY001,QS,STUDY001-SUBJ0094,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-05-11,84
STUDY001,QS,STUDY001-SUBJ0094,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-11,84
STUDY001,QS,STUDY001-SUBJ0094,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-11,84
STUDY001,QS,STUDY001-SUBJ0094,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-05-11,84
STUDY001,QS,STUDY001-SUBJ0094,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-11,84
STUDY001,QS,STUDY001-SUBJ0094,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-05-11,84
STUDY001,QS,STUDY001-SUBJ0094,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-11,84
STUDY001,QS,STUDY001-SUBJ0094,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-05-11,84
STUDY001,QS,STUDY001-SUBJ0094,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-05-11,84
STUDY001,QS,STUDY001-SUBJ0094,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-05-11,84
STUDY001,QS,STUDY001-SUBJ0094,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-06,140
STUDY001,QS,STUDY001-SUBJ0094,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-07-06,140
STUDY001,QS,STUDY001-SUBJ0094,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-06,140
STUDY001,QS,STUDY001-SUBJ0094,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-06,140
STUDY001,QS,STUDY001-SUBJ0094,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-07-06,140
STUDY001,QS,STUDY001-SUBJ0094,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-06,140
STUDY001,QS,STUDY001-SUBJ0094,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-07-06,140
STUDY001,QS,STUDY001-SUBJ0094,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-06,140
STUDY001,QS,STUDY001-SUBJ0094,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-07-06,140
STUDY001,QS,STUDY001-SUBJ0094,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-07-06,140
STUDY001,QS,STUDY001-SUBJ0094,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-07-06,140
STUDY001,QS,STUDY001-SUBJ0095,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-12-06,1
STUDY001,QS,STUDY001-SUBJ0095,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-12-06,1
STUDY001,QS,STUDY001-SUBJ0095,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-12-06,1
STUDY001,QS,STUDY001-SUBJ0095,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-12-06,1
STUDY001,QS,STUDY001-SUBJ0095,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-12-06,1
STUDY001,QS,STUDY001-SUBJ0096,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0096,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0096,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0096,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0096,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-04-26,1
STUDY001,QS,STUDY001-SUBJ0096,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0096,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0096,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0096,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0096,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0096,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0096,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0096,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0096,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0096,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0096,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,61,61,61.0,,,,2,WEEK 4,2025-05-23,28
STUDY001,QS,STUDY001-SUBJ0096,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0096,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0096,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0096,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0096,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0096,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0096,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,NOT DONE,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0096,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0096,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0096,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0096,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,70,70,70.0,,,,3,WEEK 8,2025-06-20,56
STUDY001,QS,STUDY001-SUBJ0096,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0096,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0096,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0096,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0096,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0096,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0096,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0096,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0096,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0096,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0096,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-07-18,84
STUDY001,QS,STUDY001-SUBJ0096,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0096,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0096,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0096,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0096,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0096,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0096,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0096,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0096,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0096,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0096,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-09-12,140
STUDY001,QS,STUDY001-SUBJ0097,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-08-13,1
STUDY001,QS,STUDY001-SUBJ0097,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-08-13,1
STUDY001,QS,STUDY001-SUBJ0097,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-08-13,1
STUDY001,QS,STUDY001-SUBJ0097,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-08-13,1
STUDY001,QS,STUDY001-SUBJ0097,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-08-13,1
STUDY001,QS,STUDY001-SUBJ0097,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-08-13,1
STUDY001,QS,STUDY001-SUBJ0097,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-08-13,1
STUDY001,QS,STUDY001-SUBJ0097,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-08-13,1
STUDY001,QS,STUDY001-SUBJ0097,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-08-13,1
STUDY001,QS,STUDY001-SUBJ0097,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-08-13,1
STUDY001,QS,STUDY001-SUBJ0097,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,59,59,59.0,,,Y,1,BASELINE,2025-08-13,1
STUDY001,QS,STUDY001-SUBJ0097,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-09-09,28
STUDY001,QS,STUDY001-SUBJ0097,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,,2,WEEK 4,2025-09-09,28
STUDY001,QS,STUDY001-SUBJ0097,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-09-09,28
STUDY001,QS,STUDY001-SUBJ0097,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-09-09,28
STUDY001,QS,STUDY001-SUBJ0097,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,,2,WEEK 4,2025-09-09,28
STUDY001,QS,STUDY001-SUBJ0097,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-09-09,28
STUDY001,QS,STUDY001-SUBJ0097,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,,2,WEEK 4,2025-09-09,28
STUDY001,QS,STUDY001-SUBJ0097,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-09-09,28
STUDY001,QS,STUDY001-SUBJ0097,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,,2,WEEK 4,2025-09-09,28
STUDY001,QS,STUDY001-SUBJ0097,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,,2,WEEK 4,2025-09-09,28
STUDY001,QS,STUDY001-SUBJ0097,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,56,56,56.0,,,,2,WEEK 4,2025-09-09,28
STUDY001,QS,STUDY001-SUBJ0097,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-07,56
STUDY001,QS,STUDY001-SUBJ0097,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-07,56
STUDY001,QS,STUDY001-SUBJ0097,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-10-07,56
STUDY001,QS,STUDY001-SUBJ0097,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-10-07,56
STUDY001,QS,STUDY001-SUBJ0097,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-10-07,56
STUDY001,QS,STUDY001-SUBJ0097,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,68,68,68.0,,,,3,WEEK 8,2025-10-07,56
STUDY001,QS,STUDY001-SUBJ0097,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-11-04,84
STUDY001,QS,STUDY001-SUBJ0097,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-11-04,84
STUDY001,QS,STUDY001-SUBJ0097,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-11-04,84
STUDY001,QS,STUDY001-SUBJ0097,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-04,84
STUDY001,QS,STUDY001-SUBJ0097,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,4,WEEK 12,2025-11-04,84
STUDY001,QS,STUDY001-SUBJ0097,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-04,84
STUDY001,QS,STUDY001-SUBJ0097,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,4,WEEK 12,2025-11-04,84
STUDY001,QS,STUDY001-SUBJ0097,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-04,84
STUDY001,QS,STUDY001-SUBJ0097,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,4,WEEK 12,2025-11-04,84
STUDY001,QS,STUDY001-SUBJ0097,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-11-04,84
STUDY001,QS,STUDY001-SUBJ0097,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,76,76,76.0,,,,4,WEEK 12,2025-11-04,84
STUDY001,QS,STUDY001-SUBJ0098,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-11-25,1
STUDY001,QS,STUDY001-SUBJ0098,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,FREQUENTLY,FREQUENTLY,4.0,,,Y,1,BASELINE,2025-11-25,1
STUDY001,QS,STUDY001-SUBJ0098,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-11-25,1
STUDY001,QS,STUDY001-SUBJ0098,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-25,1
STUDY001,QS,STUDY001-SUBJ0098,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SEVERE PROBLEMS,SEVERE PROBLEMS,4.0,,,Y,1,BASELINE,2025-11-25,1
STUDY001,QS,STUDY001-SUBJ0098,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-25,1
STUDY001,QS,STUDY001-SUBJ0098,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SEVERE PAIN,SEVERE PAIN,4.0,NOT DONE,,Y,1,BASELINE,2025-11-25,1
STUDY001,QS,STUDY001-SUBJ0098,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,,,Y,1,BASELINE,2025-11-25,1
STUDY001,QS,STUDY001-SUBJ0098,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SEVERELY ANXIOUS,SEVERELY ANXIOUS,4.0,,,Y,1,BASELINE,2025-11-25,1
STUDY001,QS,STUDY001-SUBJ0098,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,SEVERE,SEVERE,4.0,NOT DONE,,Y,1,BASELINE,2025-11-25,1
STUDY001,QS,STUDY001-SUBJ0098,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,37,37,37.0,,,Y,1,BASELINE,2025-11-25,1
STUDY001,QS,STUDY001-SUBJ0099,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-28,1
STUDY001,QS,STUDY001-SUBJ0099,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,Y,1,BASELINE,2025-04-28,1
STUDY001,QS,STUDY001-SUBJ0099,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-28,1
STUDY001,QS,STUDY001-SUBJ0099,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-28,1
STUDY001,QS,STUDY001-SUBJ0099,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-04-28,1
STUDY001,QS,STUDY001-SUBJ0099,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-28,1
STUDY001,QS,STUDY001-SUBJ0099,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,,,Y,1,BASELINE,2025-04-28,1
STUDY001,QS,STUDY001-SUBJ0099,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-28,1
STUDY001,QS,STUDY001-SUBJ0099,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-04-28,1
STUDY001,QS,STUDY001-SUBJ0099,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,Y,1,BASELINE,2025-04-28,1
STUDY001,QS,STUDY001-SUBJ0099,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,58,58,58.0,,,Y,1,BASELINE,2025-04-28,1
STUDY001,QS,STUDY001-SUBJ0099,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-05-25,28
STUDY001,QS,STUDY001-SUBJ0099,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-05-25,28
STUDY001,QS,STUDY001-SUBJ0099,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-05-25,28
STUDY001,QS,STUDY001-SUBJ0099,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-25,28
STUDY001,QS,STUDY001-SUBJ0099,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-05-25,28
STUDY001,QS,STUDY001-SUBJ0099,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-25,28
STUDY001,QS,STUDY001-SUBJ0099,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-05-25,28
STUDY001,QS,STUDY001-SUBJ0099,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-25,28
STUDY001,QS,STUDY001-SUBJ0099,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-05-25,28
STUDY001,QS,STUDY001-SUBJ0099,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-05-25,28
STUDY001,QS,STUDY001-SUBJ0099,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,60,60,60.0,,,,2,WEEK 4,2025-05-25,28
STUDY001,QS,STUDY001-SUBJ0099,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-22,56
STUDY001,QS,STUDY001-SUBJ0099,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,3,WEEK 8,2025-06-22,56
STUDY001,QS,STUDY001-SUBJ0099,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-22,56
STUDY001,QS,STUDY001-SUBJ0099,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-22,56
STUDY001,QS,STUDY001-SUBJ0099,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-06-22,56
STUDY001,QS,STUDY001-SUBJ0099,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-22,56
STUDY001,QS,STUDY001-SUBJ0099,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-06-22,56
STUDY001,QS,STUDY001-SUBJ0099,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-22,56
STUDY001,QS,STUDY001-SUBJ0099,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-06-22,56
STUDY001,QS,STUDY001-SUBJ0099,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,3,WEEK 8,2025-06-22,56
STUDY001,QS,STUDY001-SUBJ0099,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,74,74,74.0,,,,3,WEEK 8,2025-06-22,56
STUDY001,QS,STUDY001-SUBJ0099,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-20,84
STUDY001,QS,STUDY001-SUBJ0099,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-07-20,84
STUDY001,QS,STUDY001-SUBJ0099,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-20,84
STUDY001,QS,STUDY001-SUBJ0099,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-20,84
STUDY001,QS,STUDY001-SUBJ0099,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-07-20,84
STUDY001,QS,STUDY001-SUBJ0099,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-20,84
STUDY001,QS,STUDY001-SUBJ0099,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-07-20,84
STUDY001,QS,STUDY001-SUBJ0099,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-20,84
STUDY001,QS,STUDY001-SUBJ0099,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-07-20,84
STUDY001,QS,STUDY001-SUBJ0099,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-07-20,84
STUDY001,QS,STUDY001-SUBJ0099,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,4,WEEK 12,2025-07-20,84
STUDY001,QS,STUDY001-SUBJ0099,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-14,140
STUDY001,QS,STUDY001-SUBJ0099,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-09-14,140
STUDY001,QS,STUDY001-SUBJ0099,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-14,140
STUDY001,QS,STUDY001-SUBJ0099,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-14,140
STUDY001,QS,STUDY001-SUBJ0099,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-09-14,140
STUDY001,QS,STUDY001-SUBJ0099,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-14,140
STUDY001,QS,STUDY001-SUBJ0099,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-09-14,140
STUDY001,QS,STUDY001-SUBJ0099,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-14,140
STUDY001,QS,STUDY001-SUBJ0099,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-09-14,140
STUDY001,QS,STUDY001-SUBJ0099,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-09-14,140
STUDY001,QS,STUDY001-SUBJ0099,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-09-14,140
STUDY001,QS,STUDY001-SUBJ0100,1,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0100,1,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,OCCASIONALLY,OCCASIONALLY,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0100,2,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0100,2,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0100,3,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,MODERATE PROBLEMS,MODERATE PROBLEMS,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0100,3,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0100,4,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,MODERATE PAIN,MODERATE PAIN,3.0,NOT DONE,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0100,4,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0100,5,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,MODERATELY ANXIOUS,MODERATELY ANXIOUS,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0100,5,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MODERATE,MODERATE,3.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0100,6,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,48,48,48.0,,,Y,1,BASELINE,2025-08-04,1
STUDY001,QS,STUDY001-SUBJ0100,101,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0100,101,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0100,102,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0100,102,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0100,103,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0100,103,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0100,104,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0100,104,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0100,105,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0100,105,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0100,106,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,62,62,62.0,,,,2,WEEK 4,2025-08-31,28
STUDY001,QS,STUDY001-SUBJ0100,201,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0100,201,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,RARELY,RARELY,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0100,202,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0100,202,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0100,203,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PROBLEMS,SLIGHT PROBLEMS,2.0,NOT DONE,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0100,203,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0100,204,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,SLIGHT PAIN,SLIGHT PAIN,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0100,204,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0100,205,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,SLIGHTLY ANXIOUS,SLIGHTLY ANXIOUS,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0100,205,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,MILD,MILD,2.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0100,206,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,73,73,73.0,,,,3,WEEK 8,2025-09-28,56
STUDY001,QS,STUDY001-SUBJ0100,301,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0100,301,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0100,302,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,NOT DONE,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0100,302,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0100,303,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0100,303,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0100,304,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0100,304,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0100,305,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0100,305,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0100,306,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,86,86,86.0,,,,4,WEEK 12,2025-10-26,84
STUDY001,QS,STUDY001-SUBJ0100,401,MOB,Mobility,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-21,140
STUDY001,QS,STUDY001-SUBJ0100,401,NAUSEA,Nausea Frequency,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NEVER,NEVER,1.0,,,,5,END OF TREATMENT,2025-12-21,140
STUDY001,QS,STUDY001-SUBJ0100,402,SC,Self-Care,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-21,140
STUDY001,QS,STUDY001-SUBJ0100,402,PAIN,Pain Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-21,140
STUDY001,QS,STUDY001-SUBJ0100,403,UA,Usual Activities,EQ-5D-5L,Health-Related Quality of Life,NO PROBLEMS,NO PROBLEMS,1.0,,,,5,END OF TREATMENT,2025-12-21,140
STUDY001,QS,STUDY001-SUBJ0100,403,FATIGUE,Fatigue Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-21,140
STUDY001,QS,STUDY001-SUBJ0100,404,PD,Pain/Discomfort,EQ-5D-5L,Health-Related Quality of Life,NO PAIN,NO PAIN,1.0,,,,5,END OF TREATMENT,2025-12-21,140
STUDY001,QS,STUDY001-SUBJ0100,404,SLEEP,Sleep Problems,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,NOT DONE,,,5,END OF TREATMENT,2025-12-21,140
STUDY001,QS,STUDY001-SUBJ0100,405,AD,Anxiety/Depression,EQ-5D-5L,Health-Related Quality of Life,NOT ANXIOUS,NOT ANXIOUS,1.0,,,,5,END OF TREATMENT,2025-12-21,140
STUDY001,QS,STUDY001-SUBJ0100,405,ANXIETY,Anxiety Severity,PRO-CTCAE,Patient-Reported Outcomes Version of the CTCAE,NONE,NONE,1.0,,,,5,END OF TREATMENT,2025-12-21,140
STUDY001,QS,STUDY001-SUBJ0100,406,VAS,Health Today (VAS),EQ-5D-5L,Health-Related Quality of Life,90,90,90.0,,,,5,END OF TREATMENT,2025-12-21,140
